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Abstract 
 
Invasive aspergillosis is a major cause of morbidity and mortality in acute myeloid leukaemia (AML) 
(1–3) and Aspergillus fumigatus has been identified as the most common species causing invasive 
disease in these patients (2,4). The adoptive transfer of natural killer (NK) cells has been described as 
a promising therapeutic tool for AML (5,6) and it has been suggested as an attractive strategy in the 
prophylaxis of common infections in these patients. This PhD aimed to characterize the human NK cell 
response to A. fumigatus in order to assess the potential use of these cells to prevent this fungal 
infection.  
The interaction between NK cells and A. fumigatus in vitro resulted in cell adherence to the fungus, 
polarization of the lytic granules towards A. fumigatus, NK cell degranulation and chemokine release. 
The co-culture of NK cells and A. fumigatus also resulted in CD56 downregulation on NK cell surface, 
a process that might represent a novel mechanism of immune evasion for A. fumigatus. 
The analysis of NK cell antifungal activity demonstrated that NK cells do not contain fungal growth, 
however the cells have shown to induce fungal DNA release that has been associated to fungal damage 
(7,8) and might mediate immune cell activation since pathogen-derived DNA has been shown to 
stimulate the widely expressed TLR9 receptor (9–11).  
AML-derived NK cells were shown to maintain their ability to polarize the lytic granules towards A. 
fumigatus and to induce fungal DNA release.  
In conclusion, my findings suggest that the role of NK cells in the immune response against A. 
fumigatus infection might be indirect, through the recruitment of immune cells to the site of infection 
and the induction of immune cell activation mediated by fungal DNA. Therefore, my results suggest 
that the infusion of NK cells on their own would be insufficient to control A. fumigatus infection in 
AML patients.  
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Glossary of terms 
 
Resting conidia – with a size of 2-3μm, resting conidia disperse easily into the air and are able to survive 
in hostile environments. The outermost cell-wall layer of Aspergillus fumigatus resting conidia is 
composed of regularly arranged RodA hydrophobin proteins, conferring to the conidia hydrophobic 
properties and masking the underlying cell wall components (12,13). In addition to the hydrophobin 
layer, resting conidia are coated in a greyish-green melanin layer that forms a dense layer on the 
resting conidia surface and protects the fungal DNA from alteration by ultraviolet light and oxidation 
(14). Resting conidia are considered metabolically inactive and are largely inert towards recognition 
by the immune system (15).  
 
Swollen conidia – under the right conditions of water, carbon and oxygen, Aspergillus fumigatus 
conidia undergo a period of isotropic growth (swelling). Isotropic growth is characterized by an 
increase in spore volume, a process during which the fungal cell wall undergoes extensive remodelling 
(16). Swelling conidia loose the hydrophobin and melanin layer resulting in the exposure of their 
underlying cell wall components (17). A. fumigatus cell wall is mainly composed of polysaccharides 
including β(1,3)- and β(1,4)-glucans, α(1,3)-glucan, chitin and galactomannans. Only a few proteins are 
thought to be stably present in the cell wall layer, but they can play an important role in the interaction 
with the host, especially as antigens/allergens, adhesins or immunomodulators (18,19). 
 
Germling – the appearance of a small protuberance on the conidial cell wall initiates the polarized 
growth of Aspergillus fumigatus. An axis of polarity is established following gradients of nutrients and 
chemo attractants, or to avoid adverse habitats and is maintained as the germling elongates by tip 
growth (20,21). Polarity establishment is followed by a redirection of the cellular machinery needed 
to make new plasma membrane and cell wall at the chosen site (22).  
 
Hyphae - multicellular and multinucleated structures, internally divided in compartments separated 
by internal cross-walls called septa. Compartments can communicate with each other via a septal pore 
that is large enough to allow organelles, proteins and metabolites to be transported from one 
compartment to the other (16).  
 
Conidiophore – specialized hyphal branch with a foot cell and a spore head covered with 
conidiogenous cells that produce asexual spores by mitotic divisions. Aspergillus fumigatus 
conidiophores are up to 300μm in length, usually more or less green coloured and are able to produce 
and disperse hundreds of fresh conidia (23). 
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1. Introduction 
 
1.1 Natural Killer cells 
Natural Killer (NK) cells are highly sophisticated sentinels of the innate immune system with a crucial 
role in tumour surveillance and responses to a diverse range of pathogens (24–26). NK cells are also 
important regulatory cells engaged in reciprocal interactions with dendritic cells, 
monocytes/macrophages and T cells (27–29). 
NK cells are large granular lymphocytes and represent approximately 10-15% of all peripheral blood 
lymphocytes. Two major functionally distinct NK cell subsets can be distinguished in human peripheral 
blood based on the relative expression of the adhesion molecule CD56 (30). Over 90% of circulating 
NK cells express low levels of CD56 and high levels of CD16 and are denominated as the 
CD56dimCD16bright subset. This population also expresses KIR receptors and represent the most 
differentiated and mature NK cells with high cytotoxicity capacity (31). The remaining 10% are the 
CD56brightCD16- subset and are characterized by high expression of CD56 and absent of CD16. These 
NK cells are the precursors of the more mature NK cells and have low or absent levels of KIR receptors 
(32). CD56brightCD16- cells display relatively low cytotoxicity ex vivo but greater ability to produce 
proinflammatory cytokines (33). In contrast to blood, the CD56brightCD16- subset are the dominant NK 
cell population in human lymph nodes (34).  
NK cell function is tightly controlled by a wide array of activating and inhibitory receptors. NK cell 
target recognition is a very complex process but much progress has been made in the dissection of 
the mechanisms that allow NK cells to discriminate target cells from healthy cells. Three recognition 
models were proposed and together might explain the dynamic of NK cell activation. The proposed 
models are based on the different classes of ligands recognized by NK cells, which are ‘stress-induced 
self’, ‘non-self’ and ‘self’ ligands.  
Stress-induced self ligands are generally not constitutively expressed on normal cells but can be 
induced by stress and upregulated on tumors and virally infected cells (35,36). MICA, MICB and ULBP 
proteins are distant homologs of major histocompatibility complex (MHC) class I that have no function 
in antigen presentation (37,38). These human stress-induced ligands are recognized by the NKG2D 
receptor leading to NK cell activation (38,39).  
Non-self ligands are pathogen-encoded molecules that are not expressed by the host. Recently it was 
demonstrated that NK cells express pattern recognition receptors (PRRs) including members of the 
Toll-like receptors (TLRs) family capable of directly detecting viral and bacterial pattern-associated 
molecular patterns (PAMPs) (40). 
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An important feature of NK cells is their ability to distinguish target cells from healthy cells. This ability 
is due to the expression of inhibitory receptors that recognize self MHC class I molecules (41). The 
recognition of MHC class I molecules by NK cells and the consequent inhibition of NK cell activation, 
is a mechanism that ensures NK cell tolerance to self (42). Under stress conditions, such as virus 
infection or tumour transformation, MHC class I expression is downregulated and NK cells lose 
inhibitory signalling resulting in NK cell activation by a process called ‘missing-self recognition’ (43).  
NK cell responses are mediated by two major effector functions, the direct cytolysis of target cells and 
production of chemokines and cytokines.  
 
1.1.1 Cytotoxic mechanisms of NK cells 
NK cell response is mediated by several mechanisms, including release of cytotoxic granules containing 
perforin, granzymes and granulysin, triggering of FAS-mediated apoptosis, and TNF-related apoptosis-
inducing ligand (TRAIL)-dependent cytotoxicity. NK cells also secrete pro-inflammatory cytokines such 
as interferon gamma (IFN-γ) and tumour-necrosis factor alpha (TNF-α) (44).    
NK cell function is tightly controlled by a wide array of activating and inhibitory receptors. Upon 
interaction with specific ligands, a multiplicity of activating receptors can induce NK cell activation. 
The first step in the complex process of NK cell activation is the induction of signals for adhesion. 
Engagement of the lymphocyte function-associated antigen-1 (LFA-1) mediates firm adhesion, 
provides signals for granule polarization and orchestrates the structure of an immunological synapse 
that facilitates efficient target cell killing (45,46). The release of the cytotoxic granules (degranulation) 
and cytokine and chemokine secretion follow different secretory pathways but both pathways require 
Ca2+ influx and phospholipase C-γ (PLC-γ) activation.  
Several studies have revealed a hierarchy in terms of the strength of the activating stimuli for induction 
of specific responses. LFA-1-mediated adhesion exhibit a low threshold for activation, induction of 
chemokines requires stronger activating stimuli, whereas degranulation and production of cytokines 
display the most stringent requirements for induction (47–49).  
 
1.1.1.1 Secretion of cytotoxic granules - Degranulation (CD107a) 
The process of NK cell mediated target lysis involves discrete regulated steps namely adhesion, 
immune synapse formation, granule polarization and exocytosis.  
The initial contact between a NK cell and a target, potentially involves different NK cell receptors. LFA-
1 is presumably involved in the early interaction of NK cells with a potential target, allowing adhesion 
even before the engagement of other receptors. Further recognition of specific ligands by activating 
receptors strengthens the interaction of the NK cells with the target resulting in firm adhesion and 
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activation of intracellular pathways (48). Engagement and activation of LFA-1, initializes the first steps 
of immune synapse (IS) formation, including protein tyrosine kinase activation and filamentous actin 
(F-actin) reorganization (46,50). Accumulation of F-actin at the immune synapse is a prerequisite for 
the cytotoxic function of NK cells (51). The initial signalling cascade also includes the phosphorylation 
of the guanine exchange factor and actin regulator Vav1, its recruitment to lipid rafts and subsequent 
further activation (52). At this point the NK cell is likely still highly sensitive to a balance of activating 
and inhibitory signalling, and control of Vav1 phosphorylation and subsequent actin accumulation is 
thought to be a critical axis in the regulation of cytotoxicity (53,54). 
Talin also plays an important role mediating the adhesion process since it associates with the 
cytoplasmic tail of LFA-1 activating its ligand-binding function, plus it is also required for LFA-1-
mediated outside-in signalling leading to polarization of the actin cytoskeleton (55). Upon interaction 
of LFA-1 with its ligand, talin initiates two signalling pathways. First, talin recruits the actin nucleating 
protein complex Arp2/3 and second, it associates with type I phosphatidylinositol 4-phosphate 5-
kinase (PIPKI) leading to a localized increase of phosphatidylinositol-4, 5-biphoste (PIP2). This increase 
in PIP2 recruits WASP that promotes Arp2/3-mediated actin polymerization (50). This signalling 
cascade precedes the translocation of the granules to the microtubule-organizing centre (MTOC), 
followed by the polarization of the MTOC with associated lytic granules toward the immunological 
synapse (56,57). CD3ζ phosphorylation, SYK recruitment and activation as well as PLC-γ are also 
involved in the granules polarization signalling (58). Polarization of the lytic granules is not equivalent 
to a commitment to their secretion, and several more events are required before the granules fuse 
with the plasma membrane and their content is released into the synaptic cleft (59).  
As opposed to activating receptors that promote adhesion to target cells, inhibitory receptors can 
abrogate target cell adhesion (60). Inhibitory signalling acts swiftly and disrupt multiple points of 
activation, including conjugate formation and F-actin accumulation, LFA-1 activation, activating 
receptor clustering at the IS and critically, Ca2+ flux (48,60–62). Dephosphorylation of the activating 
phospho-tyrosine residues of Vav1 appears to be a critical molecular switch for this control since 
phosphorylated Vav1 is a substrate of SHP-1, but this response is likely fine-tuned by other factors 
(53,54). Microscopic analysis of the NK cell synapse, showed that activating receptors such as NKG2D 
and CD16, as well as the inhibitory receptor KIR2DL1 accumulate in small aggregates termed 
microclusters (61,63,64). The activation of KIR2DL2 induces the rapid formation of inhibitory receptor 
microclusters and simultaneously supress microclusters containing activating receptors, abrogating 
NK cell cytotoxic response (63).  
After polarizing to the IS and before exocytosis, lytic granules dock at the IS and fuse with the plasma 
membrane. High resolution imaging revealed that the secretion of the granules content 
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(degranulation) occurs through relatively hypodense actin regions (51). Myosin IIA may mechanically 
facilitate lytic granule motility through the F-actin-rich area of the IS or may be involved in inducing 
local changes in the F-actin structure to allow polarized lytic granules access to the plasma membrane 
(65). Granule content can be completely discharged with the contents diffusing rapidly at the plasma 
membrane, but the fusion can also be incomplete with the formation of a transient fusion pore at the 
plasma membrane accompanied by release of some but retention of most of the granule contents 
(66). NK cell granules contain a variety of lytic molecules, including perforin, granzymes, granulysin, 
Fas ligand (FasL), TNF-related apoptosis-inducing ligand (TRAIL) and small microbial peptides (67). The 
wall of these granules contains a range of lysosomal-membrane-associated glycoproteins including 
CD107a, which protect the NK cells from the granules contents. CD107a is used as a marker for NK cell 
degranulation (68).  
Following the release from the lytic granules, perforin has the ability to insert itself into a membrane, 
oligomerize, and generate pores in the target cells. These pores allow entry to granzymes and 
granulysin and also ionic exchange causing an osmotic imbalance and cell death (69). There is also 
evidence that granzymes enter into the target cells independently of perforin (70).  
The activity of granzymes in the target cell induces apoptosis through generation of reactive oxygen 
species, mitochondrial damage and DNA fragmentation. A total of five granzymes have been identified 
in humans, granzyme A, B, H, M and 3, with granzyme B having the strongest apoptotic activity. All 
granzymes are synthesized as zymogens and maximal enzymatic activity is achieved by removal of an 
amino-terminal dipeptide (71).  
Granulysin is a cytolytic and proinflammatory molecule that is made in a 15-kDa form and is cleaved 
into a 9-kDa form. Granulysin is broadly cytolytic against tumor and microbes, including bacteria, fungi 
and parasites (72). Granulysin induces membrane disruption resulting in an increase in intracellular 
calcium and decrease in postassium, contributing to mitochondrial damage followed by the activation 
of apoptosis (73). Granulysin is also a chemoattractant for T lymphocytes and monocytes and activates 
the expression of a number of chemokines and cytokines, including regulated upon activation T cell 
expressed and secreted (RANTES), monocyte chemoattractant protein (MCP)-1, MCP-3, macrophage 
inflammatory protein (MIP)-1α, interleukin (IL)-10, IL-1, IL-6 and interferon (IFN)-α (74). Granulysin 
expression showed to be co-associated with cytotoxicity receptors NKG2D and NKp46 (75).  
 
1.1.1.2 Death receptor pathways-Fas Ligand (FasL) and TNF-related apoptosis-inducing ligand 
(TRAIL) 
FasL, a type II transmembrane protein, plays an essential role in the cytotoxicity mediated by NK cells. 
FasL mediates cytotoxicity by engaging Fas, a receptor that is widely expressed in different tissues and 
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that transduces apoptotic signals into cells (76). FasL is expressed at low levels on the NK cell surface 
but is stored intracellularly at high levels on the inner surface of granules which also contain perforin 
and granzymes (77). Upon activation, the expression of FasL is rapidly upregulated on NK cell surface 
(78). Binding of FasL to Fas on a target cells initiates a cascade of caspase activation and cytochrome 
c production leading to DNA cleavage and cell death (79). A similar mechanism leads to apoptosis 
when TRAIL binds its receptors DR4 or 5 on the surface of a target cell (80). Both the Fas and TRAIL 
death receptor pathways have been shown to be important in NK cell-mediated killing of tumor cells 
(81,82).  
 
1.1.1.3 Secretion of chemokines  
NK cell activation stimulates greater expression and secretion of a set of chemokines, including MIP-
1α (CCL3), MIP-1β (CCL4) and RANTES (CCL5) (83). MIP-1α, MIP-1β and RANTES are known important 
chemoattractants for monocytes/macrophages and CD4+ and CD8+ T cells to the site of infection 
(84,85). Studies performed in vivo showed that RANTES, MIP-1α and MIP-1β together with IFN-γ are 
also coactivators of macrophages and T cells (86).  
In addition to producing chemokines, NK cells express chemokine receptors and respond to several of 
these molecules. Chemotaxis studies revealed that MIP-1α is a potent NK cell chemoatractant in vitro, 
as well as MIP-1β, RANTES, MCP-1, MCP-2 and MCP-3. In addition, chemokines enhance granule 
exocytosis and NK cell-mediated cytolytic response to K562 cells (87,88). Addition of exogenous MIP-
1α to resting NK cells do not enhance cytokine production, but do increase NK cytotoxic activity (89). 
In resume, chemokine secretion by NK cells may promote the recruitment and activation of other 
effector cells, as well as additional NK cells, during the immune response to infection or to transformed 
cells.  
 
1.1.1.4 Secretion of interferon gamma (IFN-γ) and tumour necrosis factor alpha (TNF-α) 
Target cell recognition by NK cells induces expression of IFN-γ and TNF-α cytokines (83).  
TNF-α is a proinflammatory cytokine that plays a critical role in diverse cellular events including 
proliferation, differentiation, apoptosis and induction of other cytokines (90). TNF-α is produced as a 
26kDa transmembrane precursor which is converted to its soluble form upon release via cleavage by 
ADAM-17 protease (91). Its role in NK cell cytotoxicity is mediated by either one of the two TNF 
receptors, TNF-R1 and TNF-R2 (92). The interaction of TNF-α with TNF-R1 receptor results in the 
recruitment of a number of proteins including TRADD (TNF R1 associated death domain protein) and 
FADD/MORT1 (Fas-associated death domain protein), which induce apoptosis via a caspase cascade 
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(93). TNF-α inflammatory, immune regulatory and cytokine-inducing roles are mediated through the 
NF-κB and MAP kinase pathways after binding to TNF-R1 and/or TNF-R2 (94).  
IFN-γ is produced by NK cells on target cell recognition, as well as in response to exogenous cytokines 
such as interleukin (IL)-2, 12, 15 and 18 (95). IFN-γ production by NK cells facilitates killing of tumour 
and virally infected cells (25,96). This important cytokine also has an immunoregulatory role, being 
involved in dendritic homeostasis and priming of CD4 Th1 cells (97,98).  
TNF-α and IFN-γ are produced de novo in the golgi body of the NK cell after contact with a target cell. 
They are then trafficked via a recycling endosome to the cell surface for release. These carriers 
transport the cytokines all over the cell surface, as well as to the target cell synapse, as befits the 
multifunctional role of TNF-α and IFN-γ in triggering other immune cells as well as directly influencing 
target cell death (99).  
 
1.1.2 NK cell development  
NK cells originate from CD34+ hematopoietic stem cells (HSCs) through discrete stages of 
development, by the sequential acquisition of receptors and functions (31). For a long time, the bone 
marrow (BM) has been considered the only site of human NK cell differentiation. However, there is 
evidence that NK cell development from HSCs may occur in tissues other than BM (100). Flow 
cytometric analysis of cells isolated from various peripheral tissues helped to identify NK cells at 
different stages of differentiation, suggesting that CD34+ cells or NK-lineage-committed precursors 
may recirculate from the BM to the periphery where they eventually undergo differentiation towards 
NK cells (101).  
Three main stages can be identified in NK cell differentiation, namely, NK cell precursors (NKP), 
immature NK cells (iNK), and mature NK cells (mNK) (Figure 1).  
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Figure 1: Schematic representation of Natural Killer cell differentiation 
Adapted from Montaldo et al., (2013) (101). 
 
NK cell precursors (CD34+ CD45RA+ CD117+ CD94-) are precursors for the iNK cell population that is 
completely devoid of T-cell or DC development potential in vitro (31). Functional analysis of iNK cells 
shows that this population do not display the ability to produce IFN-γ and to mediate perforin-
dependent cellular cytotoxicity against MHC-I–negative target cells (102). In addition, this population 
do not express most surface receptors found on mature NK cells, including CD94-NKG2 heterodimeric 
receptors, NKG2D, NKp46, CD16 and KIRs (31).  
During NK cell development, specific receptors are gradually and sequentially upregulated whilst 
progenitor markers such as CD34 and CD117 are gradually downregulated. The differentiation from 
iNK cells to mNK cells is characterized by the acquisition of CD94-NKG2A, NKG2D and NKp46 
expression, detectable IL-2 receptor (CD122) expression, IFN-γ production and the capacity for 
perforin-mediated killing (102).  
Two major population of NK cells can be discerned in the blood based on the relative expression of 
CD56 and CD16. Evidence suggest that CD56brightCD16- NK cells are precursors of CD56dimCD16+ NK 
cells. Following CD34+ stem cell transplantation in vivo, donor-derived CD56bright NK cells appear in the 
recipient’s blood near the time of engraftment, whereas CD56dim NK cells appear later, concomitant 
with the relative decrease of CD56bright NK cells (32). Analysis of the telomere length, which 
progressively diminishes with cell division and age, is significantly shorter in CD56dimCD16+ NK cells 
compared with CD56brightCD16- NK cells from the same donor (103).  
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1.1.3 NK cell education 
NK cell education is a complex process required for the development of fully functional NK cells. NK 
cell function is tightly regulated by a balance between positive and negative signals provided by a 
diverse array of cell surface receptors. Activating receptors recognize specific ligands inducing NK cell 
activation and cytotoxicity. However, NK cells also express inhibitory receptors that recognise MHC 
class I molecules preventing NK cell cytotoxicity against endogenous healthy cells (42). Besides its 
importance in the control of NK cell reactivity during interactions with potential target cells, the 
interaction of the inhibitory receptors with MHC class I molecules also shown to educate NK cells to 
acquire their full effector function (104). Studies performed in mice showed that NK cells lacking self 
MHC class I-specific inhibitory receptor are hyporesponsive and that the engagement of these 
receptors with MHC class I “licenses” NK cells to become functionally competent (104). In humans, 
studies performed with peripheral blood NK cells from MHC class I-deficient individuals showed an 
activation defect of NK cell population (105). Several inhibitory receptors promote NK cell education 
in humans, including several KIR receptors (KIR2DL1, KIR2DL2/3, KIR3DL1) and NKG2A (43). Because 
NK cells vary in the affinity and number of inhibitory receptors they express, the strength of the 
educating signal varies from cell to cell. It was shown that following education, NK cell function 
increases in a quantitative manner with the number of interactions with different self-MHC class I 
during development (106). Thus, only NK cells that are strongly inhibited by self-MCH class I can gain 
maximal effector functions for subsequent interactions with target cells.  
NK cell education status can be altered in response to changes in the surrounding MHC class I 
microenvironment. The adoptive transfer of NK cells from MHC-competent mice to MHC-deficient 
mice resulted in a loss of NK cell functionality (107), whereas the adoptive transfer of NK cells from 
MHC-deficient mice to MHC-competent mice resulted in a gain of NK cell functionality (108).  
Different models have been proposed to describe various aspects of NK cell education by MHC class I 
molecules. The two main proposed mechanisms are the arming model and the disarming model. The 
arming model proposes that NK cells acquire functional competence after ligation of inhibitory 
receptors by self-MHC class I molecules. Signalling from inhibitory receptors thus promotes functional 
maturation in an active way. The term NK cell ‘licensing’, is commonly used synonymously with 
arming, but could also imply other mechanism (109).  
The disarming model postulates that NK cells that lack inhibitory receptors for self-MHC class I 
molecules are ‘disarmed’ to retain self-tolerance, resulting in a form of NK cell anergy. Interactions 
with MHC class I molecules prevent this process and the NK cell matures normally (110). The arming 
and disarming model differ in the initial state of the NK cells, in the arming model NK cells are 
hyporesponsive by default, whereas the disarming model suggests that NK cells are responsive in their 
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initial state. Furthermore, arming implies a new instructive role for inhibitory receptors, whereas 
disarming implies a conventional inhibitory role. 
The active engagement of inhibitory receptors on NK cells by self-MHC class I molecules is the key 
event that determines whether an NK cell will be functionally capable of mediating missing-self 
recognition, or whether it will be hyporesponsive in terms of cytotoxicity (degranulation) and cytokine 
secretion (IFN-γ) following stimulation (111). Interestingly, uneducated NK cells promote better 
mouse survival and viral clearance of murine CMV than educated NK cells, suggesting that licensing 
by inhibitory receptors, while important for tolerance and education, may inhibit response to viral 
infections (112). Hyporesponsive NK cells can be found in normal humans but the precise role of 
unlicensed NK cells is still not known (113). Thus, educated and uneducated NK cells may have 
separate and unique functions in the immune response.  
 
1.1.4 Natural Killer cell receptors 
NK cells have a highly specific and complex target cell recognition receptor system arbitrated by the 
integration of signals provided by a multitude of inhibitory and activating receptors. The net income 
of key positive and negative signals determines whether or not NK cells will initiate a cytotoxic 
response. When activated, NK cells are potent effectors of the innate immune system through the 
polarized release of cytotoxic granules and the secretion of cytokines and chemokines (114,115).  
Important families of NK cell receptors include the C-type lectin family (including NKG2A, NKG2C and 
NKG2D), the natural cytotoxicity receptor (NCR) family, which includes NKp46, NKp44 and NKp30, the 
signal lymphocytic activating molecule (SLAM) family which includes 2B4 (CD244), and the killer 
immunoglobulin receptor (KIR)  family (116). In humans, the activating NK receptors include CD16, the 
short-tail members of KIRs, the dimer CD94/NKG2C, NKG2D, 2B4, NKp30, NKp44 and NKp46 (Figure 
2). They signal through association with either DAP10 which allows PI3-kinase activation or DAP12, 
CD3 ζ-chain, or FcεRI (high-affinity IgE receptor) γ-chain, which all contain immunoreceptor tyrosine-
based activation motifs (ITAM) (117). 
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Figure 2: NK cell activating receptors and their ligands. 
Adapted from Joyce, M. et al. 2011 (118). 
 
The inhibitory NK receptors include the long-tail members of the KIR family, the dimer CD94/NKG2A, 
leukocyte-associated immunoglobulin-like receptor-1 (LAIR-1), and killer cell lectin-like receptor 
subfamily G member 1 (KLRG-1) which signal via cytoplasmic immunoreceptor tyrosine-based 
inhibitory motifs (ITIM) (Figure 3). 
 
 
Figure 3: NK cell inhibitory receptors and their ligands. 
Adapted from Joyce, M. et al. 2011 (118).  
 
31 
 
The activation of a single activating receptor on NK cells showed to be insufficient to induce a potent 
effector response even in the absence of inhibitory signals (117). Furthermore, with the exception of 
CD16, NK cell activation requires the stimulation of two or more activating receptors simultaneously 
in order to the cells achieve an activation threshold. However, even when multiple co-receptors are 
simultaneously stimulated, not all combination leads to induction of synergy or activation. 2B4 
synergizes with the 3 receptors, NKp46, NKG2D, and DNAM-1. NKG2D and DNAM-1 each synergize 
with the 2 receptors, NKp46 and 2B4. This same study established a hierarchy on the basis of 
requirements for NK cell activation: CD16 > NKp46 > 2B4 > NKG2D, DNAM-1 > CD2 (119). It is 
noteworthy that ligands for DNAM-1, CD2 and NKG2D are widely expressed, whereas ligands for 
receptors capable of inducing a strong NK cell response, such as 2B4 and NKp46, are very restricted 
(120).  
The ligands identified for activating receptors are either “induced-self” that are structurally related to 
HLA class I molecules (such as, major histocompatibility complex [MHC] class I-like chains A and B 
[MICA and MICB] and unique long binding proteins [ULBP]), “altered-self” (HLA class I molecule loaded 
with foreign peptide) or pathogen encoded “non-self” (molecules associated with infection and tumor 
transformation) (121). 
Inhibitory receptors have a key role in the control of NK cell reactivity as a result of the interaction of 
these receptors with MHC class I molecules. The negative signals from inhibitory receptors tend to be 
dominant therefore, the functional outcome of engaging both activation and inhibitory receptors is 
tilted in favour of inhibition. More, in order to ensure inhibitory dominance, generally binding of 
activating receptors to MHC class I exhibits lower affinity than the affinity of their related inhibitory 
receptor counterparts (117,122). Identification of a vast array of specific inhibitory receptor–ligand 
combinations, has revealed a sophisticated system for the regulation of NK cell cytotoxicity.  
As referenced above, inhibitory receptors, such as KIR receptors and NKG2A, have also demonstrated 
to play an important role in NK cell education (104). 
 
1.1.4.1 NKG2 receptors family 
The NKG2 receptor family is crucially involved in target cell recognition by NK cells and comprises 
activating and inhibitory receptors. NKG2 receptors are C-type lectin-like receptors and are generally 
type II transmembrane proteins containing an extracellular C-type carbohydrate recognition domain 
(123). These receptors are encoded in a single genetic region called the NK complex (NKC) on 
chromosome 12 and have limited or no polymorphism (124). The human NKG2 family comprises seven 
members NKG2-A, -B, -C, -D, -E and H, with A/B and E/H being splice variants of the same genes (125). 
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With the exception of NKG2D, all the NKG2 receptors form disulphide-linked heterodimers with the 
CD94 receptor (126).  
Activating family members (NKG2C and potentially -E, -F, -H) are characterized by the presence of a 
charged amino acid residue in the transmembrane domain mediating interaction with DAP12 that 
contains an immunoreceptor tyrosine-based activation motif (127). In contrast, inhibitory NKG2A and 
NKG2B carry ITIMs (128).  
Despite their distinct signalling capabilities, NKG2-A, -B and -C receptors have been found to recognize 
the same ligand, the non-classical HLA class I molecule HLA-E (129).  
The recognition of HLA-E by CD94/NKG2C receptors results in the phosphorylation of ITAM structure 
on DAP12 associated molecule, followed by the recruitment and activation of the tyrosine kinase SyK 
and Zap70 (127).  
NKG2A is the first inhibitory receptor to be expressed on NK cell surface during the development 
process (31). The interaction of CD94/NKG2A with HLA-E results in the phosphorylation of the two 
ITIMs that are present in the intracytoplasmic tail of NKG2A. The phosphorylated ITIMs act as docking 
sites for the cytosolic resident phosphatases SHP-1 and SHP-2, thereby activating them. SHP-1 and 
SHP-2 inhibit NK cell response by dephosphorylating the protein substrates of the tyrosine kinases 
linked to NK cell activating receptors, resulting in the suppression of the activation signals in NK cells 
(130). Engagement of NKG2A by HLA-E on target cells overrides inside-out signals for activation of LFA-
1 from multiple activating NK cell receptors (48). CD94/NKG2A receptors accumulate at the site of 
contact with the ligand and are continuously recycled at the cell surface being largely unaffected by 
exposure to ligand (131).  
The affinity of the activating CD94/NKG2C receptors is lower than that of the corresponding 
CD94/NKG2A inhibitory receptor (132).  
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Figure 4: NKG2 receptors 
Adapted from Farag, S et al. (2002) (133). 
 
Unlike the other NKG2 receptors, NKG2D is expressed as a homodimer and does not associate with 
CD94 receptor. The intracellular domain of NKG2D does not have any signalling motif, and therefore, 
signalling is exclusively through the association with DAP10. When phosphorylated DAP10 recruits 
phosphatidylinositol (PI)-3 kinase through which activating signal transduction occurs (134). As the 
PI3K cascade is not inhibited by SHP-1 or SHP-2, NKG2D may be able to mediate a dominant activation 
signal.  
NKG2D binds to a variety of major histocompatibility complex (MHC) class I-like proteins. In humans 
these proteins belong to two different families, the MHC class-I polypeptide-related chain (MIC) 
protein family that contains MICA and MICB, and the cytomegalovirus UL16- binding proteins (ULBP) 
family, which includes ULBP1–4 (38,135).  
MIC genes are not ubiquitously expressed and the expression of the cellular stress ligands MIC-A and 
MIC-B has been reported to be induced upon malignant transformation, as a result of DNA damage 
(136). High MICA and MICB expression was detected on many human epithelial tumours, JA3 and Raji 
leukemic cell lines, as well as on primary AML blasts (136,137). Furthermore, MIC-expressing on 
fibroblasts and epithelial cells was strongly upregulated following infection with cytomegalovirus 
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(CMV) (35). Therefore, induction or upregulation of MIC expression may occur with cellular stress, 
viral infection, or neoplastic transformation and may facilitate attack of these altered cells by NK cells. 
ULBPs were initially identified by their ability to bind the human CMV protein UL16, which is expressed 
by CMV-infected cells (138). The expression of ULBPs is more widespread than that of MIC proteins 
with ULBP transcripts being detected in heart, lung, brain, lymph nodes, thymus, liver and bone 
marrow. The comparison between normal and tumour tissues showed that ULBP messages are 
upregulated in colon and stomach tumours but downregulated in kidney tumours (38). The expression 
of NKG2D ligands is tightly regulated, however, they can also be expressed on healthy tissues, 
generally at baseline levels, below a functionally relevant threshold (139). 
The interaction of NKG2D with its stress-inducible ligands of the MIC and ULBP families results in the 
stimulation of NK cell cytotoxicity and cytokine production (39,134,140). 
 
1.1.4.2 Natural Cytotoxicity Receptors 
Natural Cytotoxicity Receptors (NCRs) have been identified as the effector molecules responsible for 
the majority of NK cell-driven cytotoxicity against tumour cells or virally infected cells, with blocking 
of these receptors resulting in a significant decrease in NK cell-mediated killing (141). NCRs belong to 
the immunoglobulin superfamily and are exclusively expressed on NK cells. NCRs include the NKp30, 
NKp44 and NKp46 receptors and their surface density on NK cells correlates with the magnitude of 
the cytolytic activity against NK-susceptible target cells (142). NKp30 and NKp46 are expressed on 
most NK cells, whereas NKp44 is induced after activation (143). Analysis of the structure of these 
receptors showed a low degree of similarity to each other and to other known human molecules (118). 
Each NCR has a charged residue in the transmembrane domain which enables it to bind to diverse 
adaptor signalling molecules, including CD3ζ, FcεRIγ and DAP12 that contain ITAMs (Figure 5). ITAMs 
become tyrosine phosphorylated upon receptor engagement, initiating the activation cascade in NK 
cells. (143–145).  
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Figure 5: Natural Cytotoxicity Receptors (NCRs) 
Adapted from Moretta, A et al. 2001 (141). 
 
NKp46 is a type I transmembrane glycoprotein constituted by two N-terminal Ig-like extracellular 
domains, a 40 amino acid linker region, single transmembrane domain, and a short highly charged 25 
amino acid cytoplasmic region. NKp46 is associated with CD3ζ and FcεRIγ which can transmit a cell 
activating signal via their multiple ITAM containing domains (118). A number of viral hemagglutinin 
proteins, which become surface expressed following viral infection, have been proposed as ligands of 
NKp46 (146). NKp46 binding of specific heparin sulphate proteoglycans has also been proposed as a 
ligand and may be critical for tumour cell killing (147). NKp46 showed to play a key role in natural 
cytotoxicity and NK cell activation in response to transformed cells, Herpes simplex virus and influenza 
virus infections and in the response to mycobacterium tuberculosis infected monocytes (148–150).  
NKp30 displays several features in common with NKp46 with mAb-mediated crosslinking of NKp30 
resulting in cellular responses identical to those induced via NKp46. NKp30 extracellular portion is 
characterized by a single domain of the V-type and by a region rich in hydrophobic amino acids and is 
associated with two CD3ζ chains (144). NKp30 showed to recognize the nuclear factor HLA-B-
associated transcript 3 which can be released by tumour cells, the B7-H6 tumour cell ligand and 
heparin sulphate proteoglycans (147,151,152).  
Similar to NKp46 and NKp30, NKp44 could induce triggering of NK-mediated cytotoxicity upon 
crosslinking by specific mAbs. However, the expression of NKp44 is restricted to activated NK cells and 
it is absent in fresh peripheral blood NK cells. It is well known that following culture in the presence of 
IL-2, NK cells acquire increased cytolytic activity against targets (153). This may be an important 
mechanism in NK cells, with some receptors such as NKp44, being expressed upon activation allowing 
NK cells to recognize additional ligands on target cells. NKp44 is constituted by a single extracellular 
V-type domain and is associated with DAP12 chains (154). Reported ligands for NKp44 include 
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influenza hemagglutininns on infected cells, mycolic acids and arabinogalactan, cell wall core 
components of M. tuberculosis and the NKp44L that is highly detected in several tumour cell lines 
(155–157).  
 
 
Figure 6: NCR interaction with their known ligands 
Adapted from Kruse, P H et al, 2014 (158). 
 
NKp80 molecule also belongs to the NCR receptors family but it has different characteristics from the 
other NCRs. NKp80 is a C-type lectin-like homodimeric receptor able to induces calcium influx in 
human NK cells after triggering by appropriate antibodies (159). NKp80 is expressed by virtually all 
fresh NK cells derived from peripheral blood as well as by a minor T cell subset characterized by the 
CD3+ CD56+ surface phenotype (141). Immunoprecipitation experiments failed to demonstrate NKp80 
association with signalling molecules such as CD3ζ, FcεRIγ and DAP12 and a detailed study of NKp80 
showed that these receptor uses an atypical hemi-ITAM and Syk kinase to trigger cellular cytotoxicity 
(160). The activation-induced C-type lectin (AICL) was identified as a ligand of NKp80 and the 
crosslinking between NKp80 and AICL stimulated secretion of proinflammatory cytokines in co-
cultures of NK cells and monocytes. More, the engagement of NKp80 and AICL promoted cytolysis of 
myeloid cells (161). These results suggest that NKp80-AICL interaction is involved in the activating 
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crosstalk between NK cells and myeloid cells and thus may influence the initiation and maintenance 
of immune responses in humans. 
 
1.1.4.3 Inhibitory and activating Killer Cell Immunoglobulin-like receptors (KIRs) 
The KIR family comprises 15 receptors that are type I transmembrane glycoproteins and which can be 
either inhibitory or activating. KIR receptors are members of the immunoglobulin superfamily and 
possess two (KIR2D) or three (KIR3D) extracellular Ig-like domains, involved in ligand binding and 
either a long or short cytoplasmic tail involved in intracellular signalling. Generally long-tailed KIRs 
represent inhibitory and short-tailed KIRs are activating (162). An exception is KIR2DL4, which has a 
long intracytoplasmic tail but also displays activating function, stimulating potent cytokine production 
(163). The long tails contain a cytoplasmic region called ITIMs that trigger inhibitory signals. These 
ITIMs execute NK cell inhibition via recruitment of the protein tyrosine phosphatases SHP-1 and SHP-
2, which prevents the phosphorylation of key activating adaptor protein Vav1 and terminates further 
activation downstream (164). The short cytoplasmic tails lack ITIM but possess a positively charged 
residue in the transmembrane domain that interacts with the signalling adaptor DAP12 or FcεRIγ 
(KIR2DL4) to induce NK cell activation. DAP12 contains ITAMs, which trigger activating signals upon 
the short-tailed KIR receptor recognizing a ligand (165).  
KIRs are named on the basis of their number of Ig domains and type of cytoplasmic tail. The first digit 
following the KIR acronym corresponds to the number of Ig-like domains in the molecule and the “D” 
denotes “domain.” The “D” is followed by either an “L” indicating a “Long” cytoplasmic tail, an “S” 
indicating a “Short” cytoplasmic tail or a “P” for pseudogenes (2DP1 and 3DP1). The final digit indicates 
the number of the gene encoding a protein with this structure (166). 
KIR receptors are encoded by a polygenic and polymorphic gene family that produces remarkable 
diversity within individuals and in populations in the number and type of genes (167). The synergistic 
combination of allelic polymorphism and variable gene content individualize KIR genotypes to an 
extent where unrelated individuals almost always have different KIR genotypes (168). The KIR 
receptors are clonally expressed on mature NK cells in a stochastic manner such that each NK cell 
clone within a given individual does not express the entire set of KIR genes present in that individual’s 
genome, but rather only a portion of the genes in a apparently random combination (169,170) . 
Combinatorial diversity of KIR expression yields a broad range of functionally distinct NK cell clones, 
which presumably are critical for a rapid and sensitive detection of reduced HLA class I expression on 
target cells.  
KIR receptors specifically bind HLA-A, -B and -C molecules and recognize polymorphisms in these MHC 
class I molecules. KIRs displaying two extracellular Ig-domains (KIR2DL) recognize specifically HLA-C 
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and KIRs displaying three extracellular Ig-domains (KIR3DL) recognize specifically HLA-A and -B 
allotypes (171). Sequence comparison between inhibitory and activating ligands indicates that the 
inhibitory and activating molecules are highly close in sequence identity but the most minimal changes 
still result in differences in ligand specificity and affinity (118).  
The majority of NK cells in peripheral blood express at least one inhibitory receptor for self-MHC class 
I and are functionally competent to recognize and eliminate target cells that have downregulated their 
respective MHC class I ligands (169,170). 
 
1.1.4.4 Signalling Lymphocytic Activating Molecule (SLAM) family receptors 
NK cells express at least three members of the SLAM family. They are 2B4 (CD244), NK, T- and B-cell 
antigen (NTB-A), and CD2-like receptor-activating cytotoxic cells (CRACC) (172–174). SLAM receptors 
are members of the Ig superfamily that possess Ig-like domains in the extracellular region, in addition 
to a transmembrane segment and a cytoplasmic domain containing multiple tyrosine-based motifs 
(175). All the SLAM family receptors other than 2B4 are implicated in homotypic self-interactions and 
are self-ligands. In contrast, 2B4 interacts with CD48, a glycophosphatidylinositol-linked member of 
the CD2 family of receptors that is expressed on most hematopoietic cells and endothelial cells (176). 
In humans, 2B4, CRACC and NTB-A are present on most all mature NK cells and 2B4 is also found on 
the majority of immature NK cells (177). NK cell cytotoxicity mediated by 2B4 and NTB-A showed to 
be dependent on the SLAM-associated protein (SAP) acting downstream of receptor phosphorylation 
(178). In patients with X-linked lymphoproliferative disease, the inability to control Epstein-Barr virus 
infections may be consequent of a dysfunction of 2B4 that exerts inhibitory instead of activating 
functions (179). CRACC signalling is dependent on Ewing’s sarcoma-activated transcript-2 (EAT-2) 
adaptor and activates the PI3 kinase in human NK cells (174).  
 
1.1.4.5 CD16 receptor 
CD16 or FcγRIII is a low affinity receptor for the Fc portion of IgG and it was the first activating receptor 
to be identified on NK cells (180). CD16 mediates antibody-dependent cellular cytotoxicity (ADCC) by 
binding to the Fc portion of IgG but is also directly involved in the lysis of some virus-infected and 
tumour cells, independent of antibody ligation (181). CD16 receptor is associated with CD3ζ and/or 
FcεRIγ which can transmit a cell activating signal via their multiple ITAM containing domains (182,183).  
Engagement of CD16 induces ITAM phosphorylation, which in turn recruit and activates SYK and ZAP-
70 tyrosine kinases for downstream signalling (184). Upon activation, CD16 delivers a potent signal to 
NK cells resulting in Ca2+ influx, transcription of cytokine genes for IFN-γ and TNF-α and cytotoxic 
response (185–187). After activation CD16 receptor is downregulated from the NK cell surface (188).  
39 
 
1.1.4.6 Toll-like receptors (TLRs) 
Initially described in other innate immune cells, TLRs have more recently been characterized in NK 
cells. The presence of TLRs in NK cells was initially demonstrated based on mRNA detection and later 
by the activation of purified NK cells by TLR agonists. Analysis of mRNA expression showed that NK 
cells express TLR1-8 and TLR10 (189). In another report, all TLR mRNAs except TLR7 were detected in 
purified human NK cells (190).  
TLR2 is mainly expressed in the CD56bright subset, while CD56dim NK cells preferentially express TLR3 
and respond to the TLR3 ligand increasing expression of CD69 and producing IFN-γ (191).  
TLR2, TLR3 and TLR5 agonists showed to directly activate NK cells (189,192,193), whereas TLR7, TLR8 
and TLR9 agonists act indirectly on NK cells (191,194). NK cell activation by TLRs results in IFN-γ and 
TNF-α production preceded by nuclear translocation of NF-κB.  
Overall, the data suggest that NK cells have the potential to recognize specific bacterial and viral 
PAMPs directly, resulting in NK cell activation. However, some TLR agonists failed to directly activate 
NK cells, with NK cell activation being dependent on the presence of APCs or specific cytokines 
(194,195).  
 
1.2 Aspergillus fumigatus 
Aspergillus fumigatus (Af) is an opportunistic filamentous fungus typically found in soil and organic 
debris and plays an essential role in recycling environmental carbon and nitrogen (196). A. fumigatus 
is a member of the genus Aspergillus which to date comprises of about 250 species of saphrophytic 
fungi (197). Some species such as A. terreus, A. sojae and A.niger are industrially used for the 
production of pharmaceuticals, beverages and food additives (198–200). On the other hand, other 
species have negative effects on food production, on ecosystems and some have been reported to be 
human pathogens. A. flavus contaminates crops with the highly carcinogenic aflatoxin and A. sydowii 
has brought the Caribbean gorgonian coral close to extinction (201,202). In humans, A. fumigatus has 
emerged as a major pathogen, being responsible for over 90% of all Aspergillus infections. A. flavus, 
A. terreus, A. niger and A. nidulans are also pathogenic to humans, causing the remaining 10% of 
infections caused by Aspergillus genus (203–206).   
Humans are exposed to large amounts of A. fumigatus spores and it is estimated that an individual 
inhales several hundred conidia per day (207). The conidia released into the atmosphere have a 
diameter small enough (2 to 3 μm) to traverse the terminal respiratory bronchioles and reach the 
pulmonary alveoli. Inhalation of conidia by immunocompetent individuals rarely has any adverse 
effect, since the conidia are eliminated relatively efficiently through innate immune mechanisms. 
However, in immune-compromised individuals, such as leukaemic and transplant patients, the 
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immune system is impaired and conidia may germinate to swollen and hyphal form causing severe 
pneumonia and invasive aspergillosis (IA) (208).   
The virulence of A. fumigatus is multifactorial and is a combination of biological characteristics of the 
fungus and the immune status of the patient. The biological characteristics of the fungus include the 
small size of the conidia, the temperature tolerance, nutritional versatility, resistance to oxidative 
stress and the changing display of cell wall components during the life cycle as it negatively impacts 
the ability of the host to recognize A. fumigatus. Although A. fumigatus grows optimally at 37°C and a 
pH 3.7 to 7.6, it can be isolated wherever decaying vegetation and soil reach temperatures range 
between 12° and 65°C and the pH ranges between 2.1– 8.8 (209,210). The knockout of the gene cgrA, 
which is required for growth at 37°C but not at 22°C, attenuates virulence in a murine infection model 
but not in a D. melanogaster infection model which is characterised by a body temperature of 25°C, 
indicating that temperature tolerance is required for A. fumigatus virulence (211). As an efficient 
recycler in nature, A. fumigatus possesses a versatile metabolism that meets its nutritional 
requirements under different environmental conditions (212). A. fumigatus genome is rich in specific 
enzymes such as catalases, superoxide dismutases, and glutathione transferases for the detoxification 
of reactive oxygen species (ROS) (213,214). All these features equip A. fumigatus to survive and 
propagate in conditions that are detrimental to a broad range of other environmental organisms. 
 
1.2.1 Aspergillus fumigatus life cycle and cell wall composition 
The cell wall of A. fumigatus has an essential role in the pathobiology of this fungus. This role is linked 
directly to morphogenetic changes associated with the life cycle of this fungus. During its asexual 
reproduction cycle (Figure 7), A. fumigatus produces hundreds of spores, called conidia. Released 
conidia are in a metabolic inactive state and they can survive in hostile environments. The outermost 
cell-wall layer of A. fumigatus conidia is composed of regularly arranged RodA hydrophobin proteins, 
conferring to the conidia hydrophobic properties and masking the underlying cell wall 
components(12,13). Studies in vivo, using a mutant A. fumigatus strain (ΔrodA), showed that the RodA 
hydrophobin layer masks Dectin-1 and Dectin-2-dependent responses and enhances fungal survival 
(15).   
In addition to the hydrophobin layer, resting conidia are coated in a greyish-green melanin layer (14). 
Conidial melanin forms a dense layer on the conidial surface and protects the fungal DNA from 
alteration by ultraviolet light and oxidation and contributes to the longevity of the conidia in the 
environment. The use of mutants with white conidia has shown that the melanin of the conidial cell 
wall has a major role in protection against the phagocytic reactions within the phagolysosome. Both 
in vivo and in vitro studies have shown that white conidia were more efficiently damaged by 
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phagocytes than green conidia. When conidia were incubated in vitro with reactive oxygen species 
(ROS) such as NaOCl or hydrogen peroxide, white conidia were about 10-fold more sensitive to ROS 
than green conidia (215).  
The rodlet layer composed by the hydrophobic RodA protein and the pigment melanin on the surface 
of resting A. fumigatus conidia render the conidia largely inert towards recognition by the immune 
system (216). 
The next step in the Aspergillus life cycle is the germination of the conidium. Germination is initiated 
in the presence of water and a carbon source (217). Water uptake results in swelling of the conidium 
to double the size, a process during which the fungal cell wall undergoes extensive remodelling. 
Swelling conidia loose the hydrophobin and melanin layer and expose their underlying cell wall 
components. In A. fumigatus, the cell wall is mainly composed of polysaccharides including β(1,3) and 
β(1,4)-glucans, α(1,3)-glucan, chitin and galactomannans. Only a few proteins are thought to be stably 
present in the cell wall layer, but they can play an important role in the interaction with the host, 
especially as antigens/allergens, adhesins or immunomodulators (18,19).  Analysis of the protein 
fraction of A. fumigatus cell wall, resulted in the identification of twenty six different proteins, twelve 
of which contain a signal for secretion. Among these were the major conidial surface protein RodA, 
one acid protease PEP2, one extracelular lipase, a putative disulphide isomerase and a putative 
fructose-1,6-biphosphatase (218).  
During the process of swelling, the activity of β(1,3)-glucanase and a chitinase allows fungal expansion 
(219). In preparation for DNA replication, the chromatin de-condenses and polar growth is initiated 
(16). Fungal growth is polarized, following gradients of nutrients and chemo attractants (e.g. 
hormones), or to avoid adverse habitats (20,21). Conidia then germinate and grow in filamentous, 
multi nucleated structures, called hyphae. The cell wall composition of hyphae and conidia is different. 
Chitin and β(1,3)-glucan are not exposed on the surface of the hyphae structure. Additionally, 
galactofuran is predominantly detected on hyphae but not on conidia (219). The A. fumigatus life cycle 
completes with the formation of aerial hyphae and specialised structures called conidiophores, which 
produce and disperse hundreds of fresh conidia.  
42 
 
 
Figure 7 - Asexual life cycle of Aspergillus fumigatus. The asexual reproduction cycle of A. fumigatus 
is initiated by the production and dispersion of metabolic inactive resting conidia. Under favourable 
conditions, germination of resting conidia is initiated by conidia swelling followed by polarized growth 
and formation of germ tubes. Apical elongation and branching of the germ tubes leads to the 
formation of hyphae. The last stage in the A. fumigatus life cycle is the generation of specialized 
structures called conidiophores, which produce and disperse hundreds of fresh resting conidia.  
 
In addition to asexual reproduction, a sexual reproduction cycle has been discovered for A. fumigatus. 
The genome sequence of this fungus occurs in two idiomorphs, MAT1-1 and MAT1-2, and strains of 
the two opposite mating types occurs at the same frequency and are found in close proximity to each 
other. MAT genes encode transcription factors that are master regulators of sexual reproduction, 
required for normal sexual development in Aspergillus and other species (220). The biological 
significance of the sexual reproduction cycle of A. fumigatus is still unknown but its study and the 
possible relationship with virulence will remain a topic of interest in the coming years. 
 
1.2.2 Secondary metabolites produced by Aspergillus fumigatus 
A. fumigatus is able to produce a variety of enzymes and toxins that may facilitate fungal colonization 
of tissue and evasion of the host immune response. The most widely studied toxin is gliotoxin that 
showed to inhibit phagocytic activity of macrophages, induces apoptosis of monocytes, decreases the 
activation of NADPH oxidase in neutrophils, and impairs granule exocytosis in T cells (221–225). The 
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toxin fumagillin is also produced by A. fumigatus upon hyphal development (226). Fumagillin inhibits 
phagocytosis, degranulation and F-actin reassembly in neutrophils (227).  
A. fumigatus demonstrated to be able to evade the human complement system by binding or 
degrading complement regulators (228). A study focused on the stimulation of immune cells via TLR2 
and TLR4 receptors, suggests that the loss of TLR4-mediated signals during A. fumigatus germination 
is an evasion mechanism of the fungus to counteract the host defence (229).  
The ability of A. fumigatus to produce a variety of toxins may assist it in supressing the local immune 
response and facilitates fungal growth in the host. The identification and characterization of the 
fungus strategies to defend against the immune response is important to understand pathogenicity 
and is important for the identification of potential therapeutic targets (230).  
 
1.3. The immune response to Aspergillus fumigatus 
Inhalation of Aspergillus fumigatus conidia is a common occurrence due to their ubiquitous presence 
in the environment. In immunocompetent individuals the inhaled conidia are eliminated relatively 
efficiently by the immune system, rarely causing any adverse effect (231).  
The immune response to A. fumigatus involves several components of the innate immune system, 
such as anatomical barriers, soluble proteins and phagocytic cells. Despite the main role of the innate 
immune system in fungal clearance, the adaptive immune system has also shown to be important in 
the immune response to A. fumigatus infection.  
The components of the immune system work in synergy, in a way that is not yet fully elucidated, to 
ensure an effective clearance of A. fumigatus conidia from the respiratory airways and to avoid lung 
infection and disease establishment.  
 
1.3.1 Innate Immune response to Aspergillus fumigatus 
In an immunocompetent individual, A. fumigatus faces a broad arsenal of defence mechanisms. The 
airway epithelium and its secretions represent the first barrier for inhaled A. fumigatus conidia. The 
epithelium of the upper respiratory tract consists of various cell types, including mucous-secreting 
goblet cells and ciliated cells (232). The cilia are in constant motion and clear inhaled particles from 
the surface and the mucus lining prevents direct contact with the underlying cell layer (233,234). In 
addition, the mucus contains an array of antimicrobial peptides, such as defensins, cathelicidins, 
lysozyme and lactoferrin which have direct antimicrobial properties. Surfactant proteins and 
complement are also important constituents of the mucus and have an important role in opsonisation 
of the pathogens, aiding the uptake by the innate immune cells (235). On the luminal side of the 
epithelial layer, alveolar macrophages act as sentinels having a critical role in the host defense against 
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Aspergillus conidia. The activation of macrophages by Aspergillus conidia initiates an immune 
response characterized by the production of cytokines and chemokines and by the recruitment of 
other immune cells into the lung.  
 
1.3.1.1 Epithelial cells of the respiratory tract 
The initial point of contact between A. fumigatus and the host is a monolayer of lung epithelial cells. 
Studies performed in vitro and in vivo demonstrated that bronchial and alveolar epithelial cells in the 
lung have an active role in the immune response to A. fumigatus. This response includes the 
internalization of adherent conidia and the release of cytokines, antimicrobial peptides, and reactive 
oxygen species (236). Gene expression analysis in  bronchial epithelial cells co-incubated with A. 
fumigatus conida in vitro, showed an upregulation of several genes including genes expressing 
metalloproteinases, chemokines and glutathione S-transferase (237). More, the production of β-
defensins was detected upon the exposure of bronchial epithelial cells exposure to A. fumigatus (238). 
Bronchial epithelial cells showed to recognize A. fumigatus conida through Dectin-1 receptors that 
bind to glucan exposed on the fungal surface (239). 
Microscopic examination of the interaction of lung and nasal epithelial cells with A. fumigatus showed 
that these cells internalize 20-50 % of the present conidia into phagosomes, where they remain 
ungerminated but viable for up to 20 hours (240,241). 
In vivo studies showed that mice pre-treated with aerosolized bacterial lysates were highly protected 
against A. fumigatus. This protection occurred in immunocompromised neutropenic mice through the 
activation of multiple signalling pathways in lung epithelial cells (242). 
 
1.3.1.2 Complement 
One of the earliest host responses to microorganisms is the activation of complement, a collection of 
serum proteins that recognize and bind conserved microbial constituents, resulting in opsonization or 
destruction of the pathogen. Three activation pathways can trigger the complement cascade, the 
classical, the alternative and the lectin pathway, all of them resulting in the cleavage of the central 
complement factor C3 by proteolytic enzyme complexes (C3 convertases). Proteolytic cleavage of C3 
generates the fragments C3a and C3b, which are two important components that mediate a multitude 
of complement functions. The product C3b associates with the C3 convertases, thus forming the C5 
convertases, which cleave factor C5 into C5a and C5b. This step initiates a chain of assembly processes 
of the proteins C6, C7, C8, and C9. The bound and polymerized C9 units create the terminal 
complement complex (TCC) that can form a pore in the target lipid bilayer, called membrane attack 
complex (MAC) (243,244). Complement also displays several additional antimicrobial mechanisms 
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aiming to neutralize invading microbes and to restore body homeostasis. Surface-bound C3b 
undergoes internal cleavage steps; the derived products iC3b, C3d, and further, coat and label the 
pathogens for phagocytosis (opsonization). Opsonization of pathogens by C3 complement fragments 
is a key strategy in complement-mediated clearance. Complement opsonization represents a 
chemotactic compass for immune cells and enhances phagocytosis, ROI production, and killing by 
alveolar macrophages, monocytes, and neutrophils (244). Opsonization with complement proteins 
was shown to be of importance for the phagocytosis of A. fumigatus conidia, the key process in the 
defense against this pathogen (245).  
The complement machinery is induced by both Aspergillus conidia and hyphae. Resting conidia mainly 
activate complement by the alternative pathway. Conidial germination and hyphal formation, 
processes accompanied by changes of the cell wall composition, and exposure of surface α-and β- 
glucans shift complement activation to the classical pathway. Complement activation by all three 
forms of A. fumigatus features specific kinetics with slowest initiation by resting conidia (246). 
Opsonization strongly depends on the availability of putative docking sites for C3 fragments on the 
fungal surface. The glucan surface cell wall carbohydrate structures can bind mannose-binding lectin 
(MBL), facilitate activation of the lectin pathway, and lead to C4 deposition in a concentration-
dependent manner. MBL can then back up C3 proteolytic cleavage via C2 bypass mechanism 
disengaging the C3 convertase and thus initiating the alternative pathway (247,248).  
 
1.3.1.3 Alveolar macrophages  
Alveolar macrophages (AMs) are the major resident phagocytic cells of the lung alveoli and play a 
critical role in the defense against Aspergillus fumigatus. The recognition of fungal cell wall 
components by the AMs initiates an immune response characterized by the phagocytosis of the 
conidia, production of cytokines and chemokines and the recruitment of other immune cells to the 
lung.    
Although alveolar macrophage depletion with clodronate-loaded liposomes does not result in 
increased mortality from aspergillosis, macrophages play an essential role in controlling early events 
after infection. Alveolar macrophage depleted mice show a delay in clearance of the fungal inoculum 
which results in increased influx of neutrophils and increased production of inflammatory cytokines 
at later time points of infection (249,250). 
Contact between AMs and A. fumigatus conidia induces the formation of pseudopodia and filopodia 
surrounding the conidia, resulting in the engulfment of the fungus. Phagocytosis of A. fumigatus 
conidia requires actin polymerization and phosphatidylinositol 3-kinase activity also required in the 
phagocytic internalization of most microorganisms (251,252). Once internalized, an A. fumigatus 
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conidium is contained within a phagosome surrounded by a well-defined phagosomal membrane that 
is tightly associated with the conidium surface. Phagosome fuses with endosomal vesicles acquiring 
antimicrobial properties. The phagosome maturation process is divided into an early, late and finally 
lysosomal phase and fusion events are orchestrated by Rab family GTPases (253).  
In human and murine alveolar macrophages, the maturation of the A. fumigatus-containing 
phagosomes into a lysosome-like compartment, is associated with acidification of the phagolysosome 
and the acquisition of Lamp-1 and the hydrolase cathepsin D. Efficient killing is detected 18 hours after 
phagocytosis in vitro and after 36 hours in vivo and is dependent on phagosomal acidification (254). 
In addition to phagosomal acidification, the production of reactive oxygen species (ROS) is required 
for effective conidial killing. Both, chemical inhibition of the NADPH oxidase in vitro and knock-out of 
the NADPH phox47 subunit in vivo, abrogates conidial killing. Kinetic analysis showed that maximal 
ROS production occurs  after 3 hours of phagocytosis, when conidia sweles inside the AMs (255). 
The interaction of A. fumigatus conidia with AMs, also induces the production of TNF-α, IL-1a and IL-
6 after 6 hours co-incubation in vitro. In vivo studies, showed an increase in TNF-α, IL-6 and Monocyte 
Chemoattractant Protein-1 (MCP-1) levels in the broncho alveolar lavages of mice challenged with A. 
fumigatus conidia for 24 hours (256). The production of these cytokines and chemokines is important 
for the recruitment of cells of the innate and adaptive immune system into the lung.  
Analysis of cell populations in the bronchoalveolar lavage (BAL) of infected mice, showed that alveolar 
macrophages comprises 14.6% of the BAL-derived cells. Analysis of gene and protein expression in this 
population showed that they predominantely express Arginase 1 (Arg1), a key marker of alternatively 
activated macrophages (AAMs). Classically activated macrophages (CAMs) express nitric oxide 
synthase (NOS2), but the expression of this enzyme do not appreciably increase in the lungs of mice 
infected with A. fumigatus (257). Both, Arg1 and NOS2 metabolize L-Arginine (L-Arg), an essential 
nutrient source for the fungi (258). Arg1 activation generates polyamines and hydroxyprolines that 
help in repair processes after tissue injury caused by parasitic infections and suppress Th2 effector 
functions, possibily being more advantegous for the lung heath to use this pathway (259,260).  
The β-glucan receptor, Dectin-1, was found to play an important role in the phagocytosis of A. 
fumigatus by alveolar macrophages and its absence increases fungal burden in the lungs of the 
infected mice (257). 
 
1.3.1.4 Neutrophils 
Neutrophils are key effector cells in the immune response against A. fumigatus and the importance of 
these cells is indicated by the fact that neutropenia is a major risk factor for the development of A. 
fumigatus infection (261). In human blood, neutrophils make up to 70% of the leukocyte population, 
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whereas in mice circulating neutrophils constitute only 30% of all leukocytes (262). Neutrophils are 
characterized by a short life span of 8 hours to 5 days (262). The critical role of neutrophils in innate 
defence against A. fumigatus has been highlighted in several in vitro and in vivo studies. 
Neutrophil recruitment is initiated by changes on the surface of endothelium that result from 
stimulation by inflammatory mediators, including histamine and cytokines, that are released from 
tissue-resident sentinel leukocytes when they come into contact with pathogens (263,264). Once 
neutrophils leave the blood stream and enter the tissue, they follow a gradient of chemokines to the 
side of infection (262). Upon activation, neutrophils secrete cytokines and chemokines, e.g., CXCL1/ 
2/3, CCL2/3/4, and IL-8 to attract further immune cells (265,266). 
Neutrophil interaction with A. fumigatus initiates a range of oxidative and non-oxidative mechanisms 
that effectively eliminate germinating spores and hyphal forms of the fungus. These mechanisms 
include phagocytosis, NADPH-oxidase-mediated generation of reactive oxygen species (ROS), 
production of lactoferrin and crucially, the discharge of antimicrobial proteases by degranulation 
(267,268).  
Phagocytosis of A. fumigatus is an important mechanism of killing by neutrophils and it was shown to 
be mediated by complement activation and consequently opsonization of the fungus (269). 
Moreover, fungus phagocytosis by neutrophils leds to a shift on fungus metabolism, resembling a state 
observed under glucose limiting conditions to facilitate fungal killing (270). 
Neutrophils contain four different types of granules. Primary or azurophilic granules contain 
myeloperoxidase, lysozyme, and antimicrobial proteins like cathepsin G, elastase and proteinase 3 
(271,272). Elastase and cathepsin G have anti-Aspergillus activity and mice lacking one or other of 
these enzymes are more susceptible to A. fumigatus infection (273). Secondary or specific granules 
contain iron-sequestering lactoferrin, lysozyme and the soluble pattern recognition receptor 
pentraxin 3 (PTX3) (274). The PTX3 knock-out mouse showed increased mortality in response to A. 
fumigatus infection and adoptive transfer experiments have shown that neutrophil-derived PTX3 
contributes to protection against invasive aspergillosis (274,275). The third class, the gelatinase 
(tertiary) granules contain a range of metalloproteases, such as gelatinase and leukolysin. The fourth 
type of granules are so called secretory vesicles which accumulate during endocytic processes and 
contain albumin and a number of important membrane-bound molecules employed during neutrophil 
migration (271). In neutrophils, granule content can fuse with phagosomes or can be secreted into the 
extracellular space. In addition to the release of the granule’s content, neutrophils produce ROS in 
response to A. fumigatus. During activation the NADPH complex is assembled either on the 
phagosomal or plasma membrane and consequently the ROS produced is either released directly into 
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the phagosome or the extracellular space. This enzyme complex produces superoxide anions that are 
further converted to toxic compounds like H2O2, hydroxyl anions, and hypochlorous acid (276).  
Neutrophils have also a specific extracellular killing mechanism that is the formation of neutrophil 
extracellular traps (NETs) (277). NETs are formed during a unique form of cell death (NETosis), during 
which intracellular membranes disintegrate and the neutrophil granule content, cytoplasm and DNA 
form a homogenous mass. In a final step, the plasma membrane raptures and DNA coated with 
antimicrobial granule components is released into the surrounding (278). The antimicrobial activity of 
NETs has been linked to the associated granule components and the ability to trap microbial invaders 
and therefore block their spread (279). The formation of NETs by neutrophils in response to A. 
fumigatus was observed in vitro and in vivo and contributes to hyphal growth restriction (280,281).  
Studies in vivo demonstrated that the delay in the recruitment of neutrophils to the lungs results in 
an increase of fungal germination (282). The oxidative burst is especially important in the killing of A. 
fumigatus by neutrophils, since neutrophils from knock-out mice for the p47 subunit of the NADPH 
oxidase, are not able to kill A. fumigatus conidia in vitro and in vivo (283,284). NADPH oxidase activity 
has also demonstrated to play a key role in human host defence against A. fumigatus. Patients with 
chronic granulomatous disease (CGD), a disease characterized by the defect of NADPH oxidase activity 
and consequently deficient generation of H2O2 and ROS, have an increased susceptibility to A. 
fumigatus infection (285). 
The analysis of the interaction between neutrophils and A. fumigatus showed that neutrophils 
recognize A. fumigatus via dectin-1 and TLRs 2 and 4 (265,286).  
 
1.3.1.5 Dendritic cells 
The lung-resident Dendritic cells (DCs) population is made up of cells of various origins and functions, 
which form a complex network of sentinel cells. Lung DCs can be categorized as conventional DCs 
(cDCs), plasmacytoid DCs (pDCs) and monocyte-derived DCs (moDCs), which each represent an 
independent developmental lineage. Functionally, these lung-resident DC subsets have been 
described as fulfilling distinct and overlapping functions (287). Pathogens are constantly inhaled into 
the lungs, and lung-resident DCs are crucial for initiating appropriate immune responses to destroy 
the infection agents. They mount an immediate immune response to fungi by producing inflammatory 
mediators upon capture and phagocytosis and also have a key role in antigen presentation via the 
major histocompatibility complex class I and II (MHC I-II) (288,289). 
Most studies on dendritic cell interaction with A. fumigatus have been performed using immature 
monocyte-derived dendritic cells (iDCs). In vitro studies showed that 30% of A. fumigatus conidia is 
phagocytosed after 30 minutes and 48% after 2 hours. The phagosome of iDCs maitains a neutral to 
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alkaline pH to regulate the activity of proteolytic enzymes (290). NADPH oxidase is expressed at lower 
levels and its role is to generate ROS to regulate the pH of the phagosome to prevent antigen 
degradation rather than generating an oxidative burst (291). After phagocytosis, iDCs undergo 
maturation responsible for an enhanced expression of cytokines, chemokines, co-stimulatory 
molecules and an improved antigen presentation for efficient stimulation of naive T cells (292). TNF-
α, IL-4, IL-6, IL-10, IL-12, IL-1α and IL-1β appear to be the main proinflammatory cytokines produced 
by iDCs upon exposure to A. fumigatus conidia and hyphae (293–295). The production of specific 
cytokines it seems to be different in response to conidia or hyphae, with phagocytosis of conidia 
inducing IL-12 production and phagocytosis of hyphae inducing IL-4 and IL-10 (293).  
Analysis of gene expression in iDCs co-incubated with A. fumigatus, confirmed an upregulation in the 
gene expression of chemokines and cytokines involved in chemoattraction and activation of 
neutrophils, Th1 cells and macrophages (295). On the other side, analysis of gene expression in A. 
fumigatus in the presence of iDCs showed an upregulation of genes involved in transport, 
pathogenesis and RNA processing and downregulation of genes involved in fermentation, sulphur 
metabolism, response to oxidative stress and aminoacid metabolism (295).  
iDCs can phagocytose opsonized or unopsonized conidia and hyphae and the pathogen recognition 
occurs via Dectin-1, dendritic cell-specific intracellular adhesion molecule 3-grabbing non-integrin 
(DC-SIGN), CR3 and FCγ RII (293,294).  
Studies performed with pDCs showed that unmethylated A. fumigatus DNA induces TLR9-dependent 
response in human pDCs (9). In addition, in vitro studies with human pDCs demonstrated that these 
cells phagocytose A. fumigatus conidia, resulting in the release of proinflammatory cytokines, such as 
IFN-α and TNF-α, and also inhibit hyphae growth. Furthermore, depletion of pDCs in a mouse model 
resulted in increased mortality (296).  
During the later stages of infection, DCs activate a protective A. fumigatus-specific adaptive immune 
response which is driven by Th1 CD4+ T cells. A study performed in vivo showed that pulmonary DCs, 
after phagocytosis of conidia or hyphae, migrate to the draining lymph nodes and spleens, undergo 
functional maturation and induce selective Th priming of CD4+ T lymphocytes (293). 
DCs have demonstrated a unique role during A. fumigatus infection, as they behave as both sentinel 
for innate immune recognition and initiator of adaptive immunity. 
 
1.3.2 Adaptive Immune response to Aspergillus fumigatus 
Adaptive immunity plays an important role in the immune response to A. fumigatus infection, mainly 
through the activation of T cells. The innate immunity alone is sufficient to successfully cope with low-
grade fungal airway infections that continuously arise through routine inhalational exposures, but it 
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was demonstrated that T cells assume critically important protective roles in the settings of high 
infectious burdens and innate immune cell dysfunction (297).  
 
1.3.2.1 T cells 
Mature T lymphocytes, known as naïve T cells, circulate through blood and the lymphatic system, and 
reside in secondary lymphoid organs. Two major surface co-receptor molecules, CD4 and CD8, define 
two separate T cell lineages with different functions. CD4+ T cells recognize antigen in the context of 
MHC class II molecules and produce cytokines as effector T helper cells. CD8+ T cells are activated by 
antigenic peptides presented by MHC class I molecules and form effector cytotoxic T cells (CTL) (298).  
Adaptive immune responses are initiated by antigen presenting cells (APCs) travelling to lymph nodes 
for presentation of pathogen-derived antigen to T cells (299). Following A. fumigatus infection, DCs 
displaying specific antigens on their cell surface in the context of MHC molecules, migrate to the 
draining lymph nodes and activate naïve T cells (293). The activation, differentiation and proliferation 
of a specific T cell population is dependent on the fungal specific components to which T lymphocytes 
are exposed. In the specific case of A. fumigatus infection, the activation of T cells can induce a 
protective or harmful response of the adaptive immune system. A. fumigatus spore exposure can lead 
to the development of diverse CD4+ T-cell responses that include T helper (Th) 1, Th2, Th17, and 
regulatory T (Treg) cells (300). 
In single exposure models, the A. fumigatus - specific CD4+ T-cell airway response consists of a 
dominant Th1 population characterized by the production of IFN-γ mediating protection against the 
fungal infection (301). Similarly, CD4+ T cell responses in healthy individuals are primarily Th1-biased, 
and adoptive transfer of IFN-γ-producing A. fumigatus - specific CD4+ T cells can protect bone marrow-
transplanted mice and humans from invasive fungal disease (299,302). IL-17-secreting Th17 cells 
showed to have a negative impact on protection against primary inoculation with A. fumigatus by 
subverting Th1 responses and have been associated with eosinophilic, allergic responses in a multiple 
challenge model (303). Similarly, IL-4-secreting Th2 CD4+ T cells predominate in the response in allergic 
bronchopulmonary aspergillosis (ABPA) patients and contribute to disease progression (304).  
Repeated exposures to A. fumigatus spores in murine pulmonary infection models result in increased 
recruitment of Th2 and Th17 CD4+ T cells (305). T regulatory cells secrete IL-10 and are thought to 
prevent allergic inflamatory responses (306).  
Besides CD4+ T cell responses, CD8+ T cells may also mediate protective immunity against A. fumigatus 
infection. In vivo studies showed that CD8+ T cells are recruited to the lungs in the context of A. 
fumigatus infection (307). In addition, it was observed an increase in IFN-γ producing CD8+ T cells 
population in the BAL fluid of mice repeatedly challenged with A. fumigatus conidia coupled to the 
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maintenance of airway memory phenotype CD8+ T cells (308). The activation of memory CD8+ T cells 
seems to be dependent on TLR3 signalling in DCs pulsed with A. fumigatus conidia or fungal RNA (309). 
 
1.3.2.2 B cells 
Serum antibodies that bind Aspergillus components, particularly those of the immunoglobulin G (IgG) 
and IgM subclasses, are broadly found in patients without aspergillosis. In addition to systemic 
antibodies, the analysis of BAL fluid showed the presence of Aspergillus-specific IgA in patients without 
aspergillosis (310). Many A. fumigatus hyphal molecules are potent B cell antigens and antibodies that 
bind these molecules are commonly seen among patients with aspergilloma than among those with 
invasive disease, a finding that likely reflects differences in the predisposing conditions between these 
groups. However, an in vivo study showed that B cell-deficient μMT mice are capable of efficiently 
limiting the fungal growth upon both primary and secondary infections, suggesting that resistance to 
aspergillosis can occur in the absence of B cells and antibodies (311). More studies are needed to 
clarify the role of B cells in A. fumigatus infection. 
 
1.4 Innate immune recognition of A. fumigatus 
Recognition of invading microorganisms by the innate immune system is a first and essential step in 
their successful elimination. Innate immune cells sense pathogens via germline-encoded pattern 
recognition receceptors (PRRs), which recognise distinct evolutionarily conserved structures on 
pathogens, termed pathogen-associated molecular patterns (PAMPs) (312). Fungal PAMPs consist 
primarily of cell wall carbohydrate structures, while bacterial PAMPs range from lipoproteins, 
lipopolysaccharide (LPS), flagellin and peptidoglycan to bacterial nucleic acid structures. Viruses on 
the other hand are mainly recognized through their nucleic acids, such as double (dsRNA) or single 
stranded- RNA (ssRNA) and viral DNA, although surface envelope glycoproteins can also be recognized 
(313). Microbial recognition initiates multiple signalling cascades in the cells resulting in the activation 
of gene expression and synthesis of a broad range of molecules, including cytokines, chemokines, cell 
adhesion molecules, and immunoreceptors, which together orchestrate the early host response to 
infection and at the same time represent an important link to the adaptive immune response (314). 
PRRs comprise of Toll-like receptors (TLRs), nucleotide-oligomerisation domain (NOD)-like receptors 
(NLRs), retinoic acidinducible gene-1 (RIG-1)-like receptors (RLRs) and C-type lectin-like receptors 
(CTLRs) (315). RLRs are cytoplasmic receptors which recognise viral RNA and are not implicated in 
fungal recognition (316). All other families of PRRs, however, have been shown to recognise fungal, 
and A. fumigatus-associated PAMPs in particular. 
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1.4.1 Toll-like receptors 
The TLR family represents an important subset of the PRRs and has been subject of intense research. 
To date, 13 members of TLRs have been identified with TLR1-9 being present in both humans and 
mice, TLR10 only expressed in humans and TLR11 only in mice. The expression pattern of TLR12 and 
TLR13 have not been well characterised so far. Some TLRs, such as TLR1, 2, 5, 6 and 10, are localized 
on the plasma membrane and recognise components of bacteria and fungal cell walls, whereas TLR3, 
7, 8 and 9 are located in endosomal membranes where they sense microbial and host-derived DNA 
and RNA. TLR4 localizes at both the plasma membrane and the endosomes (317,318). TLR signalling 
is initiated by ligand-induced dimerization of the receptors. TLR2 was shown to sense lipoproteins and 
peptidoglycans and it heterodimerizes either with TLR1 to recognize triacylated lipopeptides or with 
TLR6 to recognize diacylated lipopeptides (319,320). TLR3 was shown to recognize double-stranded 
RNA, which is a major component of many viruses (321). TLR4 was identified as the signal transducer 
for lipopolysaccharide (LPS) and TLR5 for flagellin (322). TLR7 and the related receptor TLR8 were 
shown to sense single-stranded viral RNA (323). TLR9 has been identified as the receptor for CpG-rich 
hypomethylated DNA motifs (324). 
TLRs possess a Toll/IL-1 receptor (TIR) domain in their cytoplasmic tail and signals are transduced via 
TIR domain containing adaptor proteins. Myeloid differentiation primary response protein 88 (MyD88) 
contains a TIR domain adaptor molecule and has been shown to transduce signals from all TLRs except 
for TLR3 (317). Other TIR domain adaptor proteins were characterized including MYD88-adaptor-like 
protein (MAL), TIR domain-containing adaptor protein inducing IFNβ (TRIF) and TRIF-related adaptor 
molecule (TRAM). Overall, TLR signalling is often characterised as either MyD88-dependent or -
independent. Engagement of the signalling adaptor molecules stimulates downstream signalling 
pathways that involve interactions between several proteins and resulting in the activation of specific 
transcription factors (325).  
Several studies have been performed in order to determine the role of different TLRs in the immune 
response to A. fumigatus. In vitro experiments using transfected cells and isolated macrophages from 
TLR-deficient mice provided evidence for an involvement of TLR2 and TLR4 in the immune response 
to A. fumigatus. Studies performed in vivo in TLR-deficient mice also provided convincing evidence for 
an involvement of TLR2 and TLR4 in the host response to A. fumigatus (326,327). A recent study 
showed that the detection of A. fumigatus is mediated by TLR1 and TLR6 in mice and TLR1 but not 
TLR6 in humans, together with TLR2 in both species (328). TLR9 is recruited to the A. fumigatus 
containing phagosome in murine macrophages in vitro (329,330) and contributes to inflammatory 
cytokine secretion in neutropenic mice in vivo (331).  
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1.4.2 NOD-like receptors 
The nucleotide oligomerization domain (Nod)-like receptors (NLRs) are a subset of PRRs localized in 
the cytosol and are essential for detecting invading pathogens. There are 23 NLR family members in 
humans and at least 34 NLR genes in mice that are divided into subfamilies based on their N-terminal 
protein-interacting domains. NLRs are expressed in many cell types including immune cells and 
epithelial cells, although certain NLR family members are expressed primarily in phagocytes including 
macrophages and neutrophils. NLRs are multi-domain proteins composed of a variable N-terminal 
effector region consisting of caspase recruitment domain (CARD), pyrin domain (PYD), acidic domain, 
or baculovirus inhibitor repeats (BIRs), a centrally located NOD (or NACHT) that is critical for activation, 
and a C-terminal leucine-rich repeats (LRRs) that senses PAMPs (332). NOD1 and NOD2 are two well-
characterized NLRs belonging to the NLRC subfamily that recognise bacterial peptidoglycan 
breakdown products resulting in the activation of NFκB signalling (333). It was observed that A. 
fumigatus spores increase NOD2 levels in alveolar epithelial cells and macrophages in vitro and in the 
lungs of a mouse model of IPA in vivo (334). The NLRP subfamily of NOD-like receptors plays a pivotal 
role in the activation of the acute phase mediators IL-1β and IL-18. Upon activation, they oligomerize 
to form multiprotein inflammasome complexes. Inflammasome assembly results in caspase-1 
activation and pro-cytokine cleavage (335). The NLRP3 inflammasome was activated in response to A. 
fumigatus infection in vivo and is required for IL-1β production. A. fumigatus activates the NLRP3 
inflammasome through a pathway requiring ROS production and the Syk Tyrosine Kinase (336).  
 
1.4.3 C-type lectin-like receptors 
C-type lectin-like receptors (CTLRs) constitute a heterogeneous group of soluble and transmembrane 
proteins that recognise a wide range of carbohydrate structures, including the major carbohydrate 
structures found in the fungal cell walls, β-glucan and mannan (337). CTLRs comprise one or more 
carbohydrate recognition domains (CRDs), or possess structurally similar C-type lectin-like domains 
(CTLDs) which do not necessarily recognize carbohydrate ligands. The term 'C-type' arose from the 
requirement of calcium-binding for carbohydrate binding, but it has become clear that not all CTLRs 
are calcium-dependent or bind carbohydrates (338). Activation of CTLRs can induce intracellular 
signalling pathways through direct or indirect signalling. Receptors such as Dectin-1 induce 
intracellular signalling directly through ITAM-like motifs located within the cytoplasmic tail of these 
receptors. However, other receptors like Dectin-2 induce intracellular signalling indirectly, since when 
activated they associate with ITAM containing adaptor molecules such as Fc Receptor γ-chain (FcRγ) 
or DAP12 (339). Signalling via both mechanisms involves the recruitment of Syk kinases, which is a 
central mediator of CTLR-indutced cytokine transcription as it activates NFκB signalling. Syk mediates 
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the activation of protein kinase Cδ resulting in the assembly of a Card9-Bcl10 complex (340). The 
Card9-Bcl10 complex allows the NFκB translocation into the nucleus activating gene transcription. The 
importance of C-type lectin-like receptor signalling in response to A. fumigatus infection is highlighted 
by the fact that knockout mice for Syk or Card9 succumb to infection without further 
immunosuppression (284). 
Dectin-1 recognises 1,3-β-glucans and is the best characterized CTLR in the context of fungal infections 
(341). An in vivo study showed that in response to A. fumigatus challenge, Dectin-1-/- mice had 
impaired IL-1α , IL-1β , TNF-α , CCL3/MIP-1α , CCL4/MIP-1β , and CXCL1/KC production at 24 hours p.i., 
which resulted in insufficient lung neutrophil recruitment and uncontrolled A. fumigatus lung growth. 
Alveolar macrophages from Dectin-1-/- mice failed to produce proinflammatory mediators in response 
to A. fumigatus, whereas neutrophils from Dectin-1-/- mice had impaired reactive oxygen species 
production and impaired killing of A. fumigatus (286). In contrast, another study performed in vivo 
showed no significant reduction of CXCL1/KC, TNF-α, IL-1β and IL-17A at 36 hours p.i. in a Dectin-1-/- 
mice infected with A. fumigatus (284).  
In addition to activating cytokine responses, Dectin-1 is a phagocytic receptor. The mechanism for 
Dectin-mediated phagocytosis seems to be different between cell types. Src and Syk were required 
for uptake in transfected 3T3 cells, whereas uptake in Dectin-1 transfected Raw macrophages and 
bone marrow-derived macrophages from Syk-/- mice was Syk independent (342). In contrast, uptake 
in bone marrow-derived dendritic cells was Syk dependent (343). In human monocytes, Dectin-1 
phagocytosis was Syk dependent but Src independent (344). In A. fumigatus infection, Dectin-1 in 
concert with TLR-2 facilitates the uptake of swollen conidia by murine alveolar macrophages in vitro 
(345) and contributes to phagocytosis by neutrophils in vivo (284). 
Dectin-2 recognises α-mannans which are exposed on swollen A. fumigatus conidia and is up-
regulated in response to A. fumigatus infection in the lung (346). In addition, Dectin-2 demonstrated 
to contribute to cytokine responses in vitro (347).  
DC-SIGN (dendritic cell–specific intercellular adhesion molecule 3–grabbing nonintegrin) is also an 
example of a CTLR involved in the immune response to A. fumigatus. DC-SIGN recognises 
galactomannan and showed to mediate binding and internalization of A. fumigatus conidia by human 
DCs (348).  
Another important example of a CTLR is the mannose-binding lectin (MBL), a soluble CTLR that has 
shown to recognize various carbohydrate structures (349,350) and, on binding to its ligands, is able to 
activate the complement system. Upon interaction with A. fumigatus, MBL showed to facilitate the 
activation of the lectin complement pathway, and lead to C4 deposition in a concentration-dependent 
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manner. MBL can then back up C3 proteolytic cleavage via C2 bypass mechanism disengaging the C3 
convertase and thus initiating the alternative complement pathway (247,248). 
The recognition of pathogens involves multiple PRRs and it is becoming clear that the crosstalk 
between the different families of PRRS is a prerequisite for the induction of effective innate immune 
responses (351). Fungi are recognized by several CTLRs and TLRs and there are already some studies 
showing direct interactions between these two receptor families during the immune response. Dectin-
1 can collaborate with multiple MyD88-coupled TLRs to synergistically induce many cytokines, 
including TNF-α, IL-10 and IL-23, while repressing others, such as IL-12 (352–354). As referred above, 
in A. fumigatus infection, Dectin-1 in concert with TLR-2 facilitates the uptake of swollen conidia by 
murine alveolar macrophages in vitro and contributes to phagocytosis by neutrophils in vivo.  
How these collaborative responses are mediated is still unclear and further research is needed to 
understand the importance of these interactions in the immune response to pathogens.  
 
1.5 NK cell response to fungi 
Besides their role in tumour resistance and fighting viral infections, there is increasing evidence 
indicating that NK cells may also play an important role in the early defence against fungal infections.  
Studies on Cryptococcus neoformans infection showed that human NK cells interact with this fungus 
forming conjugates, resulting in the inhibition of fungal growth (355). It was also demonstrated that 
murine NK cells are able to bind, inhibit growth and kill C. neoformans (356). However, another study 
showed that human NK cells fail to inhibit growth of thirteen different C. neoformans strains in the 
absence of anticryptococcal antibodies (357). Interestingly, C. neoformans downregulates GM-CSF and 
TNF-α production by human NK cells (358).  
Results are also contradictory on NK cell interaction with Candida albicans. Several groups have 
reported interaction with human NK cells but minor or no direct antifungal activity (359–361). A study 
performed with highly purified murine NK cells showed that killed C. albicans yeast and hyphae inhibit 
IFN-γ secretion by activated NK cells (362). However, a more recent study reported that human NK 
cells actively recognize C. albicans, resulting in granzyme B and perforin release and secretion of GM-
CSF, IFN-γ, and TNF-α (363).  
NKp30 receptor seems to be responsible for recognition and killing of C. neoformans and C. albicans, 
being required for NK cell-fungal conjugate formation, PI3K signalling and perforin release (364).  
Interaction of NK cells with Paracoccidioides brasiliensis results in granulysin release and this cytolytic 
molecule is able to kill P. brasiliensis in a dose-dependent manner. NK cells also recognize and kill P. 
brasiliensis-infected monocytes but through perforin release (365). The importance of perforin for NK-
cell mediated antifungal activity was also demonstrated for Rhizopus oryzae. NK cells damage R. 
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oryzae hyphae but not resting conidia releasing perforin. Co-incubation of NK cells with this fungus 
also results in inhibition of IFN-γ and RANTES secretion (366).  
Despite the contradictory reports, these studies indicate that NK cells are able to recognize and 
damage fungi species, releasing cytotoxic molecules such as perforin, granzymes and granulysin. 
Furthermore, these studies also suggest that fungi exhibit important immunosuppressive effects on 
NK cells.  
 
1.5.1 NK cell response to Aspergillus fumigatus 
The first studies focused on the role of NK cells in the immune response to Aspergillus fumigatus were 
performed in vivo. A study conducted in a neutropenic mouse model concluded that chemokine-
mediated recruitment of NK cells to the lungs is critical for early host defence mechanism in IA. More, 
Ab-mediated depletion of NK cells resulted in impaired defences against A. fumigatus infection with a 
twofold increase in mortality and impaired clearance of the pathogen from the lungs (367). 
Furthermore, NK cells showed to be the major source of IFN-γ in the lungs of neutropenic mice with 
aspergillosis. The transfer of activated NK cells, in mice with pulmonary aspergillosis, resulted in 
greater pathogen clearance from the lungs (368). Administration of exogenous IFN-γ has been used 
successfully as adjunctive therapy in human aspergillosis infection (369–371).  
More recent studies have demonstrated the ability of NK cells to recognize and respond to A. 
fumigatus in vitro but through contrasting mechanisms of antifungal activity. Schmidt and colleagues 
showed that unstimulated and IL-2 pre-stimulated human NK cells kill A. fumigatus hyphae but do not 
affect resting conidia with perforin acting as the mediator of the cytotoxic mechanism. This study also 
showed that the levels of IFN-γ and GM-CSF produced by pre-stimulated NK cells are significantly 
reduced when NK cells are co-incubated with Af, indicating an immunosuppressive effect of the fungus 
(372). In striking contrast, another study performed in vitro found that IL-2 pre-stimulated human NK 
cells release IFN-γ and TNF-α in response to Af germling. NK cells induced damage of A. fumigatus 
germling through a mechanism independent of NK cell degranulation. They describe a two-step 
antifungal mechanism, where contact-dependent activation of NK cells by hyphae provoked the 
release of IFN-γ able to damage the fungus. Second, upon its secretion, the NK cell-derived IFN-γ was 
capable of acting against hyphae that were not in physical contact with the NK cells (373). 
Both in vitro studies, demonstrated that NK cells are activated only by germinated morphologies of A. 
fumigatus suggesting an important role of NK cells in the recognition of the fungus that has escaped 
the first line of host defence provided by neutrophils and macrophages.   
Due to the cytotoxic properties of NK cells against tumour cells and the increasing evidence indicating 
that NK cells may play an important role in the defence against fungal infections, the adoptive transfer 
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of NK cells could be an attractive strategy in the prophylaxis or treatment of invasive fungal infections 
in allogeneic hematopoietic stem cell transplant recipients. 
 
1.6 Acute Myeloid Leukaemia (AML) 
Acute myeloid leukaemia (AML) is the result of a multistep transforming process of hematopoietic 
precursor cells (HPCs) that enables them to proceed through limitless numbers of cell cycles and to 
become resistant to cell death. This disease is characterized by clonal expansion of abnormal myeloid 
progenitor cells that accumulate in the bone marrow and interfere with normal haematopoiesis. In 
the normal hematopoietic system, proliferation is tightly linked to differentiation but in contrast, 
leukemic transformation results in an excess of immature cells that are compromised in their ability 
to differentiate (374). The treatment paradigm for AML generally includes remission induction, 
followed by consolidation with either 1-4 cycles of chemotherapy or hematopoietic stem cell 
transplantation (HSCT) (375). Despite progress in the diagnosis, prognosis, and treatment of cancer 
diseases, relapse remains a major problem in acute myeloid leukaemia, and new approaches are 
needed to improve patient outcome.  
 
1.6.1 The role of natural killer cells in AML therapy 
HSCT is a major life saving treatment for haematological malignancies. Whilst graft-versus-leukemia 
(GVL) effects have resulted in the successful eradication of recipient malignant cells, the drawback of 
this procedure has been the associated graft-versus-host disease (GVHD) caused by T cells in the graft 
(376). In T cell-depleted HSCT, donor NK cells are the first lymphoid population to recover and are the 
major effector cells responsible for controlling residual cancer cells (377). Many clinical studies have 
reported a crucial role of NK cells in this context, with donor NK cells demonstrating to be able to 
mediate a successful long term GVL effect after haploidentical HSCT in AML patients, without causing 
GVHD (377–379). Several studies have shown that NK cell alloreactivity between donors and recipients 
is a critical feature predicting the clinical outcomes following HSCT (377,380,381). These observations, 
together with the extraordinary increase in the understanding of NK immunobiology, have aroused 
considerable interest among researchers and clinicians on the use of NK cell-based therapies for AML 
treatment.   
Initial NK cell-based clinical trials were performed using autologous NK cells, but this approach showed 
a poor clinical outcome with NK cells exhibiting low cytotoxic capacity in vivo as a result of NK cell 
interaction with the self MHC molecules (382). More encouraging results have been observed using 
haploidentical allogeneic NK cells that showed to be able to expand in vivo, to be fully functional after 
infusion, to be able to induced complete hematologic remission in AML patients and showed no GVHD 
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effect (383–386). Despite reports of clinical efficacy, a number of factors still limit the application of 
NK cell-based immunotherapies, such as the failure of NK cells to persist in vivo.  
KIR ligand mismatch between patients and their donors, demonstrated to play a crucial role in the 
effectiveness of NK cell alloreactivity in NK cell-based immunotherapy and HSCT (377,387). KIR family 
comprises inhibitory and activating receptors that recognize specific groups of HLA class I alleles. The 
interaction between inhibitory KIRs and HLA I molecules results in NK cell inhibition but, on the other 
hand, failure to recognize the appropriate ligand on a mismatched cell can trigger NK cell effector 
response (171). The inhibitory KIR/HLA ligand mismatch has been a main focus in the context of 
transplantation and in fact, the adoptive transfer of haploidentical allogeneic NK cells with KIR 
mismatch into patients with acute myeloid leukaemia, resulted in a significant increase of overall 
survival, better engraftment and a reduced incidence of graft-versus-host disease (GVHD) 
(377,388,389). Additional studies, showed that KIR mismatch results in increased NK cell alloreactivity 
and in a potent graft-versus-leukaemia (GVL) effect, preventing disease relapse  (133,390). 
The importance of the activating KIR2DS1 and KIR3DS1 receptors in allogeneic transplantation, was 
also evaluated and showed that donor NK cells expressing KIR2DS1 appeared to provide protection 
against relapse and NK cells expressing KIR3DS1 were associated with reduced mortality (391).  
NK cell-based immunotherapy holds great promise for AML treatment, however further investigation 
on NK cell biology and function is required in order enhance the therapeutic benefit of this therapy 
while minimizing risks and toxicities. 
 
1.6.2 Invasive Aspergillosis in Acute myeloid leukaemia patients  
The incidence of invasive fungal infections has been increasing in the last decades as a consequence 
of the increasing use of immunosuppressive therapies and chemotherapy. It has been estimated that 
invasive fungal infections cause about two million infections per year, with mortality rates ranging 
from 20 to 90%. Death is caused mainly by species that belong to one of four genera: Candida, 
Aspergillus, Cryptococus and Pneumocystis (392).  
Aspergillus spp. cause a range of pulmonary diseases dependent on the immunological status of the 
host. Aspergillomas may form in pre-existing lung cavities predominantly caused by previous M. 
tuberculosis infection (393). Allergic bronchopulmunary aspergillosis is characterised by 
hypersensitisation against Aspergillus-derived antigens which most commonly occurs in patients with 
steroid-dependent asthma or cystic fibrosis (394). Invasive aspergillosis (IA) is a result of conidial 
germination into hyphae, which can invade the lung parenchyma. The tissue invasion results in 
hypoxia and bleeding in the airways which ultimately leads to respiratory insufficiency (395). Since 
inhalation is the predominant route of host entry, the infection predominantly occurs in the lungs.  
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Unfortunately, the symptoms caused by invasive aspergillosis are non-specific, diagnosis is difficult 
and the resulting delayed start of anti-fungal therapies is a major contributor to the high mortality 
rates associated with invasive aspergillosis (396,397) . New diagnostic methods, such as the β(1,3)-
glucan and galactomannan assays are a valuable advance in screening and diagnosing invasive disease, 
but definite diagnosis is not straight and the mortality rates are still very high (398,399).  
Invasive aspergillosis is a major clinical complication in myeloid leukaemia patients before treatment, 
during chemotherapy and after transplantation (1). The high risk of AML patients to develop IA has 
been attributed to several factors, such as impairment of host defences due to intensive cytotoxic 
therapy, blood stem cell transplantation, ablative radiation therapy, use of corticosteroids or 
cyclosporine, as well as the underlying hematologic malignancy (400–403). During AML treatments, 
including chemotherapy or/and stem cell transplantation the patients are immuno-compromised 
resulting in a high susceptibility to infection. At least 10% of AML patients develop IA during the 
chemotherapy-induced period of aplasia. The mortality rate caused by IA can reach 50% in patients 
with chemotherapy-induced neutropenia and can exceed 90% in patients receiving hematopoietic 
stem cell transplantation (HSCT) (404,405). Optimal timing and choice of antifungal agents largely 
remain a matter of controversy. However, prophylaxis with posaconazole is recommended for 
allogeneic HSCT recipients, patients receiving chemotherapy and for those undergoing 
immunosuppressive therapy for graft-versus-host disease after allogeneic HSCT (406).  
Several studies have revealed that NK cells from AML patients have impaired cytotoxicity.  The analysis 
of NK cells from 32 AML patients showed that NK cells have an abnormal surface phenotype, with 
downregulation of the activating receptor NKp46 and upregulation of the inhibitory receptor NKG2A. 
More, NK cells from these patients had impaired effector function against autologous blasts and K562 
targets, with significantly reduced CD107a degranulation, TNF-α and IFN-γ production (407). Another 
study performed with cells from AML patients showed a weak NK cell cytolytic activity against 
autologous leukemic cells and a downregulation on NKp46 and NKp30 expression (408).  
The better understanding of NK cell-mediated immunity to Aspergillus fumigatus could improve our 
knowledge of the pathogenesis of IA in these patients and could open the possibility for the use of NK 
cell therapy not only to avoid relapse but also to fight IA. 
 
1.6.2.1 Diagnosis of invasive aspergillosis 
The diagnosis of IA remains a significant challenge for physicians, with delayed diagnosis being usually 
associated with poor prognosis and high mortality rates (409). The diagnosis of IA is currently based 
on a combination of different methods, including isolation of the microorganism, direct microscopy, 
histopathological examination, imaging, antigen detection and PCR analysis (410).  
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Culture of clinical samples and direct microscopy are simple and cheap methods for the diagnosis of 
pathogen infection however, they have low sensitivity and fungal culture in IA patients may be 
negative even when infection is widely disseminated (411).   
Histopathological examination of biopsy or autopsy tissue, for the visualization of tissue invasion by 
filamentous fungus is also a method used for the diagnosis of IA and provides a proven of invasive 
fungal infection (412).  
Chest computer tomography has been shown to be a useful imaging technique for the diagnosis of IA, 
allowing the visualization of the halo sign, a macronodule surrounded by a perimeter of ground-glass 
opacity that is an early indicator of invasive pulmonary infection (413).  
PCR-based methods for the detection of fungal DNA and fungal cell wall components, have also been 
developed and constitute a high sensitive methodology for IA diagnosis (414).  
More recently, new diagnostic methods, such as the detection of β(1,3)-glucan and galactomannan in 
clinical specimens, have demonstrated to be a valuable tool in screening and diagnosing invasive 
disease (398,399). 
 
1.7 Sphingolipids metabolism 
Sphingolipids are sources of important signalling molecules. The sphingolipid metabolite, sphingosine-
1-phosphate (S1P) has emerged as a new potent bioactive molecule, implicated in several cellular 
processes such as cell differentiation, proliferation and cell survival (415,416).  
Sphingomyelin (SM) is the major sphingolipid in the cell membrane and is the precursor of important 
bioactive products. SM is converted in ceramide by the action of sphingomyelinases and ceramide can 
be rapidly hydrolysed by ceramidases to yield sphingosine. Sphingosine kinases (SphKs) can 
phosphorylate sphingosine generating S1P (Figure 8) (417,418).  
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Figure 8: Sphingolipid metabolic pathway 
Adapted from Melendez, AJ. 2008 (419) 
 
Several biological effectors have been shown to promote the activation of SphKs and the synthesis of 
S1P, including growth factors, cytokines and G-protein-coupled receptor agonists (420–423). Several 
studies have shown that S1P has two distinct signalling roles, as an intracellular second messenger 
and as an extracellular ligand for a specific G-protein- coupled receptor family (424,425). The best 
studied intracellular function of S1P is the role of this bioactive sphingolipid in the triggering of Ca2+ 
release from internal stores (426,427). Cytosolic Ca2+ is a ubiquitous intracellular messenger, pivotal 
in many signal transduction pathways (428). As an extracellular mediator, S1P binds to a group of G-
protein-coupled receptors, collectively known as the S1P-receptors (S1PR) (429). Binding of S1P to 
these receptors trigger a wide range of cellular responses including proliferation, stimulation of 
adherent junctions and inhibition of apoptosis (430–433). 
In immune cells, the sphingolipid metabolism is involved in several processes such as cell activation, 
proliferation, cell survival, calcium mobilization and chemotaxis.  
SphK  and S1P showed to play a key role in neutrophil activation, including in TNF-α and superoxide 
production, and in neutrophil chemotaxis (423,434,435).  
The activation of macrophages by anaphylatoxins results in calcium release from internal stores, 
chemotaxis, cell degranulation and cytokine production, with SphK mediating all these cellular 
processes (436). Furthermore, it has been shown that inhibition of SphK by intracellular pathogens, 
on macrophages, may contribute to the survival of the pathogen. Mycobacterium tuberculosis is a 
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highly successful pathogen that parasitizes the macrophages of its host. Following its ingestion by 
macrophages, M. tuberculosis inhibits phagosome maturation preventing the progression of the 
phagosome into an acidic, bactericidal lysosomic compartment (437). Phagosome maturation is 
regulated by Ca2+ signals and it has been reported that M. tuberculosis blocks Ca2+ signalling and 
consequently phagosome maturation in human macrophages via specific inhibition of SphK (438).  
Activation of monocytes via the high-affinity IgG receptor (FcγRI) triggers SphK1 activity which is 
essential for the release of Ca2+ from internal stores and regulates the monocyte NADPH oxidase 
activity (427). 
More recent studies have shown that S1P receptors are critical for lymphocyte egress from the lymph 
organ, and that an antagonist of S1P leads to sequestration of lymphocytes in secondary lymphatic 
tissues and this prevents their access to inflammatory lesions and graft sites (439,440). 
Studies performed in endothelial cells have demonstrated that SphK activity modulates the expression 
of vascular cell adhesion molecules, essential for the recruitment of leukocytes during the 
inflammation response (422,441). More, S1P showed to be involved in endothelial cell responses 
associated with angiogenesis, including the liberation of endothelial cells from established 
monolayers, chemotactic migration, proliferation, adherens junction assembly and morphogenesis 
into capillary like structures (441–443).  
A crucial function of SphK and S1P is their contribution controlling cell proliferation and apoptosis. S1P 
promotes cell survival and suppresses apoptosis, acting as an intracellular second messenger or 
binding to the S1PRs on the cell surface. S1P showed to promote cell survival in response to apoptotic 
stimuli, such as Fas ligand, serum deprivation, ionizing radiation or anticancer drugs (444,445).  
 
1.7.1 Sphingosine Kinases 
Sphingosine kinases are lipid kinases that phosphorylate sphingosine to sphingosin-1-phosphate. 
Together with other sphingolipid metabolizing enzymes, SphKs regulate the balance of the lipid 
mediators, ceramide, sphingosine, and S1P (445). 
Two functional SphK isoenzymes, SphK1 and SphK2, have been cloned, sequenced and characterized 
in mammalian cells (446,447). They are encoded by separate genes and display different catalytic 
properties, subcellular localization and tissue expression patterns (448). SphK1 is located 
predominately in the cytosol and is translocated upon stimulation to the plasma membrane where 
sphingosine is phosphorylated generating S1P. The activation of SphK1 is triggered by ERK1/2-
mediated phosphorylation at Ser225 after cell stimulation (449). SphK2 is localized mainly in the 
nucleus, where it was reported to inhibit DNA synthesis, induce G1/S cell cycle arrest, suppress cell 
growth and induce apoptosis via regulation of the cyclin-dependent kinase inhibitor p21 (450,451). 
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Although SphK1 and SphK2 appear to have opposing roles, promoting cell growth and apoptosis, 
respectively, they can obviously also substitute for each other, as a single SphK knockout had no effect 
on development or reproduction, whereas double SphK1 and SphK2 knockout showed to cause 
embryotic lethality since S1P is not produced (452).  
The tissue expression pattern of SphKs is different, SphK1 expression is highest in lung, spleen, kidney, 
and blood, whereas SphK2 is predominantly found in liver, kidney, brain, and heart (447,453,454).  
SphKs are evolutionarily well conserved, with common regions in protozoan, yeast, plant and 
mammals (455,456). The mammalian SphKs possess a conserved kinase catalytic domain that contains 
an ATP binding site, as well as five other conserved domains, C1 through C5 (447,457). C1–C3 domains 
contain the DAG kinase catalytic domain, which is also found in DAG kinases and ceramide kinase, 
whereas C4 appears to be unique in SphKs (448,458).  
Both SphK1 and SphK 2 are capable of phosphorylating erythro-sphingosine, dihydrosphingosine and 
phytosphingosine, but no other lipids appear to be significantly phosphorylated by the enzymes 
(457,459).  
In man, three variants of SphK1 with 384, 399 and 470 amino acids, named SphK1a, SphK1b and 
SphK1c, respectively, have been identified (460). For SphK2, also three variants have been identified, 
SphK2a, SphK2b and SphK2c (460–462). Enzyme kinetics were found to be similar for the respective 
SphK1 and SphK2 variants (453).  
Several molecules such as platelet-derived growth factor (PDGF), epidermal growth factor (EGF), 
vascular endothelial growth factor (VEGF) and TNF-α, showed to stimulate SphK1 activity 
(421,449,463,464).  
 
1.7.2 Sphingosine-1-phosphate receptors 
Despite the important function of sphingosine-1-phosphate as an intracellular messenger, S1P also 
acts as an extracellular signalling molecule (424). So far, four ATP-binding cassette (ABC) transporters 
(ABCA1, ABCB1, ABCC1 and ABCG2) have been reported as S1P transporters out of the cell (465–468). 
Once released, S1P can act in an autocrine and/or paracrine manner, through interaction with specific 
G-protein-coupled receptors on the cell surface (429). Five transmembrane receptors have been 
identified as S1P receptors (S1PRs), named S1P1, S1P2, S1P3, S1P4 and S1P5 (469). Upon interaction 
of S1P with S1P receptors on the cell surface, the G proteins coupled to the S1P receptors activate a 
complex downstream cascade that includes phospholipase C activation, intracellular mobilization of 
calcium and Akt and ERK1/2 phosphorylation (470–473). 
S1P receptors play a key role in several physiological processes such as vasculogenesis and regulation 
of vascular tone, chemotaxis and lymphocyte trafficking, inflammation and immunity (474–476).   
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S1P1 was the first S1P receptor to be identified and is expressed in spleen, brain, heart, lung, adipose 
tissues, liver, thymus, kidney, and skeletal muscle (477). The knockout of S1P1 in mice revealed an 
important function of S1P1 in vascular maturation (478). S1P1 receptor also showed to be decisive for 
B- and T-cell egress from lymph nodes and for the exit of mature T cells and natural killer T (NKT) cells 
from the thymus (479–481).  S1P2 or S1P3 deletion in mice did not result in any physiological defect 
(482,483). S1P4 expression is highly restricted to immune cells and tissues, including the thymus, 
spleen, bone marrow, peripheral leukocytes and lung (483). S1P4 showed to signal suppression of T 
cell proliferation and generation of cytokines such as IL-2, IL-4 and IFN-γ. In contrast, S1P4 signals 
enhance production of IL-10 in T cells (484). S1P5 receptor expression is also restricted to specific 
tissues, including the brain, spleen and peripheral blood leukocytes in human (483,485) and seems to 
have an important function in cell migration (486,487).  
The knowledge of S1P receptors is rapidly increasing and they became attractive therapeutic targets 
in several diseases, such as chronic inflammatory pathologies, autoimmunity and cancer (488). 
 
1.7.3 Sphingosine kinases and acute myeloid leukaemia 
Sphingolipid metabolism has been demonstrated to play a key role in cancer pathogenesis, 
progression, angiogenesis, migration, drug resistance and cell death of tumour cells (489–491). The 
dynamic balance between the interconvertible sphingolipid metabolits, ceramide and S1P, is a major 
determinant of cell fate, with ceramide exerting antiproliferative effects whereas S1P promotes 
proliferation, cell survival and inhibition of apoptosis (492,493). SphKs, particularly SphK1, play a 
central role regulating the “sphingolipid rheostat” and the elevated expression of this kinase has been 
associated with the progression of various hematologic malignancies (494–497). More, SphK1 showed 
to control chemotherapy sensitivity in AML cells (498,499). These findings, have stimulated the 
research focused on this signalling pathway as a potential target for AML therapy, and the 
development of numerous SphKs inhibitors over the past decade (500). 
 
1.7.4 Role of Sphingosine kinase 1 in NK cell function 
Sphingosine kinases, spingosine-1-phosphate and S1P receptors have been demonstrated to be key 
regulators of several biological processes in immune cells. It is becoming clear that these biologic 
effectors also play an important function in NK cells trafficking and activation. The S1P pathway seems 
to be particularly important for regulating NK cell migration (487). S1P showed to be a potent 
chemoattractant for human NK cells, inducing chemotaxis of these cells dependent on the activity of 
phosphoinositide 3 kinase (PI3K) (501).  
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Some studies performed in vivo have demonstrated that NK cell trafficking is dependent on S1P5. S1P5 
showed to be implicated in NK cell homing in steady-state conditions and to be required for the 
mobilization of NK cells during inflammatory situations (487). The NK cells egress from lymph nodes 
and bone marrow requires S1P5. S1P1 also contributes to NK migration from lymph nodes to lymph, 
but the contribution is relatively minor compared to that of S1P5 (502).  
Studies performed in decidual NK cells (dNK), a specialized NK subset that regulates trophoblast 
invasion during early pregnancy, demonstrated that S1P1 and S1P5 are increased in human dNK cells. 
FTY720 treatment decreased dNK S1P5 expression and trophoblast invasion in vitro (503).  
S1P5 is expressed in NK cells in mice and humans and the analysis of S1P5 expression showed that the 
expression of this receptor increases with NK cell maturation (487). This differential S1P5 expression 
correlates with the tissue distribution of human NK cell subsets, as CD56dim subset prevail in the blood 
and spleen and CD56 bright subset is predominate in lymphoid nodes (504).  
Sphingolipids metabolism seems to be also involved in NK cell activation but the few existing studies 
are contradictory. SphK1 activity was shown to be essential for IL-18-induced IFN-γ production in 
human primary NK cells, with the inhibition of this enzyme resulting in the reduction of IFN-γ mRNA 
and protein expression (505). On the other hand, another study concluded that S1P inhibits the release 
of inflammatory cytokines such as IFN-γ and IL-17a from human NK cells and reduces NK cell 
cytotoxicity against target cells. These inhibitory effects were S1P1-independent. (506). These 
contradictory results might indicate a dual response of SphK enzymes and their product, depending 
of the cellular state.  
Analysis of sphingosine kinase activity in single NK cells from peripheral blood, suggests that the 
activity of these enzymes is highly heterogeneous between NK cells from the same donor and also 
between different donors (507).  
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1.8 Hypothesis 
Natural killer cells play an important role in host defence against Aspergillus fumigatus 
 
1.9 Project Aims 
1. To characterize the human NK cell response to Aspergillus fumigatus, including phenotypic and 
functional analysis  
 
2. To understand how NK cell response to Aspergillus fumigatus is affected in acute myeloid leukaemia 
 
3. To determine the effect of FTY720 and SKI-II, two inhibitors of the sphingosine kinase pathway, on 
human NK cell response to cancer cells 
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2. Materials and Methods 
 
2.1 Cell lines 
 
2.1.1 K562 cell line 
The K562 erythroleukaemia cell line was initially isolated from a chronic myeloid leukaemia patient in 
blast crisis and is commonly used in NK cell functional assay studies as it makes an excellent positive 
control for NK cytotoxicity (508–510). Due to the lack of MHC Class I expression, K562 is susceptible 
to NK cell lysis according to the missing-self theory. K562 cells were cultured in RPMI 1640 [+] L-
Glutamine [+] 25mM HEPES (Gibco by Life Technologies) supplemented with 10% FBS (Fetal Bovine 
Serum) (Gibco by Life Technologies), 0.5mM Sodium Pyruvate (Sigma-Aldrich) and 1% Non-essential 
amino acids (NEAA) (Gibco by Life Technologies). The cells were maintained in a tissue culture 
incubator at 37°C, >95% humidity and 5% CO2.  
 
2.1.2 YTS cell line 
The human YTS Natural Killer cell line is a sub-clone of the YT lymphoid cell line derived from a patient 
with acute lymphoblastic lymphoma. YTS do not express any KIRs (NK inhibitory receptors), is 
independent of IL-2 and is not cytotoxic to K562 (511–513). 
 
2.1.3 NK92 cell line 
NK92 is an IL-2-dependent tumour Natural Killer cell line established from peripheral blood 
mononuclear cells from a patient with rapidly progressive non-Hodgkin’s lymphoma. The NK92 cell 
line is highly cytotoxic to human cancer cells, including K562 cells and exhibits an unusual receptor 
expression profile. These cells display a relatively large number of activating receptors but it expresses 
few inhibitory receptors. NK92 cells are strictly dependent on interleukin-2 (IL-2) for sustained growth 
(514). 
 
2.1.4 NKL cell line 
NKL cell line was established from the peripheral blood of a patient with CD3-CD16+CD56+ large 
granular lymphocyte (LGL) leukaemia. NKL cells can mediate ADCC (Antibody‐dependent cell‐
mediated cytotoxicity) as well as NK cells (515). NKL cells are strictly dependent on interleukin-2 (IL-2) 
for sustained growth.  
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2.1.5 Culture media  
YTS, NK92 and NKL cells were cultured in RPMI 1640 [+] L-Glutamine [+] 25mM HEPES (Gibco by Life 
Technologies) supplemented with 10% heat-inactivated foetal bovine serum (FBS) (Gibco by Life 
Technologies), 0.5mM Sodium Pyruvate (Sigma-Aldrich), 1% Non-Essential Amino Acids (NEAA) (Gibco 
by Life Technologies) and 50μM 2-Mercaptoethanol (Gibco by Life Technologies). NK92 and NKL cells 
were cultured in the presence of 200U/mL of recombinant human interleukin 2 (IL-2) (Peprotech). 
The cells were maintained in a tissue culture incubator at 37°C, >95% humidity and 5% CO2. 
YTS, NK92 and NKL cell lines were kindly donated by Professor Daniel Davis (Faculty of Life Sciences, 
University of Manchester). 
 
2.2 Culture of primary human cells  
 
2.2.1 Isolation of PBMCs from healthy donors  
Fresh whole blood from healthy volunteers was collected in K2 EDTA-treated 10ml BD vacutainer 
blood collection tubes (BD Biosciences). In some experiments requiring large numbers of mononuclear 
cells, buffy coat was purchased from NHS Blood and Transplant United Kingdom. Peripheral blood 
mononuclear cells (PBMCs) were isolated by density gradient centrifugation using Ficoll-PaqueTM PLUS 
solution (GE Healthcare). Blood samples were diluted with RPMI (Gibco by Life Technologies) and 30 
mL of the diluted blood was gently layered over 12mL of Ficoll-PaqueTM PLUS solution. The samples 
were centrifuged at 1800rpm for 40 minutes at 20°C, low acceleration and brake off. After 
centrifugation, the mononuclear cell layer was carefully collected with a sterile transfer pipette, 
washed once in RPMI, followed by two washes in phosphate-buffered saline (PBS) (Gibco by Life 
Technologies) by centrifugation at 1500rpm for 10 minutes. The remaining erythrocytes in solution 
were lysed incubating cells for 10 minutes in red blood cell lysing buffer (Sigma-Aldrich). Cells were 
washed in PBS and counted for viability. PBMCs were either plated/incubated, used for NK cell 
isolation or cryopreserved in FBS with 10% DMSO (Acros Organics) and stored at -80°C. 
 
2.2.1.1 Freezing process 
PBMCs were resuspended in cold FBS 10% DMSO (Acros Organics) at a concentration of 2×106 
cells/mL. The cell suspension was quickly aliquoted into cryovials on ice and transferred into a pre-
chilled controlled freezing-rate Nalgene box (Fisher Scientific), which was stored in -80°C overnight. 
Cryovials were then transferred into liquid nitrogen.  
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2.2.1.2 Thawing 
Cryovials were removed from liquid nitrogen or -80°C freezer and placed on ice. Vials were quick-
thawed in a 37°C water-bath and immediately transferred to 15ml of pre-warmed medium. Cells were 
centrifuged at 1500 rpm for 10 minutes and resuspended in supplemented media for counting and 
viability assessment by trypan blue exclusion (516). Following freeze-thaw procedure, the yield of 
viable cells ranged between 80-90%. Cells were rested overnight at 37°C, 5% CO2 prior to experiments. 
 
2.2.2 Isolation of PBMCs from acute myeloid leukaemia patients 
Leukodepletion samples from AML patients were kindly sent by Professor Katy Rezvani from MD 
Anderson Cancer Center, Houston, Texas, USA. Leukodepletion is defined as a blood processing step 
for reducing the leukocyte content of whole blood and is a procedure often used in the treatment of 
hematologic malignancies (517–521). Leukodepletion samples were collected in blood collection bags 
containing EDTA and stored at -80°C. Leukodepletion samples were shipped to our lab with dry ice 
and upon arrival they were immediately stored at -80°C. In order to isolate PBMCs from AML patients, 
the apheresis bags containing the leukodepletion samples were thawed in a water bath and as soon 
as the port end was thawed, 1mL of benzonase was injected into the bag. The apheresis bag was then 
thawed in a water bath whilst massaging gently in order to homogenise the benzonase in the sample. 
As soon as the entire content became semi-fluid, the content was poured into previously prepared 
PBS/benzonase buffer and immediately centrifuged at 1500 rpm for 12 min. The cell pellet was 
resuspended in PBS/benzonase buffer and cells were re-spin at 1500 rpm for 12 min. The cell pellet 
was then resuspended in PBS followed by the ficoll gradient separation. The samples were centrifuged 
at 1800rpm for 40 minutes at 20°C, low acceleration and brake off. After centrifugation, the 
mononuclear cell layer was carefully collected with a sterile transfer pipette, washed once in RPMI, 
followed by two washes in phosphate-buffered saline (PBS) (Gibco by Life Technologies) centrifuging 
the cells at 1500 rpm for 10 min. The remaining erythrocytes in solution were lysed incubating cells 
for 10 min in red blood cell lysing buffer (Sigma-Aldrich). Cells were washed in PBS and counted for 
viability. PBMCs were either plated/incubated, used for NK cell isolation or cryopreserved in FBS with 
10% DMSO (Acros Organics) and stored at -80°C. 
Benzonase is a genetically-engineered endonuclease that cleaves all kinds of DNA and RNA variants 
into small fragments resulting in minimal nuclei acid load, and hence low viscosity of blood preventing 
cell clumping.  
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2.2.3 Purification of NK cells from PBMCs using the Miltenyi bead selection method 
NK cell isolation was performed using the NK Cell isolation kit human from MACS Miltenyi Biotec 
according to manufacturer’s instructions. PBMCs were washed in MACS buffer containing 0.5% bovine 
serum albumin (BSA) and 2mM EDTA and resuspended in 40μL of the same buffer per 107 total cells. 
10μl of NK Cell Biotin-antibody cocktail was added to the suspension per 107 total cells and incubated 
in the refrigerator (2-8℃) for 10 minutes after mixing thoroughly. A further 30 μl of buffer per 107 
total cells was added to the suspension along with 20μl of NK Cell MicroBead cocktail per 107 total 
cells, which was mixed thoroughly and incubated for an additional 15 minutes in the refrigerator (2-
8°C). After the incubation period, cells were washed in MACS buffer, centrifuged at 1500rpm for 10 
minutes and resuspended in 500μL of the same buffer. Immediately prior to proceeding to magnetic 
separation, an appropriate number of LS MACS Separator Columns were prepared by rinsing with 3ml 
of MACS buffer. The cell suspension was applied to the column at a ratio of maximum 1×108 cells per 
column. Isolation of highly pure NK cells was achieved by depletion of magnetically labelled cells 
retaining them inside the MACS column in the magnetic field of a MACS Separator, while the un-
labelled NK cells ran through the column and were collected in a suitable collection tube. Isolated NK 
cells were incubated at a concentration of 1Х106 cells/mL in DMEM (Gibco by Life Technologies) 
supplemented with F-12 feeder (Gibco by Life Technologies), 10% Human serum (Sigma-Aldrich), 1% 
sodium pyruvate(Sigma-Aldrich), 1% NEAA (Gibco by Life Technologies), 50μM of mercaptoethanol 
(Gibco by Life Technologies) and 300U/mL of recombinant human IL-2 (Peprotech). 
Purity of the selected NK cells was evaluated by flow cytometry. Cells were surface stained with anti-
CD56 and anti-CD3 for 25 minutes in the dark before analysis. Purity was ensured to be >90% for all 
experiments. Negative selection was chosen for the separation strategy to avoid any downstream 
interference that could occur from direct labelling of surface molecules (e.g, activation). 
 
2.2.3.1 Representative example plot of purity and viability evaluation 
Purity and viability of isolated NK cells were analysed on FACS after NK cell selection, to ensure high 
quality and purity (> 90%) of the isolated cells. Zombie Aqua staining was used in order to check cell 
viability and NK cell purity assessment was based on the expression of CD56 and the absence of CD3 
on NK cells (CD56+ CD3-). The following FACS plots are representative samples selected from a 
consistent set of interpretable data (Figure 9).  
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A) Unstained cell population 
          
 
 
B) Cell population stained with live/dead staining (Zombie Aqua), CD56 and CD3 antibodies  
          
Figure 9: Example of FACS plots showing cell viability and NK cell purity of NK cells isolated from fresh 
blood from healthy donors after isolation using the NK cell isolation kit, human from MACS Miltenyi 
Biotec. Cells were first gated using forward and side scatter, followed by the identification of the live 
population using Aqua zombie staining. NK cell population purity was determined gating on CD56+, 
CD3- cell population. A) Unstained cell population; B) Cell population stained with live/dead staining 
(Zombie Aqua), CD56 and CD3 antibodies. 
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A) Unstained cell population 
  
 
B) Cell population stained with live/dead staining (Zombie Aqua), CD56 and CD3 antibodies  
  
 
Figure 10: Example of FACS plots showing cell viability and NK cell purity of NK cells isolated from AML 
patients after isolation using the NK cell isolation kit, human from MACS Miltenyi Biotec. Cells were 
first gated using forward and side scatter, followed by the identification of the live population using 
Aqua zombie staining. NK cell population purity was determined gating on CD56+, CD3- cell population. 
A) Unstained cell population; B) Cell population stained with live/dead staining (Zombie Aqua), CD56 
and CD3 antibodies. 
 
2.3 Aspergillus fumigatus preparation  
A. fumigatus American Type Culture Collection (ATCC) strain 46645 was obtained from Elaine Bignell’s 
lab. An eGFP-expressing derivate of the ATCC46645 strain (ATCC46645-eGFP) was a kind gift from 
Frank Ebel (522). Aspergillus fumigatus strain CEA10 (FGSC A1163) was obtained from the Fungal 
Genetics Stock Center and the Aspergillus fumigatus tdTomato (ATCC 46645 strain expressing 
tdTomato protein) was a kind gift from Sven Krappamann from Universitaet Wuerzburg. A. fumigatus 
ΔgliGAF293 (293 gliG-deleted strain) was a kind gift from Professor Sean Doyle from Department of 
Biology and National Institute for Cellular Biotechnology.  
 
All strains were cultured on Sabouraud dextrose agar (Oxoid) and incubated at 37°C for 3-5 days. 
Conidia were harvested in 0.1 % Tween 20/H2O, filtered through Miracloth (Calbiochem) to remove 
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the mycelium. The suspension was washed twice with 0.1% Tween 20/H2O and resuspended in H2O. 
Conidia were swollen by incubation of resting conidia in RPMI 1640 (Gibco by Life Technologies) for 4 
hours at 37°C. For germling preparation the incubation time was 6 hours and for hyphae 12 hours.   
Fixed swollen conidia were generated by fixing A. fumigatus in 2 % paraformaldehyde (PFA) overnight 
at 4°C. 
Heat killed A. fumigatus were generated by autoclaving at 121°C for 30min. 
 
2.3.1 Preparation of Aspergillus fumigatus culture supernatant 
A. fumigatus ATCC46645 WT was incubated for 16 hours in supplemented medium at a concentration 
of 5×105 resting conidia/mL in a 6 well plate. After the incubation period, supernatant was collected 
and centrifuged twice at 4000 rpm for 5 minutes to remove all A. fumigatus in suspension. 
 
2.4 Analysis of NK cell cytokine production in response to Aspergillus fumigatus 
Isolated NK cells were challenged with A. fumigatus at different developmental stages of the fungus, 
including swollen conidia, germlings and hyphae. Several MOIs (multiplicity of infection) were tested 
and different time points were analysed. NK cell activation via cytokine production was assessed by 
ELISA, Luminex multiplex and FACS. The incubation of NK cells with K562 cell line at a ratio of 1:1 was 
used as a positive control for NK cell activation. 
 
2.4.1 TNF-α and IFN-γ enzyme-linked immunosorbent assay (ELISA)  
For the quantification of cytokines in the supernatant of co-cultures, ELISAs were performed according 
to the manufacturer's instructions using the TNF-α and IFN-γ DuoSet kits from R& D systems. Briefly, 
capture antibody was diluted in PBS at the recommended working concentration and distributed in a 
96 well plate (100 μL/well). Plates were sealed and incubated overnight at room temperature. Plates 
were washed with 0.05% Tween 20 in PBS and blocked for 1 hour with 1% BSA in PBS. After washing, 
100 μL of sample or standard were added to each well and the plate was incubated for 2 hours at 
room temperature. Plates were washed and 100 μL of detection antibody, at recommended working 
concentration, were distributed into the plate. Washing steps were performed followed by the 
addition of 100 μL of diluted streptavidin-HRP. After 20 min incubation, plates were washed and 100 
μL of substrate solution was added to each well. Plates were incubated for 20 min at room 
temperature and then the reaction was stopped adding 50 μL of stop solution. The optical density of 
each well was determined at 450 nm. All samples and standards were ran in duplicates. The 
concentration of the cytokines in the samples was calculated based on the standard curve generated 
for each set of samples assayed. 
74 
 
2.4.2 Luminex multiplex assay 
For the quantification of cytokines and chemokines in the supernatant of co-cultures, Luminex 
multiplex assay was performed according to the manufacturer's instructions using the Milliplex Map 
kit from EMD Millipore Corporation. Luminex technology allows the measurement of multiple specific 
analytes in a single sample using colour coded magnet microspheres coated with a specific capture 
antibody. Different analytes from a test sample are captured by the colour coded magnetic beads, 
followed by the binding of a biotinylated detection antibody that is added to the reaction. Streptavidin 
PE conjugate is the reporter molecule allowing the quantification of each analyte. The microspheres 
pass through a laser which excites the internal dyes marking the microsphere set and a second laser 
excites PE, the fluorescent dye on the reporter molecule. 
The following analytes were determined: IFN-γ, TNF-α, GM-CSF, IL-10, IL-12p40, IL-15, IL-17, IL-1RA, 
IL-1α, IL-1β, IL-4, IL-7, IL-8, MCP-1, MIP-1α, MIP-1β and RANTES.  
Briefly, 25 μL of sample or standard was added to appropriate wells followed by the addition of 25 μL 
of magnetic beads. The plate was sealed and incubated with agitation on a plate shaker overnight at 
4°C in the dark. After incubation time, the plate was gently washed and 25 μL of detection antibody 
was added. The incubation was performed for 1 hour with agitation at room temperature in the dark. 
Streptavidin-PE (25 μL) was added to each well containing the detection antibody, followed by an extra 
30 min incubation. The wells were gently washed and 150 μL of sheath fluid were added to resuspend 
the beads. The plate was analysed on MAGPIX multiplex reader (Millipore) and xPONENT software 
determined the concentration of each analyte from the standard curve.  
 
2.4.3 Flow cytometry 
All data acquisition for multicolour flow cytometry assays were performed on a BD LSR Fortessa 
analyser equipped with 4 lasers. Detailed configurations are as follows; Violet 405nm laser (4 filters), 
Blue 488nm laser (3 filters), Yellow-Green 561nm laser (5 filters) and Red 640nm laser (3 filters). Data 
were analysed using FlowJoTM software (Treestar, San Carlos, CA). 
 
2.4.3.1 Analysis of NK cell activation via cytokine production by FACS – Intracellular cytokine 
staining 
Isolated NK cells (2×105 cells/well) were cultured in 96 well flat bottom plates and challenged with A. 
fumigatus or with K562 cells at a ratio 1:1 (positive control). In order to determine the intracellular 
expression of IFN-γ and TNF-α, 5 μg/mL of brefeldin A (BFA) was added to each well. BFA is a fungal 
metabolite which disrupts intracellular Golgi-mediated transport and allows cytokines to accumulate 
inside the cells allowing the detection of cytokine production by flow cytometry (523,524). 
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After the co-incubation period, cells were collected in FACS tubes and washed with PBS. Incubation 
with surface antibodies (CD56 and CD3) was performed for 25 minutes in the dark.  Cells were washed, 
permeabilized and fixed using permeabilizing solution 2 (BD biosciences), and finally stained for 
intracellular components (anti-human IFN-γ and anti-human TNF-α). After 30min incubation in the 
dark at room temperature, cells were washed and acquired on the Fortessa analyser (BD biosciences). 
Data was analysed on FlowJo Software. 
 
2.4.3.2 NK cell activation in response to K562 cells on FACS – Positive control 
NK cells showed a potent response to K562 cells, a HLA class I deficient leukemia cell line. Co-
incubation of NK cells with K562 cell line (ratio 1:1) was used as a positive control for NK cell activation 
(Figure 11).  
 
Figure 11: Representative FACS plots of CD107a, IFN-γ and TNF-α expression on NK cells in response 
to K562 cell line. Co-culture of NK cells with K562 cell line induces NK cell activation, including NK cell 
degranulation and cytokine production. CD107a, IFN-γ and TNF-α expression was assessed by FACS.   
 
2.5 Analysis of NK cell cytotoxic response to Aspergillus fumigatus 
Isolated NK cells were challenged with A. fumigatus at different developmental stages of the fungus, 
including swollen conidia and germlings. Several MOIs (multiplicity of infection) were tested and 
different time points were analysed. NK cell activation via degranulation was assessed by FACS, 
confocal microscopy and ELISA. The incubation of NK cells with K562 cell line at a ratio of 1:1 was used 
as a positive control for NK cell activation. 
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2.5.1 Analysis of NK cell activation via degranulation by FACS – CD107a analysis 
The wall of NK cell lytic granules contains a range of lysosomal-membrane-associated glycoproteins 
including CD107a, which protect the NK cells from the granules contents. CD107a is upregulated on 
NK cell surface following the release of cytotoxic granules. CD107a has been extensively used as a 
marker of NK cell functional activity, allowing the identification of cell degranulation (68).  
Isolated NK cells (2×105 cells/well) were cultured in 96 well flat bottom plates and challenged with A. 
fumigatus or with K562 cells at a ratio 1:1 (positive control). CD107a antibody was added to the co-
culture at time 0 hours. After the co-incubation period, cells were collected in FACS tubes and washed 
with PBS. Incubation with surface antibodies (CD56 and CD3) was performed for 25 minutes in the 
dark. Cells were washed in PBS, followed by staining with zombie aqua dye (BioLegend) dilution 1:1000 
for 30 min. A washing step was performed followed by cell permeabilizaton and fixation using 
permeabilizing solution 2 (BD biosciences). Cells were washed and acquired on the Fortessa analyser 
(BD biosciences). Data was analysed on FlowJo Software. See representative example of CD107a 
analysis by FACS on Figure 12. 
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A) NK cells stained with Zombie Aqua + CD56 + CD3 
 
B) NK cells stained with Zombie Aqua + CD56 + CD3 + CD107a 
Figure 12: Representative example of CD107a analysis on NK cell surface by FACS. Cells were first 
gated using forward and side scatter, followed by the identification of the live population using Aqua 
zombie staining. NK cell population purity was determined gating on CD56+, CD3- cell population 
followed by the analysis of CD107a expression. A) NK cells were stained with zombie aqua dye, CD56 
and CD3 antibodies (no CD107a) in order to define the CD107a positive population; B) NK cells were 
stained with zombie aqua dye, CD56, CD3 and CD107a antibodies and gates defined on example A 
were applied to the population on example B to determine the percentage of cells positive for CD107a 
antibody.  
 
2.5.2 Analysis of NK cell degranulation by confocal microscopy 
GFP-expressing Af were seeded on glass cover slips in 24 well plates until they were germlings. NK 
cells were added at an MOI of 0.05 and the co-incubation was performed overnight. Before staining, 
cells were washed twice with phosphate buffered saline and fixed and permeabilized in permeabilizing 
solution 2 from BD biosciences. Cells were washed once more with PBS and blocked in PBS containing 
10% goat serum for 2 hours, followed by incubation with a primary antibody (Table 1) overnight at 
4°C. The cover slips were washed 3 times in PBS, followed by incubation with a secondary antibody 
and Alexa Fluor® 633 phalloidin diluted 1:500 for 1 hour at room temperature. All antibody incubation 
steps were performed in PBS containing 10% goat serum. Cover slips were washed 3 times in PBS 
before being mounted with Vectashield mounting medium containing DAPI (Vectorlabs). Cover slips 
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were sealed with nail varnish to avoid evaporation. All images were taken with a Zeiss LSM-510 
confocal microscope. 
Antibody Clone and supplier Dilution 
Lamp-1 (CD107a) H4A3, Biolegend 1:50 
Perforin dG9, Biolegend 1:50 
Granulysin Santa Cruz 1:50 
Table 1: Primary antibodies used for confocal microscopy 
 
2.5.2.1 Quantitative analysis of granule polarization in NK cells in response to Aspergillus 
fumigatus 
In order to analyse quantitatively the granule polarization on NK cells towards A. fumigatus, a Matlab 
code was developed by Dr. Yuriy Alexandrov, who is an expert in biomedical imaging and data analysis. 
He is currently collaborating with the Facility for Imaging by Light Microscopy (FILM) at Imperial 
College London. The mathematical code developed by Dr. Yuriy Alexandrov was named 
“FungusDependentGranuleRelease_tools” and analyses several parameters on the images that I 
obtained by confocal microscopy such as, number of granules per cell, granules mean area, granules 
mean distance to cell centre, granules mean fungi to cell angle, minimum distance of the cell to fungus, 
mean distance of the cell to fungus, minimum distance of the granules to fungus, mean distance of 
the granules to fungus and granules mean fungi cosine. The quantitative analysis is performed using 
the mathematical code on Matlab software.  
The granules mean fungi cosine is a key parameter on the analysis of NK cell interaction with A. 
fumigatus. The mathematical code calculates the cosine of the angle between the direction of a line 
from granule to the fungus and the direction of a line from granule to the cell centre (Figure 13). If 
granules are located on the side of the cell opposite of the fungus side the angle is close to 0° and 
consequently cosine close 1. If on the other hand, the granules are located between the cell centre 
and the fungus, angle is close to 180° and cosine close to -1. 
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Figure 13: Representative scheme showing the principle behind the calculation of the granules mean 
fungi cosine parameter.   
 
Example of data analysis using FungusDependentGranuleRelease_tools 
2D images, obtained by confocal microscopy, were initially opened and analysed on ImageJ in order 
to save them in a TIFF format. Figure 14 shows an example of a 2D image opened and analysed using 
ImageJ software. Each laser was analysed separately followed by the creation of a composite image 
(TIFF format) with nuclei indicated in blue, A. fumigatus GFP in green and CD107a indicated in pink 
(Figure 14 C). For the quantitative analysis, the image obtained with brightfield laser is not used.  
TIFF format images were further analysed using the “FungusDependentGranuleRelease_tools” code.  
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Figure 14: Example of a 2D image obtained by confocal microscopy. NK cells were incubated with A. 
fumigatus germling overnight. Images were obtained by confocal microscopy and analysed on ImageJ. 
Nuclei are indicated in blue, A. fumigatus GFP in green and CD107a staining indicated in pink. A) Image 
with 405/420-480 laser on. B) Image with 405/420-480 and 488/505-530 lasers on. C) Image with 
405/420-480, 488/505-530 and 549/565 lasers on. D) Image with 405/420-480, 488/505-530, 549/565 
and brightfield lasers on. 
 
As previously referred, quantitative analysis of the images, was performed using the mathematical 
code “FungusDependentGranuleRelease_tools” on Matlab. ICY software was also used together with 
Matlab. ICY is an open source software that provides an integrated platform to visualize, annotate and 
quantify bioimaging data (525). Icy was used to execute some functions from Matlab application 
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during the quantitative analyses using the mathematical code 
“FungusDependentGranuleRelease_tools”.  
The analysis was performed following the steps: Run → File → Load single → Download the image → 
Icy → Send original → Segmentation → Adjust → Apply segmentation → Ok → Analysis → Run current.  
 
The pictures below show the detailed analysis of one 2D image obtained by confocal microscopy using 
the mathematical code developed specifically to quantitatively analyse NK cell degranulation in 
response to A. fumigatus.  
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Figure 15: Mathematical code “FungusDependentGranuleRelease_tools” opened on Matlab. 
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Figure 16: Load single file on Matlab. 
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Figure 17: 2D image in TIFF format opened on Matlab to be analysed using 
“FungusDependentGranuleRelease_tools” mathematical code. Image is sent to Icy software using 
Icy plugin on Matlab.  
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Figure 18: Image opened on Icy software.  
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Figure 19: Adjust segmentation. Image segmentation divides the image into multiple parts. 
Parameters for Granules, Fungus and Cells were adjusted for each individual image.  
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Figure 20: Segmentation applied. After segmentation adjustment, segmentation is applied and Icy 
creates a segmented image. 
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Figure 21: Analysis of the image on Matlab using “FungusDependentGranuleRelease_tools” 
mathematical code.  
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Figure 22: Analysis is completed. 
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After analysis, an Excel file is generated showing all the parameters calculated for each single cell in 
the image (Figure 23).  
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Figure 23: Excel file generated after analysis of a 2D image on Matlab, using 
“FungusDependentGranuleRelease_tools” mathematical code. Parameters such as, number of 
granules, granules mean area, granules mean distance to cell centre, granules mean fungi to cell angle, 
minimum distance of the cell to fungus, mean distance of the cell to fungus, minimum distance of the 
granules to fungus, mean distance of the granules to fungus and granules mean fungi cosine are 
calculated.  
 
2.5.3 Perforin and granzyme B enzyme-linked immunosorbent assay (ELISA)  
For the quantification of perforin and granzyme B in the supernatant of co-cultures, ELISAs were 
performed according to the manufacturer's instructions using the Perforin Human Elipair Kit (Abcam) 
and ELISA from Human Granzyme B kit (MabTech), respectively. Briefly, capture antibody was diluted 
in PBS at the recommended working concentration and distributed in a 96 well plate (100 μL/well). 
Plates were sealed and incubated overnight at room temperature. Plates were washed with 0.05% 
Tween 20 in PBS and blocked for 1 hour with 1% BSA in PBS. After washing, 100 μL of sample or 
standard were added to each well and the plate was incubated for 2 hours at room temperature. 
Plates were washed and 100 μL of detection antibody, at recommended working concentration, were 
distributed into the plate. Washing steps were performed followed by the addition of 100 μL of diluted 
streptavidin-HRP. After 20 min incubation, plates were washed and 100 μL of substrate solution was 
added to each well. Plates were incubated for 20 min at room temperature and then the reaction was 
stopped adding 50 μL of stop solution. The optical density of each well was determined at 450 nm. All 
samples and standards were ran in duplicates. The concentration of perforin and granzyme B in the 
samples was calculated based on the standard curve generated for each set of samples assayed. 
 
2.6 Phenotypic characterization of NK cells in response against A. fumigatus in vitro 
Human NK cells display a wide array of activating receptors on their surface that are able to recognize 
specific ligands. Upon interaction with these ligands, activating receptors can induce NK cell activation. 
In order to identify the receptors involved in NK cell interaction with A. fumigatus, I analysed the 
phenotypic changes of several activating receptors on NK cells, when incubated with A. fumigatus in 
vitro. The expression of CD56, CD16, NKG2D, NKp30, NKp46, NKp80, TLR2 and TLR4 was determined 
by FACS analysis.  
Isolated NK cells (2×105 cells/well) were cultured in 96 well flat bottom plates and challenged with A. 
fumigatus overnight. After the co-incubation period, cells were collected in FACS tubes and washed 
with PBS. Incubation with the tested antibodies was performed for 25 minutes in the dark. Cells were 
washed in PBS, followed by staining with zombie aqua dye (BioLegend) dilution 1:1000 for 30 min. A 
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washing step was performed followed by cell permeabilizaton and fixation using permeabilizing 
solution 2 (BD biosciences). Cells were washed and acquired on the Fortessa analyser (BD biosciences). 
Data was analysed on FlowJo Software. 
 
Antibody Fluorochrome Clone and supplier Volume 
CD56 PE Cy7 B159, BD biosciences 3 μL 
CD3 APC H7 SK7, BD biosciences 2.5 μL 
CD16 Alexa Fluor 647 3G8, BD biosciences 3 μL 
NKG2D PE 1D11, Biolegend 3.5 μL 
NKp46 PerCP Cy5.5 9E2, Biolegend 3 μL 
NKp30 PE P30-15, Biolegend 3.5 μL 
NKp80 PE 5D12, Biolegend 3.5 μL 
TLR2 Alexa Fluor 647 TL2.1, Biolegend 3 μL 
TLR4 PE HTA125, Biolegend 3.5 μL 
Live/Dead staining Zombie Aqua Biolegend Dil 1:1000 
Table 2: Antibody description and full product details  
 
2.6.1 Analysis of receptor internalization in NK cells in response to A. fumigatus in vitro 
Isolated NK cells (2×105 cells/well) were cultured in 96 well flat bottom plates and challenged with A. 
fumigatus overnight. After the co-incubation period, cells were collected in FACS tubes and washed 
with PBS. Incubation with the tested antibodies was performed for 25 minutes in the dark. Cells were 
washed in PBS, followed by staining with zombie aqua dye (BioLegend) dilution 1:1000 for 30 min. A 
washing step was performed followed by cell permeabilizaton and fixation using permeabilizing 
solution 2 (BD biosciences). After the permeabilization step, cells were washed and incubated again 
for an extra 25 min with the antibodies of interest. Cells were washed in PBS and acquired on the 
Fortessa analyser (BD biosciences). Data was analysed on FlowJo Software. 
A total of five conditions were prepared and performed in duplicates: 
- NK cells (no staining) 
- NK cells (surface staining) 
- NK cells (surface + intracellular staining) 
- NK cells + A. fumigatus (surface staining) 
- NK cells + A. fumigatus (surface + intracellular staining) 
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2.7 Analysis of fungal damage  
 
2.7.1 XTT assay  
XTT is a colorimetric assay used to assess fungal viability based on the measurement of metabolic 
activity. 2,3-bis(2-methoxy-4-nitro-5-[(sulphenylamino)carbonyl]-2H-tetrazolium-hydroxide (XTT) salt 
can penetrate rapidly into intact cells and in the presence of active mitochondria is converted to a 
water-soluble formazan derivative that absorbs light in the visible spectrum (430-490 nm). The 
reaction occurs in the presence of menadione as an electron-coupling agent. The formazan production 
correlates linearly with the fungal viability (526,527).  
A. fumigatus were seeded in a 96 well plate at a density of 1×104 conidia per well until they form 
germlings. NK cells were added at an MOI 0.05 and the co-incubation was performed overnight. 
Amphotericin B was used as positive control for fungal killing at a concentration of 1 μg/mL. After the 
incubation period, supernatant was removed from the plate and 100 μL of cold water were added to 
each well to lyse and remove NK cells. XTT/menadione solution was added in order to have a final 
concentration of 200 μg/mL of XTT and 25μM of menadione. After 2 hours incubation at 37°C, 100 μL 
of the suspension were transferred to a clean plate, followed by the measurement of the optical 
density at 450nm. Fungal burden was in the samples was determined based on the standard curve 
generated for set of samples assayed. 
A total of four conditions were prepared and performed in quadruplicates: 
- Blank (No A. fumigatus, No NK cells) 
- A. fumigatus germling 
- A. fumigatus germling + 1 μg/mL Amphotericin B 
- A. fumigatus germling + NK cells (MOI 0.05) 
 
2.7.2 Detection and relative quantification of galactomannan 
Detection and quantification of galactomannan in the supernatant of co-cultures, was performed 
using the PLATELIATM Aspergillus galactomannan enzyme immunoassay (Bio-Rad), an 
immunoenzimatic sandwich microplate assay used for the detection of Aspergillus galactomannan 
antigen. The assay uses the rat EBA-2 monoclonal antibodies, which are directed against Aspergillus 
galactomannan and have been characterized in previous studies (528,529). Galactomannan is a 
polysaccharide cell-wall component in Aspergillus species that is released by the fungus during growth 
(530). 
The samples (50 μL) and conjugate reagent (50 μL), containing peroxidase-linked monoclonal 
antibodies, are added to the wells coated with monoclonal antibodies and incubated for 90 minutes 
at 37°C. A monoclonal antibody - galactomannan – monoclonal antibody/peroxidase complex is 
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formed in the presence of galactomannan antigen. The wells are washed, followed by the addition of 
200 μL of substrate solution. Plates are incubated at room temperature for 30 minutes and the 
reaction is stopped by the addition of 100 μL of stop solution. The optical density of each well was 
determined at 450nm.   
 
2.7.3 Analysis of fungal damage induced by NK cells – Live imaging 
Propidium iodide (PI) is a membrane impermeant dye that has been extensively used to detect dead 
or dying cells since it penetrates only cells with compromised membranes. PI binds to double stranded 
DNA and has been used to identify death cells by flow cytometry and confocal microscopy. This 
approach has also been shown to be useful to assess cell viability and plasma membrane damage in 
yeast (531–533). PI was also demonstrated to be useful to stain extracellular DNA and it was 
particularly important on the identification of neutrophil extracellular traps (NETs) consisting of 
nuclear DNA decorated with fungicidal proteins (280). 
In order to assess fungal damage by confocal microscopy, isolated NK cells were incubated with A. 
fumigatus at a MOI of 0.05. Co-culture was performed overnight in μ-slide 8 well plates (Ibidi), 
incubating 3Х105 NK cells with 1.5Х104 A. fumigatus germling per well. After the incubation period, 
propidium iodide was added to each well (Dil 1:500) and live imaging was performed on confocal 
microscope.  
A total of two conditions were prepared and performed in duplicates: 
- A. fumigatus germling 
- A. fumigatus germling + NK cells 
 
2.8 Quantification of fungal gDNA in the supernatant of co-cultures of NK cells and A. fumigatus 
In order to determine if the DNA released, observed by confocal microscopy, was being released from 
A. fumigatus, fungal gDNA was quantified in the supernatant of the co-cultures by quantitative real-
time PCR.  
Isolated NK cells were incubated with A. fumigatus at a MOI of 0.05. Co-culture was performed 
overnight in a 24 well plate, incubating 1Х106 NK cells with 5Х104 A. fumigatus germling per well. The 
total volume per well was 1mL. After the incubation period, the supernatant was collected and 
centrifuged at 2000 rpm for 5 min to pellet possible cells and fungi in suspension. Supernatant was 
collected and kept at -80°C for subsequent analysis. Quantification was performed following a 
protocol previously published by P. Lewis White et al. The assay demonstrated to be highly specific 
and sensitive with the lower limit of detection of ∼2 input copies (414). Quantification was performed 
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using specific primers and an Aspergillus-specific probe designed to bind an Aspergillus-specific region 
of the 28S rRNA gene (Table 3). Primers and probe were synthesized by Sigma-Aldrich.  
Detection of A. fumigatus is based on hybridisation and cleavage of the ASP28P probe.   
 
 Sequence 5’-3’ 
ASF1 GCA CGT GAA ATT GTT GAA AGG 
ADR1 CAG GCT GGC CGC ATT G 
ASP28P FAM-CATTCGTGCCGGTGTACTTCCCCG-TAMRA 
Table 3: Sequence of primers and probe for fungal burden real-time PCR 
 
15 μL of sample were added to 20 μL of Master Mix, containing 10 μM of ASP28P probe and 20 μM of 
oligonucleotide amplification primers. Known concentration of purified genomic DNA from A. 
fumigatus was used to generate a standard curve. For reaction parameters see Table 4. The amount 
of A. fumigatus DNA was determined comparing the amplification threshold cycle of the unknown 
sample with the threshold cycle values of the standards. Statistical significance was determined using 
Graphpad Prism software. 
 
Activation 95°C 15 min  
Denaturing 95°C 5 sec 
50 cycles 
Annealing/Extension/Aquisition 60°C 30 sec 
Table 4: Parameters for fungal gDNA PCR 
 
A total of three conditions were prepared and performed in duplicates: 
- NK cells  
- A. fumigatus germling 
- NK cells + A. fumigatus germling 
 
2.9 Analysis of NK cell response to A. fumigatus in the presence of other populations of PBMCs by 
FACS 
The analysis of NK cell response to A. fumigatus in the presence of other populations of PBMCs was 
not straightforward. The main surface marker of NK cell population is CD56 antigen that showed to be 
downregulated when NK cells are incubated with A. fumigatus. The staining of specific surface 
receptors to gate NK cell population out of PBMCs was the possible approach despite potential 
exclusion of small populations of NK cells.  
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In order to be able to assess NK cell activation when PBMCs are incubated with A. fumigatus, including 
analysis of IFN-γ and TNF-α production and NK cell degranulation, different antibodies were used. 
CD56 staining was preferably chosen when no significant reduction of CD56 population was observed.  
PBMCs were isolated from fresh blood, plated in a 24 well plate at a cell density of 1×106 cells per well 
and rested for 24 hours. Then, PBMCs were challenged with resting conidia, swollen conidia or 
germling A. fumigatus for 12 hours. To assess NK cell degranulation, 20 μL of CD107a antibody were 
added at time 0 hours. In order to analyse IFN-γ and TNF-α production, Brefeldin A was added to the 
co-culture after 12 hours incubation followed by an extra 4 hours co-incubation. After the incubation 
period, cells were collected in FACS tubes and washed in PBS. Incubation with surface antibodies was 
performed for 25 minutes in the dark.  Cells were washed, permeabilized and fixed using 
permeabilizing solution 2 (BD biosciences), and finally stained for intracellular components (anti-
human IFN-γ and anti-human TNF-α). After 30min incubation in the dark at room temperature, cells 
were washed and acquired on the Fortessa analyser (BD biosciences). Data was analysed on FlowJo 
Software. 
 
2.10 Analysis of the effect of FTY720 and SKI-II inhibitors on NK cell response to K562 
 
2.10.1 Sphingosine kinase signalling pathway inhibitors 
2.10.1.1 FTY720  
FTY720 (Selleckchem, cat# S5002) is a sphingosine analogue that is synthetically derived from myriocin 
(ISP-1), a metabolite isolated from fungus Isaria Sinclairii (534,535). FTY720 becomes active following 
phosphorylation by sphingosine kinases with SphK2 being quantitatively the more important enzyme 
in producing the active form FTY720-P (453). Phosphorylated FTY720 act as an agonist for four of the 
five known S1P receptors, S1P1, S1P4 and S1P5 (EC values of 0.3-0.6 nM) and S1P3 (EC values of 3 nM) 
(536). FTY720-P is also a functional antagonist of S1P1, leading to internalization and degradation of 
this specific S1P receptor (472,537). In addition, FTY720 possess SphK1-, but not SphK2-inhibiting 
properties (538). 
FTY720 is a clinically licensed oral drug also known as Fingolimod, administered for the treatment of 
relapsing-remitting multiple sclerosis. 
 
2.10.1.2 SKI-II 
SKI-II [2-(p-hydroxyanilo)-4-(p-chlorophenyl)thiazole] (Calbiochem, cat# 567731) is a potent 
sphingosine kinase inhibitor (539). Treatment of cells with this compound results in reduction of SphK1 
activity and reduction of intracellular S1P levels (540,541). SKI-II has been reported to cause an 
irreversible inhibition of SphK1 by inducing its lysosomal and/or proteasomal degradation (542). SKI-
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II is orally bioavailable and has been extensively used to study the involvement of SphK1 and S1P in 
different cellular processes (543–545). SKI-II showed to induce SphK inhibitory effect at 
submicromolar to micromolar concentrations (539). SKI-II has been widely cited as a specific SphK1 
inhibitor, however has been showed that this compound also inhibits SphK2 (546). SKI-II do not inhibit 
ERK2, PI3-kinase or PKCα at concentrations up to 60 μM (539).  
 
2.10.2 Analysis of apoptotic and necrotic cells with Annexin V/7-AAD staining assay 
In order to establish the toxicity of FTY720 and SKI-II against NK cells, the Annexin V/7-AAD staining 
assay was performed with different concentrations of SphK1 inhibitors. NK cells were incubated with 
different concentrations of SphK1 inhibitors for 6 hours. NK cells were collected, washed with Annexin 
V binding buffer (BD Pharmingen) followed by the incubation of the cells with 5 μL of PE Annexin V 
antibody (BD Pharmingen), 5 μL of the vital dye 7-Amino-Actinomycin (7-AAD) (BD Pharmingen) plus 
3 μL of CD56 and CD3. After 25 min incubation in the dark, cells were washed and acquired on the 
Fortessa analyser (BD biosciences). Data was analysed on FlowJo Software. 
In apoptotic cells, the membrane phospholipid phosphatidylserine (PS) is translocated from the inner 
to the outer leaflet of the plasma membrane, thereby exposing PS to the external cellular 
environment. Annexin V is a 35-36 kDa Ca2+ dependent phospholipid-binding protein that has a high 
affinity for PS, and binds to cells with exposed PS. Since externalization of PS occurs in the earlier 
stages of apoptosis, Annexin V staining can identify apoptosis at an early stage. Staining with Annexin 
V is typically used in conjunction with a vital dye such as 7-AAD. Viable cells with intact membranes 
exclude 7-AAD, whereas the membranes of dead and damaged cells are permeable to 7-AAD. 
The cells were considered viable when negative for both Annexin V and 7-AAD; cells were considered 
in the early apoptosis when showed Annexin V positive and 7-AAD negative; and cells were considered 
in late apoptosis or already dead if were both Annexin V and 7-AAD positive. 
 
2.10.3 Analysis of NK cell viability using Zombie Aqua fixable viability kit 
In order to confirm that incubation of NK cells with 5 μM of FTY720 or SKI-II do not result in reduction 
of NK cell viability, NK cells were incubated with FTY720 or SKI-II for 5 hours. After incubation time, 
NK cells were harvested, washed and incubated with CD56 and CD3 antibodies for 25 min. Cells were 
washed in PBS, followed by staining with zombie aqua dye (BioLegend) dilution 1:1000 for 30 min. 
After incubation period, cells were washed and acquired on the Fortessa analyser (BD biosciences). 
Data was analysed on FlowJo Software. 
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2.10.4 Immuno-modulatory effects of FTY720 and SKI-II inhibitors on NK cell response to K562 
 
2.10.4.1 Immuno-modulatory effects of FTY720 and SKI-II inhibitors on NK cell cytokine production 
in response to K562 
Isolated NK cells were incubated with 5μM of FTY720, SKI-II or the equivalent dilution of DMSO. After 
1 hour incubation, cells were collected, washed and resuspended in culture media at a concentration 
of 2Х106 cells/mL. 100 μL of cell suspension was distributed into a 96 well flat bottom plate. K562 cells 
were resuspended in culture media at a concentration of 2Х106 cells/mL and 100 μL of cell suspension 
was added to the plate with NK cells at a ratio of 1:1. In order to determine the intracellular expression 
of IFN-γ and TNF-α, 5 μg/mL of brefeldin A (BFA) was added to each well. BFA is a fungal metabolite 
which disrupts intracellular Golgi-mediated transport and allows cytokines to accumulate inside the 
cells allowing the detection of cytokine production by flow cytometry (523,524). NK cell co-incubation 
with K652 cells was performed for 5 hours. After the co-incubation period, cells were harvested and 
collected in FACS tubes. Incubation with surface antibodies (CD56 and CD3) was performed for 25 
minutes in the dark.  Cells were washed, permeabilized and fixed using permeabilizing solution 2 (BD 
biosciences), and finally stained for intracellular components (anti-human IFN-γ and anti-human TNF-
α). After 30min incubation in the dark at room temperature, cells were washed and acquired on the 
Fortessa analyser (BD biosciences). Data was analysed on FlowJo Software. 
 
A total of six conditions were prepared and performed in duplicates: 
- Unstimulated NK cells (negative control) 
- Unstimulated NK cells pre-treated with 5 μM FTY720 
- Unstimulated NK cells pre-treated with 5 μM SKI-II 
- NK cells + K562 cells  
- NK cells pre-treated with 5 μM FTY720 + K562 
- NK cells pre-treated with 5 μM SKI-II + K562 
 
2.10.4.2 Immuno-modulatory effects of FTY720 and SKI-II inhibitors on NK cell degranulation in 
response to K562 
Isolated NK cells were incubated with 5μM of FTY720, SKI-II or the equivalent dilution of DMSO. After 
1 hour incubation, cells were collected, washed and resuspended in culture media at a concentration 
of 2Х106 cells/mL. 100 μL of cell suspension was distributed into a 96 well flat bottom plate. K562 cells 
were resuspended in culture media at a concentration of 2Х106 cells/mL and 100 μL of cell suspension 
was added to the plate with NK cells at a ratio of 1:1. NK cell co-incubation with K652 cells was 
performed for 5 hours. CD107a antibody was added at time 0 hours. After the co-incubation period, 
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cells were harvested and collected in FACS tubes. Incubation with surface antibodies (CD56 and CD3) 
was performed for 25 minutes in the dark. Cells were washed, permeabilized and fixed using 
permeabilizing solution 2 (BD biosciences). Cells were washed and acquired on the Fortessa analyser 
(BD biosciences). Data was analysed on FlowJo Software. 
A total of six conditions were prepared and performed in duplicates: 
- Unstimulated NK cells (negative control) 
- Unstimulated NK cells pre-treated with 5 μM FTY720 
- Unstimulated NK cells pre-treated with 5 μM SKI-II 
- NK cells + K562 cells  
- NK cells pre-treated with 5 μM FTY720 + K562 
- NK cells pre-treated with 5 μM SKI-II + K562 
 
2.10.4.3 Analysis of the effect of FTY720 and SKI-II inhibitors on NK cell-mediated cytotoxicity 
against K562 cells 
Isolated NK cells were incubated with 5μM of FTY720, SKI-II or the equivalent dilution of DMSO. After 
1 hour incubation, cells were collected, washed and resuspended in culture media at a concentration 
of 2Х106 cells/mL. 100 μL of cell suspension was distributed into a 96 well flat bottom plate. K562 cells 
were resuspended in culture media at a concentration of 2Х106 cells/mL and 100 μL of cell suspension 
was added to the plate with NK cells at a ratio of 1:1. NK cell co-incubation with K652 cells was 
performed for 5 hours. After the co-incubation period, cells were harvested and collected in FACS 
tubes. Incubation with surface antibodies (CD56 and CD3) was performed for 25 minutes in the dark.   
Cells were washed in PBS, followed by staining with zombie aqua dye (BioLegend) dilution 1:1000 for 
30 min. After the incubation period, cells were washed and acquired on the Fortessa analyser (BD 
biosciences). Data was analysed on FlowJo Software. 
A total of four conditions were prepared and performed in duplicates: 
- Unstimulated NK cells (negative control) 
- NK cells + K562 cells  
- NK cells pre-treated with 5 μM FTY720 + K562 
- NK cells pre-treated with 5 μM SKI-II + K562 
 
2.10.5 Quantification of mRNA expression in NK cells in response to K652 cell line 
Isolated NK cells were incubated with K562 cell line at a ratio of 1:1. Co-incubation was performed in 
a 24 well plate at density of 2Х106 cells per well (1Х106 NK cells + 1Х106 K562 cells). Cells were collected 
after 1h, 2hrs, 4hrs and 6hrs co-incubation, washed and resuspended in DMEM supplemented with 
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2% FBS at a concentration of 2Х106 cells/mL. Cells were sorted in a BD FACS AriaTM III sorter in order 
to collect live NK cell population. DAPI was added to the cell suspension in order to distinguish 
between the live and dead cells (Figure 24). Live NK cells were collected, washed, centrifuged and cell 
pellet was ressuspended in 500 μL of Tri Reagent. The cells were then homogeneized and the cell 
lysate stored at -20°C for subsequent RNA extraction. 
After sorting, a small aliquot of the collected cell population was stained with CD56 and CD3 in order 
to confirm NK cell purity (Figure 25). 
 
 
Figure 24: Gating strategy used on cell sorting. Cells were first gated using forward and side scatter, 
followed by the identification of the live/dead cell population using DAPI staining. Live NK cell 
population was collected in an eppendorf and the remaining cells were discarded.  
 
 
Figure 25: FACS plots showing NK cell purity after cell sorting. Cell population was first gated using 
forward and side scatter, followed by the identification of NK cell population purity gating on CD56+, 
CD3- cell population. 
 
Total RNA was extracted using phenol/chloroform extraction protocol. Chloroform was added at 2/5 
of the starting volume. The sample was vortexed and spun down at maximum speed for 10 min at 4°C. 
The aqueous phase was transferred into a fresh tube and an equal volume of isopropanol (Fisher 
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Scientific) was added. The sample was thoroughly mixed and spun down at maximum speed for 15 
min at 4°C. The pellet was washed in 70% ethanol and resuspended in RNase-free H2O (Ambion). 
Reverse transcription was carried out with the QuantiTect Reverse Transcription kit (Qiagen) 
according to the manufacturer's instruction. Importantly, this kit includes a DNAse digestion step 
that removes any contaminating genomic DNA. Quantification was performed using the SYBR Green 
JumpStartTM Taq Ready MixTM (Sigma-Aldrich). All primers (Table 5) were used at 250nM and targets 
were amplified with the following cycling profile: hold at 95°C for 10 min, followed by 45 cycles of 
Denaturation (95°C for 5 sec) and Annealing/Extension/Acquisition at 56°C, 72°C and 78°C for 5, 8 and 
15 seconds respectively (Table 6). The cytokine and SphK1 expression levels are expressed as copy 
numbers per 100,000 β-actin copies.  
 
Gene Forward primer sequence Reverse primer sequence 
β-actin ATTGCCGACAGGATGCAGAA GCTGATCCACATCTGCTGGAA 
IFN-γ AAACGAGATGACTTCGAAAAGCTGA CTTCGACCTCGAAACAGCATCTGACT 
TNF-α AGGCGGTGCTTGTTCCTCA GTTCGAGAAGATGATCTGACTGCC 
SphK1 TATGAATGCCCCTACTTGGTATATG GCCTCGCTAACCATCAATTCC 
Table 5: Primer sequences for RT-PCR 
 
Cycle Cycle Point 
Hold at 95°C, 10 min 
Cycling, 45 repeats 
 
Denaturing           at 95°C for 5 seconds 
Annealing             at 56°C for 5 seconds 
Elongation            at 72°C for 8 seconds 
Acquisition           at 78°C for 15 seconds 
Melt (72-95°C), hold 45 seconds on the first step, thereafter hold 5 seconds 
Table 6: Thermal cycling profile for real-time PCR 
 
2.10.6 Analysis of SphK1 protein expression by confocal microscopy  
Isolated NK cells were incubated with K562 cell line at a ratio of 1:1. Co-incubation was performed in 
a 96 well plate at density of 4Х105 cells/well (2Х105 NK cells + 2Х105 K562 cells). Cells were collected 
after 2h, 4hrs and 6hrs co-incubation, washed, permeabilized and fixed using permeabilizing solution 
2 (BD biosciences). Cell were resuspended in 0.1% BSA/PBS buffer and centrifuged (250 rpm for 3 min) 
onto a microscope slide (cytospin). Blocking buffer (PBS 10% FBS) was immediately added on the slide 
to prevent the cells drying out. Incubation with blocking buffer was performed for 15 min at room 
temperature, followed by washing with PBS. Cells were incubated with 5 μg/mL SphK1 antibody 
(Abcam) overnight at 4°C in a wet chamber. After the incubation period, cells were washed and 
incubated with secondary antibody FITC anti-rabbit (Dil. 1:80) for 1 hour at RT. Cells on the slides were 
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washed with PBS and mounted with one drop of vectashield DAPI and a coverslip. Images were 
acquired with a Zeiss LSM-510 confocal microscope.  
 
2.10.6.1 Determination of SphK1 protein expression in NK cells  
ImageJ is a public domain Java image processing program. It is a downloadable application on any 
computer with Java. It can display, edit, analyse, process, save and print 8-bit, 16-bit and 32-bit images. 
It can calculate area and pixel value statistics of user-defined selections. It can also measure distances 
and angles. 
 
The SphK1 protein expression in NK cells was quantified using the threshold particle analysis in ImageJ 
software. The analysis was performed following the steps: File → Open → Choose image → Rectangular 
selection → Image → Duplicate → All channels → All Z → Duplicate hyperstack → Ok → Image → Color 
→ Split channels → Choose image with SphK1 staining → Process → Filters → Mediam → Image → Stacks 
→ Z project → Max intensity → Ok → Image → Adjust Threshold → Analyse → Analyse particles. To 
accurately reflect the quantity of SphK1 expressed in each NK cell analysed, the same threshold was 
used for all NK cells from the same donor. The threshold was defined on unstimulated NK cells and 
the same threshold was used to analyse the SphK1 protein expression in all conditions tested.  The 
analysis performed using Image J allowed calculation of the following quantitative parameters: area, 
mean, minimum, maximum and median intensity. The results are expressed in mean intensity*total 
area. 
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Figure 26: Example of data analysis using Image J software. The above example shows the detailed 
analysis of SphK1 expression in one unstimulated NK cell. 3D images of NK cells from 9 fields of view 
were obtained by confocal microscopy. SphK1 staining is indicated in green and the nuclei is indicated 
in blue. To accurately reflect the quantity of SphK1 expressed in each NK cell analysed, the same 
threshold was used for all NK cells from the same donor. Quantitative analysis was performed using 
Image J and quantitative parameters, such as area, mean, minimum, maximum and median intensity 
were calculated. 
 
2.10.7 Antibody-dependent cytotoxicity assay 
The antibody-dependent cytotoxicity assay was previously described by Bryceson et al. (119) and 
consists in the activation of NK cells using purified antibodies that engage to specific activating 
receptors on NK cell surface resulting in NK cell activation. In the study describing this assay, it was 
demonstrated that most NK cell receptors are unable to function independently and require the 
engagement of synergistic receptors in order to induce NK cell activation. CD16 receptor showed to 
be the only activating receptor able to independently induce NK cell activation. In order to induce NK 
cell activation, isolated NK cells were incubated in CD16, NKG2D/2B4 or NKp30/2B4 – coated plates. 
2B4 purified antibody was used to activate the 2B4 receptor since NKG2D and NKp30 activation do 
not induce NK cell activation without a co-receptor. Purified antibodies were diluted in PBS at specific 
concentrations (Table 7) and distributed into 96 well non-tissue culture treated plates (100 μL per 
well). The plate was sealed and incubated overnight at 4°C. Isolated NK cells were incubated with 5μM 
of SKI-II or the equivalent dilution of DMSO. After 1 hour incubation, cells were collected, washed and 
resuspended in culture media at a concentration of 2Х106 cells/mL. The mA-coated plates were gently 
aspirated and NK cells were added to each well at cell density of 2x105 cells per well in the presence 
of Brefeldin A (as per the protocol for K562 stimulation described above). After 5 hours incubation, 
NK cells were collected, washed and stained with CD56 and CD3 surface staining and IFN-γ and TNF-α 
intracellular staining as described above. Cells were acquired on the Fortessa analyser (BD 
biosciences). Data was analysed on FlowJo Software. 
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A total of six conditions were prepared and performed in duplicates: 
- Unstimulated NK cells (negative control) 
- Unstimulated NK cells pre-treated with 5 μM SKI-II 
- NK cells incubated in CD16-coated wells 
- NK cells pre-treated with 5 μM SKI-II incubated in CD16-coated wells 
- NK cells incubated in NKG2D/2B4-coated wells 
- NK cells pre-treated with 5 μM SKI-II incubated in NKG2D/2B4-coated wells 
- NK cells incubated in NKp30/2B4-coated wells 
- NK cells pre-treated with 5 μM SKI-II incubated in NKp30/2B4-coated wells 
 
Antibody Clone and Supplier Concentration used  
Purified anti-human CD16 3G8, Biolegend 5 μg/mL 
Purified anti-human NKG2D 1D11, Biolegend 10 μg/mL 
Purified anti-human NKp30 P30-15, Biolegend 10 μg/mL 
Purified anti-human 2B4 C1.7, Biolegend 10 μg/mL 
Table 7: Purified anti-human antibodies used for antibody-dependent cytotoxicity assay 
 
2.11 Statistical Analysis 
All statistical analysis was performed using GraphPad Prism software, two groups were compared by 
Students two-tailed t-test (paired or unpaired) or by Mann-Whitney U test and multiple comparisons 
were performed using one-way analysis of variance (ANOVA). 
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3. Phenotypic characterization of NK cell receptors in response against A. fumigatus in vitro 
3.1 Introduction 
NK cells have a highly specific and complex target cell recognition receptor system governed by the 
integration of signals provided by a multitude of inhibitory and activating receptors. Activating 
receptors are central to NK cell recognition of their targets. The interaction of these receptors with 
specific ligands is the first step in the formation of an immune synapse between NK cells and targets. 
In addition to cellular-derived ligands, a range of viral, bacterial and parasitic ligands have been shown 
to activate NK cells through interaction with specific activating receptors (158).  
NK cells are commonly identified as CD3-CD56+ lymphocyte population. CD56 antigen is a 180-200kDa 
glycoprotein and is widely used as a marker to identify the NK population. CD56 was identified as an 
isoform of the well characterized neural cell adhesion molecule (NCAM), which is expressed on neural 
and muscle tissues and that mediates cell-to-cell homophilic interactions (547). Initial experiments 
examining NK cell interaction with A. fumigatus in vitro, surprisingly showed a major downregulation 
on CD56 expression on NK cell surface. Based on this observation, I decided to investigate the 
mechanistic basis of CD56 downregulation and to determine whether the exposure of NK cells to the 
fungus influenced the expression of other receptors on the NK cell surface. Up to now, little is known 
about the function of CD56 on NK cells but the few published studies on this subject suggest that it is 
involved in NK-target cell interactions playing an important role in the process of target cell killing 
(548,549). More, a significant increase in the frequency of CD3negCD56negCD16+ NK cell population was 
observed in HIV-1 and HCV chronically infected patients, together with an impaired effector function 
of the cells, suggesting an important role of CD56 in the NK cell response (550–552).  
The natural cytotoxicity receptor (NCR) family has been demonstrated to be of particular importance 
mediating the direct interaction of NK cells with pathogen-derived ligands (158). Another important 
family of NK cell activating receptors is the C-type lectin-like family. C-type lectin receptors are known 
to recognize highly conserved carbohydrate recognition domains, but to date most C-type lectin-like 
NK cell receptors have been shown to recognize membrane-bound protein ligands independent of 
carbohydrates (118). Toll-like receptors (TLRs) have more recently been identified in NK cells, first 
based on mRNA detection and later by the direct activation of NK cells by bacterial and parasitic TLR 
ligands (553).  
To date no studies were performed in order to identify the receptors involved in the NK cell interaction 
with A. fumigatus. The first aim of this chapter was to identify the mechanisms underlying the loss of 
CD56 expression on NK cell surface, induced by the presence of A. fumigatus. In addition, I analysed 
the alteration in the expression of activating receptors on NK cells when they are co-incubated with 
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the fungus in vitro. The studies described in this chapter were performed using the A. fumigatus strain 
ATCC46645.  
 
3.2 NK cell interaction with A. fumigatus results in major reduction of CD56 expression 
The co-incubation of NK cells with A. fumigatus resulted in major reduction of CD56 expression. The 
reduction on CD56 expression occurs when NK cells are incubated with both, swollen conidia and A. 
fumigatus germlings in a MOI-dependent manner (Figure 27). Analysis of CD56 mean florescence 
intensity (MFI) was also performed and showed a reduction of MFI on NK cells in vitro, induced by the 
co-incubation with A. fumigatus (Figure 28).   
 
 
Figure 27: CD56 expression on NK cell surface in the presence of A. fumigatus. Isolated human NK 
cells were incubated with A. fumigatus at effector : target (E:T) ratios of 1:1, 20:1 and 100:1. The co-
incubation was performed overnight. A) NK cells + A. fumigatus swollen; B) NK cells + A. fumigatus 
germling. CD56 expression was determined by FACS, gating live NK cells. Bar graphs show the mean + 
SEM of CD56 expression on NK cells. This data is representative of three independent experiments. 
Statistical analysis was performed using the Student’s unpaired t-test. **p<0.01, ***p<0.001 
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Figure 28: Representative flow cytometry histograms of CD56 expression on NK cell surface. The red 
lines on histograms represent unstained NK cells and blue lines on histograms represent NK cells at 
different incubation conditions, stained with CD56 antibody. A) NK cells + A. fumigatus swollen at 
different E:T ratios; B) NK cells + A. fumigatus germlings at different E:T ratios. This data is 
representative of three independent experiments.  
 
 
 
 
 
 
 
110 
 
 
 
 
Figure 29: Representative FACS plots of CD56 expression on NK cell surface. CD56 expression was 
assessed on the surface of fresh isolated human NK cells from healthy donors. Cells were first gated 
using forward and site scatter, followed by the identification of the live population using Aqua zombie 
staining. CD56+ CD3- cell population was then gated. A) Unstained NK cells; B) Stained NK cells; C) NK 
cells incubated overnight with A. fumigatus germlings at an MOI of 0.05.  
 
CD56 downregulation on NK cells in the presence of A. fumigatus, was then assessed on NK cells from 
ten different healthy donors. The analysis showed a significant reduction on the expression of this 
marker, when NK cells are co-incubated with swollen A.fumigatus or germlings in vitro (Figure 30). 
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Figure 30: CD56 expression on NK cells surface in the presence of A. fumigatus. Isolated human NK 
cells were incubated with A. fumigatus overnight. A) NK cells + A. fumigatus swollen at an E:T ratio of 
1:1; B) NK cells + A. fumigatus germling at an E:T ratio of 20:1. CD56 expression was determined by 
FACS, gating live NK cells. Graph shows the mean ± SEM of CD56 expression on NK cells. Statistical 
analysis was performed using the Student’s paired t-test. n=10 ***p<0.001 
 
3.2.1 A. fumigatus induces CD56 internalization on NK cells 
The observation that A. fumigatus induced a major downregulation on NK cell surface, raised the 
possibility that CD56 antigen was internalized or degraded. In order to determine if the 
downregulation of CD56 expression on NK cell surface was a result of CD56 internalization, CD56 
staining was performed extracellularly and intracellularly. Results showed that a high percentage, 
around 60%, of CD56 antigen is internalized when NK cells are co-incubated with A. fumigatus (Figure 
31). The remaining CD56 antigen might be degraded.  
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Figure 31: A. fumigatus induces CD56 internalization on NK cells in vitro. Isolated human NK cells 
were either left non-stimulated, or stimulated with A. fumigatus germlings at an E:T ratio of 20:1. After 
overnight co-incubation, NK cells were stained extracellularly or extracellularly and intracellularly with 
CD56 antibody. CD56 expression was analysed by FACS, gating live NK cells. Bar graph shows the mean 
+ SEM of CD56 expression on NK cells. This data is representative of three independent experiments. 
Statistical analysis was performed using the Student’s unpaired t-test. **p<0.01 
 
3.2.2 CD56 downregulation is also induced by A. fumigatus in NK cells in the presence of other 
populations of PBMCs 
In order to assess if CD56 downregulation on NK cell surface was also induced by A. fumigatus in the 
presence of other populations of PBMCs, PBMCs were incubated with different developmental stages 
of the fungus at different E:T ratios. The results showed a significant reduction in the percentage of 
CD56+ population when PBMCs are co-incubated with A. fumigatus (Figure 32). No significant 
reduction of CD56+ population was observed when PBMCs are co-incubated with K562 cell line at an 
E:T ratio of 1:1.  
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Figure 32: CD56 expression on NK cells surface when co-incubated with A. fumigatus in the presence 
of other populations of PBMCs. PBMCs were incubated with A. fumigatus resting conidia, swollen 
conidia or germlings at E:T ratios of 1:1 and 5:1. The co-incubation was performed overnight. CD56 
positive cell population was determined by FACS, gating live cells. Bar graph shows the mean + SEM 
of CD56 expression on NK cells. This data is representative of three independent experiments. 
Statistical analysis was performed using the Student’s unpaired t-test. *p<0.05, **p<0.01, ***p<0.001 
 
3.2.3 CD56 downregulation induced by A. fumigatus on NK cell surface is contact-dependent 
In order to determine if CD56 downregulation on NK cell surface was dependent on the direct contact 
between NK cells and A. fumigatus, isolated human NK cells were incubated overnight with A. 
fumigatus culture supernatant. CD56 expression on NK cell surface was determined by flow cytometry 
analysis. The incubation of NK cells with A. fumigatus culture supernatant did not result in CD56 
downregulation on the NK cell surface (Figure 33). The obtained results suggest that the CD56 
downregulation induced by A. fumigatus on NK cell surface, is dependent on the direct interaction 
between the cells and the fungus.  
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Figure 33: CD56 downregulation on NK cell surface is dependent on the direct interaction of the cells 
with A. fumigatus. Isolated human NK cells were incubated with A. fumigatus supernatant. The co-
incubation was performed overnight. CD56 expression was determined by FACS, gating live NK cells. 
Bar graph shows the mean + SEM of CD56 expression on NK cells. This data is representative of three 
independent experiments. Statistical analysis was performed using the Student’s unpaired t-test. 
 
3.2.4 Analysis of CD56 expression on NK cell surface when cells are incubated with fixed A. 
fumigatus 
The co-incubation of NK cells with live A. fumigatus resulted in a major downregulation on CD56 
surface expression as a result of CD56 internalization upon interaction with the fungus. CD56 
downregulation induced by A. fumigatus, showed to be contact dependent. CD56 expression was then 
analysed on NK cells incubated with fixed A. fumigatus in order to determine if the pathogen viability 
was required to induce CD56 downregulation. Results showed that CD56 downregulation is not 
induced by fixed A. fumigatus swollen conidia or hyphae, indicating that pathogen viability is required 
to induce CD56 downregulation and internalization in NK cells (Figure 34).  
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Figure 34: Representative flow cytometry histograms of CD56 expression on NK cell surface. The red 
lines on histograms represent unstained NK cells, blue lines on histograms represent NK cells stained 
with CD56 antibody and orange lines represent NK cells incubated with fixed A. fumigatus. A) NK cells 
+ fixed A. fumigatus swollen at different E:T ratios; B) NK cells + fixed A. fumigatus hyphae at different 
E:T ratios. This data is representative of three independent experiments.  
 
3.3 Analysis of CD16 surface expression on NK cells in the presence of A. fumigatus 
CD16 was the first activating receptor to be identified on NK cells (180). CD16 mediates antibody-
dependent cellular cytotoxicity (ADCC) by binding to the Fc portion of IgG bound to the surface of 
target cells. In addition, CD16 was also shown to be directly involved in the lysis of some virus-infected 
and tumour cells, independent of antibody ligation (181). CD16 was also shown to be the only 
activating receptor able to independently induce NK cell activation without the requirement for the 
engagement of synergistic receptors (119). After activation, CD16 receptor has been shown to be 
downregulated on the NK cell surface (188). 
In order to determine the involvement of CD16 receptor on the NK cell interaction with A. fumigatus, 
I analysed CD16 expression on NK cell surface by FACS. My results showed that the expression of CD16 
on NK cell surface was not affected when NK cells were incubated with swollen A. fumigatus or 
germlings (Figure 35). Since it was previously reported that upon activation CD16 is downregulated on 
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NK cell surface, my results suggest that CD16 activating receptor is not involved in the interaction 
between NK cells and A. fumigatus in vitro.  
 
 
Figure 35: CD16 expression on NK cells surface in the presence of A. fumigatus. Isolated human NK 
cells were incubated with A. fumigatus swollen at an E:T ratio of 1:1 or with A. fumigatus germlings at 
an E:T ratio of 20:1. The co-incubation was performed overnight. CD16 expression was determined by 
FACS, gating live NK cells. Graph shows the mean ± SEM of CD16 expression on NK cells. Statistical 
analysis was performed using the Student’s paired t-test. n=4 
 
3.4 NK cell interaction with A. fumigatus induces downregulation of NKG2D receptor on NK cell 
surface 
NKG2D is a C-type lectin-like receptor. Two families of NKG2D ligands have been identified in human, 
the MIC protein family that includes MICA and MICB, and the ULBP family, which includes ULBP1–4 
(38,135). NKG2D ligands are self-proteins that are expressed poorly or not at all by most normal cells, 
but are upregulated in cancer cells and cells infected with bacteria or viruses (554,555). Up to date, 
no foreign antigens were identified as ligands for NKG2D activating receptor.   
NKG2D expression on NK cell surface was assessed by FACS. Data showed that the incubation of NK 
cells with A. fumigatus in vitro results in a significant downregulation of this activating receptor on NK 
cell surface (Figure 36). The alteration on NKG2D expression induced by A. fumigatus, suggests that 
this receptor might be involved in the recognition of this fungus by NK cells.  
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Figure 36: NKG2D expression on NK cells surface in the presence of A. fumigatus. Isolated human NK 
cells were incubated with A. fumigatus overnight. A) NK cells + A. fumigatus swollen at an E:T ratio of 
1:1; B) NK cells + A. fumigatus germling at an E:T ratio of 20:1. NKG2D expression was determined by 
FACS, gating live NK cells. Graphs show the mean ± SEM of NKG2D expression on NK cells. Statistical 
analysis was performed using the Student’s paired t-test. n=3 and n=4 *p<0.05 
 
3.5 NK cell interaction with A. fumigatus induces downregulation of NKp46 receptor on NK cell 
surface 
NKp46 has been shown to play a key role in NK cell activation in response to transformed cells, Herpes 
simplex virus and influenza virus infections and in the response to Mycobacterium tuberculosis 
infected monocytes (148–150). The analysis of NKp46 expression showed a significant downregulation 
of this receptor on NK cell surface, when cells are co-cultured in vitro with A. fumigatus swollen conidia 
or germling (Figure 37). The downregulation observed suggests that NKp46 receptor might be involved 
in the interaction between NK cells and A. fumigatus.  
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Figure 37: NKp46 expression on NK cells surface in the presence of A. fumigatus. Isolated human NK 
cells were incubated with A. fumigatus overnight. A) NK cells + A. fumigatus swollen at an E:T ratio of 
1:1; B) NK cells + A. fumigatus germling at an E:T ratio of 20:1. NKp46 expression was determined by 
FACS, gating live NK cells. Graphs show the mean ± SEM of NKp46 expression on NK cells. Statistical 
analysis was performed using the Student’s paired t-test. n=3 *p<0.05, **p<0.01 
 
3.6 Analysis of NKp30 surface expression on NK cells in the presence of A. fumigatus 
NKp30 is an activating receptor that belongs to the Natural Cytotoxicity Receptors family. NKp30 
showed to recognize the nuclear factor HLA-B-associated transcript 3 which can be released by tumour 
cells, the B7-H6 tumour cell ligand and heparin sulphate proteoglycans (147,151,152). In addition, 
NKp30 showed to be responsible for recognition and killing of fungal pathogens Cryptococcus and 
Candida (364). NKp30 expression on NK cells was analysed in the absence and presence of swollen A. 
fumigatus and germlings. The individual analysis of each donor showed a significant downregulation 
of NKp30 expression on NK cell surface when cells are incubated with swollen A. fumigatus and 
germlings. However, the combined analysis of results from three different healthy donors showed 
that the incubation of NK cells with swollen A. fumigatus or germlings does not induce significant 
changes on NKp30 expression on NK cell surface (Figure 38). 
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Figure 38: NKp30 expression on NK cells surface in the presence of A. fumigatus. Isolated human NK 
cells were incubated with A. fumigatus swollen at an E:T ratio of 1:1 or with A. fumigatus germlings at 
an E:T ratio of 20:1. The co-incubation was performed overnight. NKp30 expression was determined 
by FACS, gating live NK cells. Graph shows the mean ± SEM of NKp30 expression on NK cells. Statistical 
analysis was performed using the Student’s paired t-test. n=3 
 
3.7 Analysis of NKp80 surface expression on NK cells in the presence of A. fumigatus 
NKp80 is a C-type lectin-like homodimeric receptor expressed by virtually all fresh NK cells derived 
from peripheral blood (141). The activation-induced C-type lectin (AICL) was identified as a ligand of 
NKp80 and the interaction between the receptor and the ligand stimulates granule exocytosis and 
cytokine secretion by NK cells (161). The results obtained showed that the incubation of NK cells with 
swollen A. fumigatus or germlings does not induce significant changes on NKp80 expression on NK cell 
surface (Figure 39). Up to date, it was not demonstrated that the interaction of NKp80 with its ligand, 
results in NKp80 downregulation. Therefore, the involvement of NKp80 activating receptor on NK cell 
interaction with A. fumigatus, cannot be excluded.  
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Figure 39: NKp80 expression on NK cells surface in the presence of A. fumigatus. Isolated human NK 
cells were incubated with A. fumigatus swollen at an E:T ratio of 1:1 or with A. fumigatus germlings at 
an E:T ratio of 20:1. The co-incubation was performed overnight. NKp80 expression was determined 
by FACS, gating live NK cells. Graph shows the mean ± SEM of NKp80 expression on NK cells. Statistical 
analysis was performed using the Student’s paired t-test. n=3 
 
3.8 Analysis of TLR2 and TLR4 expression on NK cells in the presence of A. fumigatus 
TLR2 and TLR4 receptors have been shown to be important in the immune response to A. fumigatus, 
contributing to pro-inflammatory cytokine production in vitro and in vivo (326,522). Moreover, TLR2 
facilitates the uptake of swollen conidia by murine alveolar macrophages in vitro and contributes to 
phagocytosis by neutrophils in vivo (284,345). NK cells express Toll-Like receptors and TLR2, TLR4 and 
TLR5 agonists demonstrated to directly activate NK cells. NK cell activation by TLRs results in IFN-γ and 
TNF-α production (189,192,193). TLR2 and TLR4 expression was assessed on NK cell surface, and also 
intracellularly, in the absence and presence of A. fumigatus. Analysis of TLR2 and TLR4 expression on 
the NK cell surface by FACS, showed that the percentage of NK cells expressing TLR2 or TLR4 on the 
cell surface is residual (Figure 40). Intracellular expression was also assessed revealing that NK cells 
express intracellular TLR2 and TLR4 (Figure 41). These observations are in agreement with previous 
studies reporting that TLR2 and TLR4 expression in NK cells is mainly intracellular (556,557).   
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Figure 40: Representative FACS plots of TLR2 and TLR4 expression on NK cell surface. TLR2 and TLR4 
expression was assessed on the surface of fresh isolated human NK cells from healthy donors. A) Cells 
were first gated using forward and site scatter, followed by the identification of the live population 
using Aqua zombie staining; B) Unstained NK cells; C) NK cells stained with TLR2 and TLR4 antibodies.  
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Figure 41: Representative FACS plots of TLR2 and TLR4 intracellular expression in NK cells. TLR2 and 
TLR4 intracellular expression was assessed in fresh isolated human NK cells from healthy donors. A) 
Cells were first gated using forward and site scatter, followed by the identification of the live 
population using Aqua zombie staining; B) Unstained NK cells; C) NK cells stained with TLR2 and TLR4 
antibodies. 
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Analysis of intracellular expression of TLR2 and TLR4 in NK cells from sepsis patients, showed a 
significant increase in the percentage of TLR2 and TLR4-positive NK cells together with a profound 
reduction of their capacity to produce IFN-γ compared to healthy subjects (556). In order to determine 
a possible role of TLR2 and TLR4 during A. fumigatus infection, intracellular expression of TLR2 and 
TLR4 in NK cells was assessed by FACS. Isolated human NK cells were incubated with swollen A. 
fumigatus and germlings and TLR2 and TLR4 expression levels were compared with unchallenged cells. 
Results showed no significant difference on TLR2 or TLR4 expression in NK cells after stimulation with 
A. fumigatus in vitro (Figure 42). Both, percentage of positive cells and mean fluorescence intensity 
(MFI) were analysed.  
 
 
Figure 42: Analysis of the intracellular expression of TLR2 and TLR4 in NK cells co-incubated with A. 
fumigatus. Representative flow cytometry histogram of intracellular expression of TLR2 and TLR4 in 
NK cells co-incubated with A. fumigatus swollen and germling. Red line: unstained NK cells; blue line: 
NK cells stained for TLR2 and TLR4; orange line: NK cells co-incubated overnight with A. fumigatus 
swollen or germling. This data is representative of three independent experiments. 
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3.9 Discussion 
Overall, phenotypic analysis of NK cells, showed that different receptors belonging to different 
families, are involved in the interaction between NK cells and A. fumigatus. CD56 glycoprotein showed 
to be highly downregulated on NK cell surface as a result of its internalization. CD56 downregulation 
on NK cell surface is dependent on the direct contact between the cells and the fungus and pathogen 
viability is required. CD56 downregulation on NK cell surface showed to be also induced by A. 
fumigatus in NK cells in the presence of other populations of PBMCs. 
Up to now, little is known about the function of CD56 glycoprotein on NK cells, but the few published 
studies on this subject suggest that it is involved in NK-target cell interactions playing an important 
role in the process of target cell killing (548,549). Some studies have demonstrated that patients with 
chronic viral infections, including patients with HIV-1 and/or HCV infection, have a significant increase 
in the frequency of CD56neg NK cell population. This population is characterized by an impaired 
capacity to kill target cells and to produce IFN-γ, but showed a normal ability to produce chemokines  
(550–552). To date, no studies have analysed if the CD56neg NK cell population is a result of CD56 
internalization, a result of the lack of CD56 expression in the cells or a consequence of cell exhaustion. 
It would be also important to understand if the increase in the frequency of CD56neg NK cell population 
in these patients is induced by viruses as a mechanism to evade detection and activation of NK cells. 
Several mechanisms of viral evasion of NK cells have been described, including infection of NK cells 
and ligation of non-class I NK cell inhibitory receptors by viral envelope proteins; inhibition of NK cell 
activation, trafficking, or both, resulting from viral modulation of cytokine–chemokine networks or 
virus-encoded cytokine or chemokine homologs that prevent NK cell function; interference with NK 
cell–activating receptor function caused by virus-mediated inhibition of the expression of the 
corresponding ligand, of their signalling in infected host cells or of the production of virus encoded 
antagonists of NK cell–activating receptors; ligation of inhibitory class I receptors on NK cells by virus-
encoded MHC class I homologs; virus-induced regulation of class I protein expression resulting in 
selective expression or up-regulation of class I molecules that can bind NK cell class I inhibitory 
receptors (558). HIV was shown to infect cultured NK cells in vitro and it was found ex vivo in NK cells 
from HIV-seropositive individuals (559). Interactions between virus particles and NK cells that do not 
result in infection may exert other direct effects upon NK cells. E2, an envelope protein of HCV showed 
to inhibit NK cells cytotoxicity via CD81 binding (560). 
A. fumigatus have also evolved various means of evading or subverting normal host defences. Fungal 
melanin was demonstrated to inhibit cell apoptosis and to be involved in the inhibition of 
phagolysosomal acidification. Moreover, A. fumigatus was shown to sabotage the complement 
system activities via secretion of extracellular proteases (561). Several studies have reported that A. 
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fumigatus is able to produce a variety of enzymes and toxins that may facilitate fungal colonization of 
tissues and evasion of the host immune response. The most widely studied toxin is gliotoxin that was 
shown to inhibit phagocytic activity of macrophages, induces apoptosis of monocytes, decreases the 
activation of NADPH oxidase in neutrophils, and impairs granule exocytosis in T cells (221–225). 
Since CD56 is an isoform of N-CAM, which is known to be involved in homophilic adhesive interactions, 
a BLAST analysis was performed in order to identify similar protein sequences in A. fumigatus species. 
The analysis performed on NCBI, showed one sequence with 33% homology, named SH3 domain-
containing protein (appendix 1). The function of this protein in A. fumigatus is not known but the SH3 
domain is known to be present in a large number of proteins involved in signal transduction. In 
addition, SH3 domains are known to bind proline-rich regions and have been shown to play an 
important role mediating protein-protein interactions in a variety of signalling pathways (562,563).  
To the best of our knowledge, this is the first time that CD56 downregulation and internalization has 
been reported in NK cells as a result of the direct interaction of these cells with a pathogen. These 
observations clearly demonstrate that CD56 is involved in the interaction between NK cells and A. 
fumigatus and might be inducing NK cell activation in response to the fungus. On other hand, the 
induction of CD56 internalization might represent a novel mechanism of immune evasion for A. 
fumigatus, a consequence of NK cells exhaustion or both, with NK cell exhaustion being induced by A. 
fumigatus in order to inhibit NK cell effector functions.  
NK cell exhaustion has been observed in several viral infections as a consequence of constant exposure 
to persistent antigens resulting in impaired cytotoxic function, altered cytokine production and 
impaired antibody-dependent cell-mediated cytotoxicity (ADCC) (564,565). In addition to chronic viral 
infections, NK cell exhaustion has been also observed in several human cancers with repeated NK cell 
interaction with target cells lacking MHC class I as the cause of exhaustion (566). It is surprising to 
observe that A. fumigatus induced CD56 downregulation on NK cell surface in a few hours. Co-
incubation of NK cells with A. fumigatus for 5 hours showed to be enough to reduce CD56 expression 
on NK cell surface. Regardless whether or not CD56 downregulation is a mechanism of immune 
evasion, all data previously reported demonstrated that CD56neg NK cell population is impaired in its 
effector function against target cells.   
The phenotypic analysis of NK cell activating receptors on NK cells when co-incubated overnight with 
A. fumigatus in vitro, also showed a downregulation of important activating receptors on NK cell 
surface, including NKG2D and NKp46. These results suggest that these receptors are involved in the 
recognition of A. fumigatus by NK cells. NKG2D is a C-type lectin-like receptor and up to date no foreign 
antigens were identified as ligands for this receptor. However, C-type lectin-like receptors comprise a 
large number of receptors that recognize a wide range of carbohydrate structures, including the major 
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carbohydrate structures found in the fungal cell walls, β-glucan and mannan (337). The direct 
interaction between NKp46 and fungal pathogens was still not reported, but this activating receptor 
showed to directly interact with other pathogens, including virus and bacteria (567,568).  
Analysis of CD16, NKp30, NKp80, TLR2 and TLR4 expression on NK cells was also performed. CD16 is a 
key NK cell receptor and is the only activating receptor able to independently induce NK cell activation 
without require the engagement of synergistic receptors (119). Previous studies have shown that upon 
activation, CD16 receptor is downregulated from the NK cell surface (188). The interaction of NK cells 
with A. fumigatus do not result in an alteration of CD16 expression on NK cell surface, suggesting that 
this receptor is not implicated in the interaction between the cells and the fungus.  
NKp30 has previously been recognized to be involved in the recognition and killing of Cryptococcus 
and Candida (364), indicating that might be an important receptor in the NK cell interaction with 
fungal pathogens. My results showed no significant changes on NKp30 expression on NK cell surface, 
suggesting that this receptor is not involved in the interaction of NK cells and A. fumigatus. NKp80 is 
a C-type lectin-like receptor that is broadly expressed on human NK cells derived from peripheral 
blood (141). Knowing that C-type lectin-like receptors recognize a wide range of carbohydrate 
structures, including β-glucan and mannan (337), I decided to analyse the expression of this receptor 
on NK cells when challenged with A. fumigatus in vitro. My results showed no changes on NKp80 
expression on NK cell surface, suggesting that this receptor is not involved in the interaction of NK 
cells and A. fumigatus. To date, there are no published reports demonstrating that the interaction of 
NKp30 or NKp80 with their ligands, results in the receptor downregulation so the involvement of 
NKp30 or NKp80 activating receptors on NK cell interaction with A. fumigatus, cannot be excluded. 
Several studies have showed that TLR2 and TLR4 receptors have an important role in the immune 
response to A. fumigatus in vitro and in vivo (326,522). I assessed the effect of NK cell incubation with 
A. fumigatus on TLR2 and TLR4 expression. My results showed no significant alterations on TLR2 or 
TLR4 expression extracellularly or intracellularly in NK cells when challenged with the fungus, 
suggesting that these receptors are not implicated in the interaction between NK cells and A. 
fumigatus. 
NK cell activation is tightly regulated by a balance between positive and negative signals provided by 
activating and inhibitory receptors. The net income of key positive and negative signals, determines 
whether or not NK cells will initiate a cytotoxic response (117,120). My studies were mainly focused 
on the analysis of NK cell activating receptors in order to determine which receptors could be 
important in the recognition of A. fumigatus and consequently involved in NK cell activation. The 
phenotypic analysis of inhibitory receptors was not performed, largely because the majority of these 
receptors recognize cell-derived antigens, including HLA-A, -B, -C and -E, that are expressed on the cell 
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surface of all nucleated cells (170,569,570). In addition, NKG2A is continuously recycled at the cell 
surface being largely unaffected by exposure to ligand (131). This fact makes the phenotypic analysis 
by FACS not suitable for NKG2A analysis. 
In conclusion, the interaction between NK cells and A. fumigatus in vitro results in a significant 
downregulation of CD56 expression on NK cell surface as a consequence of the internalization of this 
glycoprotein. The induction of CD56 downregulation, showed to be dependent on the direct contact 
between the cells and the fungus and on the pathogen viability. The co-incubation of NK cells with A. 
fumigatus also results in the downregulation of NKG2D and NKp46 on NK cell surface, suggesting that 
these activating receptors are involved in the interaction between NK cells and the fungus. On the 
other hand, my results suggest that activating receptors such as CD16, NKp30, NKp80, TLR2 and TLR4 
are not implicated in this interaction. 
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4. Functional characterization of human natural killer cell response to Aspergillus fumigatus 
4.1 Introduction 
NK cell effector function is mediated by several mechanisms, including secretion of pro-inflammatory 
cytokines and chemokines, release of cytotoxic granules, triggering of FAS-mediated apoptosis and 
TRAIL-dependent cytotoxicity (44). The NK cell response is tightly controlled by activating and 
inhibitory receptors that recognize and interact with a wide range of antigens expressed by different 
targets. The net income of key positive and negative signals, determines whether or not NK cells will 
initiate a cytotoxic response. Several studies have revealed a hierarchy in terms of the strength of the 
activating stimuli for induction of specific responses. The process of adhesion exhibits a low threshold 
for activation, induction of chemokines requires stronger activating stimuli, whereas degranulation 
and production of cytokines display the most stringent requirements for induction (47–49). 
There is increasing evidence indicating that NK cells may play an important role in the early defence 
against fungal infections. Several studies have shown that human NK cells interact with Cryptococcus 
neoformans, Candida albicans, Paracoccidioides brasiliensis and Rhizopus oryzae but the studies 
published so far are contradictory. Some studies claim that the NK cell response is mediated by the 
secretion of cytokines, on the other hand, other studies reported that NK cell respond via release of 
cytotoxic molecules such as perforin, granzymes and granulysin. Furthermore, some studies also 
suggest that fungi exhibit important immunosuppressive effects on NK cells.  
The few studies focussed on NK cell interaction with A. fumigatus are also contradictory and describe 
different mechanisms of NK cell response to this fungus. Schmidt and colleagues (372) showed that 
human NK cells kill A. fumigatus hyphae with perforin acting as the mediator of the cytotoxic 
mechanism. The same study suggests an immunosuppressive effect of A. fumigatus on NK cells, 
resulting in the inhibition of IFN-γ and GM-CSF produced by pre-stimulated NK cells. In striking 
contrast, another study performed in vitro found that IL-2 pre-stimulated human NK cells release IFN-
γ and TNF-α in response to A. fumigatus germlings, with IFN-γ showing to directly damage the fungus 
(373).  
The aim of this chapter was to characterize the NK cell response to A. fumigatus in vitro, including the 
analysis of cytokine and chemokine secretion, assessment of lytic granules polarization and release 
and analysis of fungal damage. In addition, I assessed the effect of the presence of A. fumigatus on NK 
cells response to K562 cell line. 
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4.2 Analysis of NK cell response to A. fumigatus via cytokine and chemokine production   
Besides the ability to release lytic granules in response to different targets, NK cells have the capacity 
to produce a variety of chemokines and cytokines. NK cells have been reported to secrete chemokines 
such as MIP-1α, MIP-1β and RANTES and to produce immunoregulatory cytokines such as IFN-γ, TNF-
α, IL-5, IL-8, IL-10 and IL-13 (25,571). Chemokine production is an early feature of NK-cell responses 
and is triggered with relatively weak activating signals, requiring less stimulation than that necessary 
for degranulation or cytokine production. A detailed study on NK cell activation, revealed a hierarchy 
among factors released upon NK-cell interactions with target cells, with graded responses according 
to the degree of ligand expression for activating receptors. The study showed that engagement of the 
activating receptor NKG2D sufficed for secretion of chemokines but secretion of IFN-γ and TNF-α 
requires engagement of multiple different receptors and occurred later, revealing a tighter control 
and higher activation threshold for induction of cytokine secretion (83). Chemokines produced by NK 
cells upon activation, including MIP-1α, MIP-1β and RANTES, are important to alert and recruit other 
immune cells to the site of infection (84,85). In addition, chemokines enhanced granule exocytosis and 
NK cell-mediated cytolytic response to K562 cells (87,88). TNF-α is a proinflammatory cytokine that 
plays a critical role in diverse cellular events including proliferation, differentiation, apoptosis and 
induction of other cytokines (90). IFN-γ was shown to be involved in up-regulation of pathogen 
recognition, stimulation of cell migration and also in the activation of macrophages and monocytes 
via stimulation of reactive oxygen species (ROS) and reactive nitrogen species (RNIs) production (572). 
The production of cytokines and chemokines by NK cells in response to A. fumigatus in vitro, was 
assessed by ELISA assay, FACS and luminex multiplex. 
 
4.2.1 YTS, NK92 and NKL cell lines do not respond to Aspergillus fumigatus via cytokine production 
Cell lines have been extensively used as models to study several biological processes, including cell 
proliferation, differentiation and apoptosis and to dissect signalling pathways involved in the 
regulation of cell activation and function. Cell lines have been a valuable research tool since they 
display characteristics similar to the original primary cells and provide an unlimited source of cells.  
My first approach in order to assess NK cell response to A. fumigatus was performed using three NK 
cell lines NK92, NKL and YTS cells. NK92 is an IL-2-dependent tumour natural killer cell line established 
from peripheral blood mononuclear cells from a patient with rapidly progressive non-Hodgkin’s 
lymphoma. The NK92 cell line is highly cytotoxic to human cancer cells, including K562 cells (514). NKL 
cell line was established from the peripheral blood of a patient with CD3-CD16+CD56+ large granular 
lymphocyte (LGL) leukaemia and can mediate antibody‐dependent cell‐mediated cytotoxicity as well 
as NK cells (515). NKL cells are also strictly dependent on interleukin-2 (IL-2) for sustained growth. The 
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human YTS natural killer cell line is a sub-clone of the YT lymphoid cell line derived from a patient with 
acute lymphoblastic lymphoma. YTS cells are independent of IL-2 and are not cytotoxic to K562 cells 
(511–513). All these three NK cell lines expressed LFA-1, which is required for conjugate formation 
and actin polymerization. NK92 cells express a relatively large number of activating receptors including 
NKG2D, NKp30, NKp46 and 2B4 but express a few inhibitory receptors, lacking most of the KIRs (573). 
NKL cell line express NKG2D, NKp46 and 2B4 (513). YTS cells express NKG2D, NKp30, NKp80 and 2B4 
receptors.  
NK92, NKL and YTS cell cytokine response to A. fumigatus was assessed by qPCR and ELISA.  
 
Analysis of IFN-γ mRNA levels in NK92, NKL and YTS cell lines challenged with A. fumigatus 
In order to determine cell activation induced by A. fumigatus, IFN-γ and TNF-α mRNA expression levels 
were quantified by real-time PCR. NK92 and YTS cell lines were incubated with A. fumigatus germlings 
and mRNA expression was quantified at different time points. Quantitative analysis of IFN-γ mRNA 
expression showed no significant production of IFN-γ when NK cells are incubated with the fungus 
(Figure 43). TNF-α mRNA expression was also assessed but no significant amounts were detected even 
for PMA/Ionomycin activation. 
 
 
Figure 43: Analysis of IFN-γ mRNA levels in NK92 and YTS cell lines challenged with A. fumigatus. NK 
cell lines were co-incubated with A. fumigatus germlings (MOI 1) for 4h, 6h, 12h and 24 hours. 
Incubation with PMA/Ionomycin was used as a positive control. IFN-γ mRNA levels were quantified by 
quantitative real-time PCR and normalized against β-actin gene expression. A) NK92 cell line + A. 
fumigatus; B) YTS cell line + A. fumigatus. Bar graphs represent mean + SEM from 2 technical 
replicates. These graphs represent the results obtained from three individual experiments. Statistical 
analysis was performed using the Student’s unpaired t-test. ***p<0.001 
 
Further analysis was performed using NK92, NKL and YTS cell lines, incubating the cells with A. 
fumigatus resting conidia, swollen conidia or germlings at MOI 1. After 6 hours incubation, cells were 
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collected, lysed and total RNA was extracted for further analysis. The co-incubation of NK92, NKL or 
YTS cells with A. fumigatus did not induce a significant increase of IFN-γ mRNA expression in the cells 
(Figure 44). TNF-α mRNA expression was also assessed but no significant amounts were detected even 
for PMA/Ionomycin activation.  
 
 
Figure 44: Analysis of IFN-γ mRNA levels in NK92, NKL and YTS cell lines challenged with A. 
fumigatus. NK cell lines were co-incubated with A. fumigatus resting conidia, swollen conidia or 
germlings (MOI 1) for 6 hours. Incubation with PMA/Ionomycin was used as a positive control. IFN-γ 
mRNA levels were quantified by quantitative real-time PCR and normalized against β-actin gene 
expression. A) NK92 cell line + A. fumigatus; B) NKL cell line + A. fumigatus; C) YTS cell line + A. 
fumigatus. Bar graphs represent mean + SEM from 2 technical replicates. These graphs represent the 
results obtained from three individual experiments. Statistical analysis was performed using the 
Student’s unpaired t-test. ***p<0.001 
 
Analysis of TNF-α production by NK92, NKL and YTS cell lines challenged with A. fumigatus 
Quantification of TNF-α protein levels was performed in the supernatant of co-cultures of NK cell lines 
and A. fumigatus. NK92, NKL and YTS cell lines were incubated with A. fumigatus resting conidia, 
swollen conidia or germlings at MOI 1. After overnight incubation, supernatant of the co-cultures was 
collected and TNF-α protein levels were determined by ELISA. Results showed that the co-incubation 
with A. fumigatus did not induce TNF-α release by NK92, NKL or YTS cell lines (Figure 45). Surprisingly, 
PMA/Ionomycin also did not induce an increase of TNF-α production by NKL or YTS cells.  
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Figure 45: TNF-α protein levels produced by YTS, NK92 and NKL cell lines in response to A. fumigatus. 
NK cell lines were co-incubated overnight with A. fumigatus resting conidia, swollen conidia or 
germlings (MOI 1). Incubation with PMA/Ionomycin was used as a positive control. TNF-α levels were 
quantified by ELISA. A) NK92 cell line + A. fumigatus; B) NKL cell line + A. fumigatus; C) YTS cell line + 
A. fumigatus. Bar graphs represent mean + SEM from 2 technical replicates. These graphs represent 
the results obtained from three individual experiments. Statistical analysis was performed using the 
Student’s unpaired t-test. ***p<0.001 
 
Analysis of cytokine production by NK cell lines in response to A. fumigatus, showed that NK92, NKL 
or YTS cells do not produce IFN-γ or TNF-α when co-incubated with A. fumigatus resting conidia, 
swollen conidia or germling. Quantification of IFN-γ mRNA levels showed no induction of IFN-γ 
expression in response to the fungus and showed that PMA/ionomycin did not induce significant IFN-
γ mRNA expression in NKL and YTS cell line. Quantitative analysis of TNF-α mRNA expression was also 
assessed but no significant amounts were detected for any cell line even for induction with 
PMA/Ionomycin. However, further quantification of protein levels showed that the NK92 cell line 
releases TNF-α when activated with PMA/ionomycin but again neither NKL nor YTS cell line do. No 
significant TNF-α secretion was detected when NK cell lines were challenged with A. fumigatus. These 
observations demonstrated that the NK92 cell line did not respond to A. fumigatus via cytokine 
production. Results obtained for YTS and NKL cells do not allow to draw any conclusions since cell 
activation was not observed even when cells were challenged with PMA. Analysis of NK92, NKL and 
YTS degranulation in response to the fungus was not performed.   
 
4.2.2 Primary human NK cells do not produce IFN-γ or TNF-α in response to A. fumigatus 
Since the analysis of cytokine production by NK cell lines in response to A. fumigatus showed no 
significant responses and the studies previously published were performed with primary human NK 
cells, I decided to follow my studies using primary human NK cells isolated from fresh blood collected 
from volunteer healthy donors.  
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Aiming to assess the NK cell response to A. fumigatus via cytokine production, several assays in vitro 
were performed incubating NK cells with A. fumigatus at different stages of the fungal cycle, at 
different MOIs and in the presence of different interleukins.  
The first approach in order to detect IFN-γ and TNF-α production by NK cells in response to A. 
fumigatus, was an attempt to replicate the results published by Bouzani et al (373) showing a high NK 
cell cytokine response induced by the incubation with A. fumigatus germling in the presence of 
1000U/mL of IL-2. NK cells were incubated for 12 hours with A. fumigatus germling at different E:T 
ratios and cytokine production was measured in the supernatant of the co-cultures. My results 
showed no significant production of IFN-γ or TNF-α by NK cells when co-incubated with the fungus in 
these conditions (Figure 46).  
 
 
Figure 46: Analysis of cytokine production by NK cells in response to A. fumigatus. Primary human 
NK cells were incubated for 12 hours with A. fumigatus germling at E:T ratios of 1:1, 10:1 and 100:1 in 
the presence of 1000 U/mL of IL-2. Incubation with PMA/Ionomycin was used as a positive control. 
IFN-γ (A) and TNF-α (B) levels were determined in the supernatant of the co-cultures by ELISA assay. 
Graphs show the mean ± SEM of IFN-γ and TNF-α production. Statistical analysis was performed using 
the Student’s paired t-test. n=3 
 
FACS analysis was also performed with NK cells from four different donors. NK cells were co-incubated 
with swollen A. fumigatus or germlings at an E:T ratio 1:1 and IFN-γ and TNF-α production was 
determined by intracellular staining. Co-cultures were incubated in the presence of 300 U/mL of IL-2. 
Similarly to the results obtained with ELISA assay, no significant IFN-γ or TNF-α production was 
observed when NK cells were incubated with the fungus (Figures 47 and 48). 
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Figure 47: Analysis of cytokine production by NK cells in response to A. fumigatus. Primary human 
NK cells were incubated overnight with A. fumigatus germling at an E:T ratio of 1:1 in presence of 300 
U/mL of IL-2. Co-incubation with K562 cell line at an E:T ratio of 1:1 was used as positive control for 
cytokine production. After incubation time, cells were collected and washed with PBS, stained with 
surface antibodies CD56 and CD3 and after permeabilization were incubated with IFN-γ and TNF-α 
antibodies. Intracellular expression of A) IFN-γ and B) TNF-α by NK cells was determined by FACS 
analysis. Graphs show the mean ± SEM of IFN-γ and TNF-α production. Statistical analysis was 
performed using the Student’s paired t-test. n=4 
 
 
Figure 48: Analysis of cytokine production by NK cells in response to A. fumigatus. Primary human 
NK cells were incubated overnight with A. fumigatus swollen at an E:T ratio of 1:1 in presence of 300 
U/mL of IL-2. Co-incubation with K562 cell line at an E:T ratio of 1:1 was used as positive control for 
cytokine production. After incubation time, cells were collected and washed with PBS, stained with 
surface antibodies CD56 and CD3 and after permeabilization were incubated with IFN-γ and TNF-α 
antibodies. Intracellular expression of A) IFN-γ and B) TNF-α by NK cells was determined by FACS 
analysis. Graphs show the mean ± SEM of IFN-γ and TNF-α production. Statistical analysis was 
performed using the Student’s paired t-test. n=4 
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IL-15 exhibits many biological activities in common with IL-2, including the ability to stimulate NK cells. 
IL-15 has been shown to enhance NK cell cytotoxic activity and production of IFN-γ, TNF-α and GMC-
SF (574). Co-incubation assays were performed using this cytokine in addition to IL-2. Human NK cells 
from different healthy donors were challenged with A. fumigatus at E:T ratios of 1:1, 20:1 and 100:1. 
IFN-γ and TNF-α levels were measured in the supernatant of the co-cultures by ELISA. The results 
obtained were variable, with one of the donors showing a significant increase in cytokine production 
when NK cells were incubated with A. fumigatus germling at MOI of 0.01, but with NK cells from the 
other two donors showing IFN-γ and TNF-α levels compared with the levels measured for the control 
(Figure 49). 
 
 
Figure 49: Analysis of cytokine production by NK cells in response to A. fumigatus. Primary human 
NK cells were incubated overnight with A. fumigatus germlings at E:T ratios of 1:1, 20:1 and 100:1 in 
the presence of 300 U/mL of IL-2 and 400 U/mL of IL-15. Incubation with PMA/Ionomycin was used as 
a positive control. IFN-γ (A) and TNF-α (B) levels were determined in the supernatant of the co-culture 
by ELISA assay. Graphs show the mean ± SEM of IFN-γ and TNF-α production. Statistical analysis was 
performed using the Student’s paired t-test. n=3 
 
Further assays were performed incubating NK cells with A. fumigatus germling at MOI 0.01 for 30 
hours. Cytokine production was measured at different time points and results showed no significant 
increase in IFN-ɣ or TNF-α production induced by the presence of A. fumigatus (Figure 50).  
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Figure 50: Analysis of cytokine production by NK cells in response to A. fumigatus. Primary human 
NK cells were incubated with A. fumigatus germlings at an E:T ratio of  100:1 in presence of 300 U/mL 
of IL-2 and 400 U/mL of IL-15. Incubation with PMA/Ionomycin was used as a positive control. IFN-γ 
(A) and TNF-α (B) levels were determined in the supernatant of the co-culture by ELISA at 4h, 8h, 12h 
and 30h post-incubation. Graphs show the mean ± SEM of IFN-γ and TNF-α production. Statistical 
analysis was performed using the Student’s paired t-test. n=4 
 
NK cell response to A. fumigatus via cytokine production, was then assessed for six different healthy 
donors, incubating primary human NK cells with A. fumigatus germlings at an E:T ratio of  100:1. IFN-
γ and TNF-α levels were determined in the supernatant of the co-cultures by ELISA. No significant IFN-
γ or TNF-α production was observed when NK cells are challenged with the fungus in vitro (Figure 51).  
 
 
Figure 51: Analysis of cytokine production by NK cells in response to A. fumigatus. Primary human 
NK cells were incubated for 12 hours with A. fumigatus germlings at an E:T ratio of  100:1 in presence 
of 300 U/mL of IL-2 and 400 U/mL of IL-15. Incubation with PMA/Ionomycin was used as a positive 
control. IFN-γ (A) and TNF-α (B) levels were determined in the supernatant of the co-culture by ELISA 
assay. Graphs show the mean ± SEM of IFN-γ and TNF-α production. Statistical analysis was performed 
using the Student’s paired t-test. n=5 
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I also examined the ability of fixed A. fumigatus germlings to induce cytokine production by NK cells. 
Primary human NK cells were incubated with fixed A. fumigatus germlings at different MOIs and IFN-
γ and TNF-α levels were determined at different incubation times. Fixed A. fumigatus did not stimulate 
cytokine production by NK cells (Figure 52).  
 
 
Figure 52: Analysis of cytokine production by NK cells in response to fixed A. fumigatus. Primary 
human NK cells were incubated with fixed A. fumigatus germlings at E:T ratios of A) 10:1, B) 20:1 and 
C) 100:1 in presence of 300 U/mL of IL-2 and 400 U/mL of IL-15. Incubation with PMA/Ionomycin was 
used as a positive control. IFN-γ and TNF-α levels were determined in the supernatant of the co-culture 
by ELISA at 4h, 8h, 12h and 30h post-incubation. Bar graphs show the mean + SEM of IFN-γ and TNF-
α production. This data is representative of three independent experiments. Statistical analysis was 
performed using the Student’s unpaired t-test. ***p<0.001 
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4.2.3 NK cells secrete MIP-1α, MIP-1β and RANTES in response to Aspergillus fumigatus 
Chemokine production by NK cells in response to A. fumigatus was also assessed in the presence of 
IL-2 and IL-2 plus IL-15. Isolated human NK cells were incubated with A. fumigatus germlings at 
different E:T ratios and multiple analytes were measured in the supernatant of co-cultures, including 
MIP-1α, MIP-1β, RANTES, GM-CSF, IL-10, IL-12p40, IL-15, IL-17, IL-1RA, IL-1α, IL-1β, IL-4, IL-7 and IL-8. 
Quantification of these analytes was performed by Luminex multiplex assay and results showed a 
significant increase in the release of MIP-1α, MIP-1β and RANTES chemokines when NK cells were 
incubated with A. fumigatus (Figures 53 and 54). MIP-1α, MIP-1β and RANTES are known important 
chemoattractants for monocytes/macrophages and distinct populations of lymphocytes to the site of 
infection (84,85). Studies performed in vivo showed that RANTES, MIP-1α and MIP-1β together with 
IFN-γ were also coactivators of macrophages and T cells (86). 
Co-cultures performed in the presence of IL-2 showed a significant increase in MIP-1α, MIP-1β and 
RANTES levels after 14 hours incubation (Figure 53). Co-cultures performed in presence of IL-2 and IL-
15 showed a significant increase in MIP-1α levels and RANTES hovered at nearly significance (p = 
0.0512) after 12 hours co-incubation. Quantification of chemokines levels, 30 hours post-incubation, 
showed significant secretion of RANTES, MIP-1α and MIP-1β by NK cells, induced by the presence of 
A. fumigatus (Figure 54).  
 
 
Figure 53: NK cells produce MIP-1α, MIP-1β and RANTES in response to A. fumigatus. Primary human 
NK cells were incubated overnight with A. fumigatus germlings at E:T ratios of 1:1 and 20:1 in presence 
of 300 U/mL of IL-2. Co-incubation with K562 cell line at an E:T ratio of 1:1 was used as positive control. 
After incubation time, supernatant of co-cultures was collected. A) MIP-1α, B) MIP-1β and C) RANTES 
levels were determined by Luminex multiplex assay. Bar graphs show the mean + SEM of MIP-1α, MIP-
1β and RANTES production. This data is representative of results from two different donors. Statistical 
analysis was performed using the Student’s unpaired t-test. *p<0.05, **p<0.01, ***p<0.001. 
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Figure 54: NK cells produce MIP-1α, MIP-1β and RANTES in response to A. fumigatus. Primary human 
NK cells were incubated with A. fumigatus germlings at an E:T ratio of 100:1 in the presence of 300 
U/mL of IL-2 and 400 U/mL of IL-15. Incubation with PMA/ionomycin was used as positive control. A) 
MIP-1α, B) MIP-1β and C) RANTES levels were determined in the supernatant of the co-cultures by 
Luminex multiplex at 4h, 8h, 12h and 30h post-incubation. Bar graphs show the mean + SEM of MIP-
1α, MIP-1β and RANTES production. This data is representative of results from two different donors. 
Statistical analysis was performed using the Student’s unpaired t-test. *p<0.05, **p<0.01, ***p<0.001 
 
4.2.4 NK cells do not produce GM-CSF, IL-7 or IL-8 in response to Aspergillus fumigatus 
GM-CSF is an important immune modulator that is produced by a variety of immune cells including 
NK cells, T cells, macrophages and endothelial cells (575,576). GM-CSF has shown to be involved in 
the recruitment and activation of neutrophils, monocytes and lymphocytes (576–578) and it is been 
used clinically in cancer patients undergoing chemotherapy and after bone marrow transplantation 
due to its effect as a hematopoietic growth factor (579,580). In addition, GM-CSF have shown to play 
a central role in the recruitment of neutrophils into the lung during A. fumigatus infection (581). As 
referred above, an in vitro study from Schmidt et al. showed that the co-culture of pre-stimulated NK 
cells with A. fumigatus results in the inhibition of GM-CSF production (372). The quantitative analysis 
of GM-CSF production by NK cells showed that NK cells do not produce GM-CSF when challenged with 
A. fumigatus in vitro.  
Interleukin-8 (IL-8) is a chemokine produced by NK cells, monocytes and macrophages (83,582,583) 
and has been shown to be a potent neutrophil activator and chemotactic factor (584,585). A. 
fumigatus has been shown to induce IL-8 synthesis by respiratory epithelial cells, possibly resulting in 
the recruitment of neutrophils into the lung (236,586,587). The analysis of IL-8 production by NK cells 
showed that NK cells do not produce IL-8 when challenged with A. fumigatus in vitro. 
Interleukin-7 (IL-7) has been shown to play a critical role in T cell development, trafficking and 
activation (588,589) and has been shown to be important in engagement of multiple mechanisms to 
overcome viral infections (590,591). NK cells have been shown to produce IL-7 that in addition to be 
able to activate other immune cells, have also shown to enhance NK cell survival (592). The analysis 
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of IL-7 production by NK cells showed that NK cells do not produce IL-7 when challenged with A. 
fumigatus in vitro (Figure 55 and 56). 
 
 
Figure 55: Analysis of GM-CSF, IL-7 and IL-8 production in response to A. fumigatus. Primary human 
NK cells were incubated overnight with A. fumigatus germlings at E:T ratios of 1:1 and 20:1 in presence 
of 300 U/mL of IL-2. Co-incubation with K562 cell line at an E:T ratio of 1:1 was used as positive control. 
After incubation time, supernatant of co-cultures was collected. A) GM-CSF, B) IL-7 and C) IL-8 levels 
were determined by Luminex multiplex assay. Bar graphs show the mean + SEM of GM-CSF, IL-7 and 
IL-8 production. This data is representative of results from two different donors. Statistical analysis 
was performed using the Student’s unpaired t-test. **p<0.01, ***p<0.001. 
 
 
Figure 56: Analysis of GM-CSF, IL-7 and IL-8 production in response to A. fumigatus. Primary human 
NK cells were incubated with A. fumigatus germlings at an E:T ratio of 100:1 in the presence of 300 
U/mL of IL-2 and 400 U/mL of IL-15. Incubation with PMA/ionomycin was used as positive control. A) 
GM-CSF, B) IL-7 and C) IL-8 levels were determined in the supernatant of the co-cultures by Luminex 
multiplex at 4h, 8h, 12h and 30h post-incubation. Bar graphs show the mean + SEM of GM-CSF, IL-7 
and IL-8 production. This data is representative of results from two different donors. Statistical 
analysis was performed using the Student’s unpaired t-test. **p<0.01, ***p<0.001 
 
4.2.5 NK cells do not produce IFN-γ or TNF-α in response to ΔgliG A. fumigatus 
Several studies have reported that A. fumigatus is able to produce a variety of enzymes and toxins 
that may facilitate fungal colonization of tissues and evasion of the host immune response. The most 
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widely studied toxin is gliotoxin that showed to inhibit phagocytic activity of macrophages, induces 
apoptosis of monocytes, decreases the activation of NADPH oxidase in neutrophils, and impairs 
granule exocytosis in T cells (221–225). In order to assess if gliotoxin, produced by A. fumigatus, was 
inhibiting cytokine production by NK cells, A. fumigatus ΔgliGAF293 (293 gliG-deleted strain) was used 
to challenge NK cells in vitro. Deletion of gliG gene results in abrogation of gliotoxin biosynthesis (593). 
Similarly to the results obtained for the co-incubation with A. fumigatus ATCC 46645 WT strain, the 
co-culture of NK cells with A. fumigatus ΔgliGAF293 did not induce IFN-γ or TNF-α production by NK cells 
(Figure 57).  
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Figure 57: Analysis of cytokine production by NK cells in response to ΔgliG A. fumigatus. Primary 
human NK cells were incubated with ΔgliG A. fumigatus germling at E:T ratios of A) 1:1, B) 10:1 and C) 
100:1 in presence of 300 U/mL of IL-2. Incubation with PMA/Ionomycin was used as a positive control. 
IFN-γ and TNF-α levels were determined in the supernatant of the co-cultures by ELISA at 6h, 12h, 24h 
and 32h post-incubation. Bar graphs show the mean + SEM of IFN-γ and TNF-α production. This data 
is representative of two independent experiments. Statistical analysis was performed using the 
Student’s unpaired t-test. **p<0.01, ***p<0.001 
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4.3 Analysis of NK cell cytotoxic response to Aspergillus fumigatus  
The release of cytotoxic granules containing perforin, granzymes and granulysin is a key mechanism 
of NK cell effector function (67). This process, designated as the NK cell cytotoxic response, involves 
discrete regulated steps namely adhesion, immune synapse (IS) formation, granule polarization and 
exocytosis. Different assays were performed in order define NK cell cytotoxic response to A. 
fumigatus.  
 
4.3.1 NK cell interaction with A. fumigatus results in NK cell adhesion to the fungus 
The co-incubation of isolated human NK cells with A. fumigatus in vitro resulted in NK cell adhesion to 
the fungus. The inoculation of A. fumigatus in a cell culture plate results in strong fungal adherence to 
the wells. On the other hand, NK cells are not adherent cells and when incubated in cell culture plates 
are easily removed from the wells using 5mM EDTA. The co-culture of NK cells with A. fumigatus 
resulted in adherence of the cells to the fungus, easily visible under optical microscope. The images 
below show the culture of isolated NK cells (Figure 58A) and NK cells incubated with A. fumigatus at 
MOIs of 1 and 0.05 (Figure 58B and 58C). Figures 58D and 58E are images taken after removing the 
culture supernatant from the wells containing NK cells and A. fumigatus and it is possible to visualize 
the NK cells attached to the hyphae. FACS analysis, confirmed this observation. NK cells were 
incubated in the presence or absence of A. fumigatus, after the incubation time cells were collected 
and prior to FACS analysis cells were filtered in order to exclude the hyphae and all NK cells attached 
to the fungus. Cell counting on FACS revealed that more than 50% of the cells were retained by the 
filter as a consequence of NK cell adherence to the fungus (Figure 59).  
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Figure 58: NK cells adhere to A. fumigatus when co-incubated with the fungus in vitro. Isolated 
human NK cells were incubated with A. fumigatus overnight. After the incubation period, images were 
captured using an optical microscope. A) Culture of human isolated NK cells; B) NK cells incubated 
with A. fumigatus germlings at an E:T ratio of 20:1; C) NK cells incubated with A. fumigatus swollen at 
an E:T ratio of 1:1; D) NK cells incubated with A. fumigatus after removal the culture supernatant from 
the well; E) NK cells incubated with A. fumigatus after remove the culture supernatant from the well 
followed by several washes with 5mM EDTA and PBS.  
 
 
Figure 59: NK cells strongly adhere to A. fumigatus when co-incubated with the fungus in vitro. 
Isolated human NK cells were incubated with A. fumigatus overnight. After the incubation period, cells 
were collected, washed in PBS and filtered with 100 μm cell strainer to remove the hyphae and all the 
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cells attached to the fungus. The number of cells was determined by FACS. Bar graph shows the mean 
+ SEM. This data is representative of ten independent experiments. Statistical analysis was performed 
using the Student’s unpaired t-test. ***p<0.001 
 
4.3.2 Observation of filamentous actin (F-actin) accumulation at the immune synapse 
F-actin reorganization is one of the first steps of immune synapse formation. Accumulation of F-actin 
at the immune synapse is a prerequisite for the cytotoxic function of NK cells (51). Phalloidin is a high-
affinity F-actin probe conjugated to a fluorescent dye and is commonly used in imaging applications 
to selectively label F-actin, including to study the dynamic rearrangement of F-actin at the IS in NK 
cells (594).  
Isolated human NK cells were incubated with A. fumigatus and accumulation of F-actin at the immune 
synapse was assessed by confocal microscopy, using phalloidin staining. The images below show F-
actin accumulation at the interface formed between NK cells and A. fumigatus (Figure 60). 
 
 
 
Figure 60: Accumulation of filamentous actin at the immune synapse formed between NK cells and 
A. fumigatus. Isolated human NK cells were incubated with A. fumigatus GFP germling at an E:T ratio 
of 20:1. The co-incubation was performed overnight. After the incubation period, cells were washed, 
fixed, permeabilized and incubated in blocking buffer. F-actin staining was performed incubating the 
cells with Alexa Fluor® 633 phalloidin (Dil 1:500) for 1 hour at room temperature. Cover slips were 
washed 3 times in PBS before being mounted with Vectashield mounting medium containing DAPI 
(Vectorlabs). Phalloidin staining is indicated in red, the nuclei are indicated in blue and A. fumigatus 
GFP is shown in green. All images were taken with a Zeiss LSM-510 confocal microscope. 
 
4.3.3 NK cell interaction with A. fumigatus results in lytic granule polarization towards the fungus 
F-actin reorganization and accumulation at the interface formed between NK cells and the targets, 
precedes the translocation and polarization of the lytic granules to the immune synapse. NK cell 
mediated-cytotoxicity is characterized by polarized delivery of the granules to the immunological 
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synapse, in order to prevent damage of normal cells. A key step during this process is the intracellular 
polarization of the cytolytic granules towards the target. In order to assess the polarization of the lytic 
granules towards A. fumigatus, granule polarization was analyse by confocal microscopy. Isolated 
human NK cells were incubated overnight with A. fumigatus germling, at an E:T ratio of 20:1, followed 
by the intracellular staining of CD107a, perforin and granulysin.  
Confocal microscopy analysis showed that NK cells polarize the cytotoxic granules towards A. 
fumigatus. Granule polarization was observed when NK cells were stained with CD107a (Figure 61), 
perforin (Figure 62) or granulysin (Figure 63). Two different antibodies were tested in order to visualize 
granzyme B-containing granules by confocal microscopy, however the intensity of the signal was very 
weak and insufficient to perform an accurate analysis.  
 
 
Figure 61: NK cell incubation with A. fumigatus induces granule polarization towards the fungus. 
Isolated human NK cells were incubated overnight with A. fumigatus GFP germling at an E:T ratio of 
20:1. After the incubation period, cells were washed, fixed, permeabilized and incubated overnight 
with anti-human CD107a antibody at 4°C. Cells were then washed in PBS, followed by the incubation 
with Alexa Fluor 555 goat anti-mouse secondary antibody and Alexa Fluor® 633 phalloidin for 1 hour 
at room temperature. Cover slips were washed 3 times in PBS before being mounted with Vectashield 
mounting medium containing DAPI (Vectorlabs). Phalloidin staining is indicated in red, the nuclei are 
indicated in blue, CD107a staining is indicated in magenta and A. fumigatus GFP is shown in green. All 
images were taken with a Zeiss LSM-510 confocal microscope. 
 
149 
 
 
Figure 62: NK cell incubation with A. fumigatus induces perforin granule polarization towards the 
fungus. Isolated human NK cells were incubated overnight with A. fumigatus GFP germling at an E:T 
ratio of 20:1. After the incubation period, cells were washed, fixed, permeabilized and incubated 
overnight with anti-human perforin antibody at 4°C. Cells were then washed in PBS, followed by the 
incubation with Alexa Fluor 555 goat anti-mouse secondary antibody and Alexa Fluor® 633 phalloidin 
for 1 hour at room temperature. Cover slips were washed 3 times in PBS before being mounted with 
Vectashield mounting medium containing DAPI (Vectorlabs). Phalloidin staining is indicated in red, the 
nuclei are indicated in blue, perforin staining is indicated in magenta and A. fumigatus GFP is shown 
in green. All images were taken with a Zeiss LSM-510 confocal microscope. 
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Figure 63: NK cell incubation with A. fumigatus induces granulysin granule polarization towards the 
fungus. Isolated human NK cells were incubated overnight with A. fumigatus GFP germling at an E:T 
ratio of 20:1. After the incubation period, cells were washed, fixed, permeabilized and incubated 
overnight with anti-human granulysin antibody at 4°C. Cells were then washed in PBS, followed by the 
incubation with Alexa Fluor 555 goat anti-mouse secondary antibody and Alexa Fluor® 633 phalloidin 
for 1 hour at room temperature. Cover slips were washed 3 times in PBS before being mounted with 
Vectashield mounting medium containing DAPI (Vectorlabs). Phalloidin staining is indicated in red, the 
nuclei are indicated in blue, granulysin staining is indicated in magenta and A. fumigatus GFP is shown 
in green. All images were taken with a Zeiss LSM-510 confocal microscope. 
 
Quantitative analysis of granule polarization in NK cells in response to Aspergillus fumigatus 
In order to analyse quantitatively the granule polarization on NK cells towards A. fumigatus, I used a 
mathematical code that analyses several parameters on the images I obtained by confocal microscopy. 
The granules mean fungi cosine is a key parameter on the analysis of NK cell interaction with A. 
fumigatus. If granules are located on the side of the cell opposite of the fungus side the angle is close 
to 0° and consequently cosine close 1. If on the other hand, the granules are located between the cell 
centre and the fungus, angle is close to 180° and cosine close to -1. After analysis of all images using 
“FungusDependentGranuleRelease_tools” code, I considered that NK cells with negative granules 
mean fungi cosine had polarized granules towards A. fumigatus and NK cells with positive granules 
mean fungi cosine had non-polarized granules towards A. fumigatus (Figure 64).  
 
151 
 
 
Figure 64: Representative scheme showing granules mean fungi cosine parameter. Granules mean 
fungi cosine is calculated for each cell expressing CD107a, perforin or granulysin and is directly 
correlated with granule polarization towards A. fumigatus. NK cells with negative granules mean fungi 
cosine were considered to have polarized granules towards the fungus and NK cells with positive 
granules mean fungi cosine were consider to have non-polarized granules towards the fungus.  
 
Quantitative analysis of CD107a  
CD107a is a lysosomal-membrane-associated glycoprotein that is widely used as a lysosome marker. 
Previous studies have used CD107a staining to visualize intracellular NK cell granules and assess 
granule polarization (47). I used the same approach and using confocal microscopy I captured several 
images for further quantitative analysis. Minimum cell distance and minimum granule distance to A. 
fumigatus were determined, with results showing that most of NK cells were in close proximity to the 
fungus as well as the granules inside the cells (Figures 65 and 66). 
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Figure 65: Minimum distance between NK cells and A. fumigatus. Isolated human NK cells were 
incubated overnight with A. fumigatus GFP germling at an E:T ratio of 20:1. Minimum distance 
between NK cells and A. fumigatus was calculated using “FungusDependentGranuleRelease_tools” 
code. A total of 688 cells were analysed for this donor. This data is representative of three independent 
experiments performed with NK cells from three different donors. 
 
 
Figure 66: Minimum distance between NK cell granules and A. fumigatus. Isolated human NK cells 
were incubated overnight with A. fumigatus GFP germling at an E:T ratio of 20:1. CD107a was detected 
by intracellular staining of fixed and permeabilized NK cells. Minimum distance between NK cell 
granules and A. fumigatus was calculated using “FungusDependentGranuleRelease_tools” code. A 
total of 381 NK cells, expressing CD107a, were analysed for this donor. This data is representative of 
three independent experiments performed with NK cells from three different donors. 
 
Quantitative analysis of Perforin  
Perforin is a cytolytic mediator produced by NK cells and stored in cytoplasmic granules. Upon 
activation, NK cells release perforin by degranulation and this protein has the ability to insert itself 
into the target membrane, oligomerize, and generate pores in the target cells. In order to assess 
polarization of intracellular lytic granules containing perforin, NK cells were stained with anti-human 
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perforin antibody after fixed and permeabilized. Several images were captured under a confocal 
microscope for further quantitative analysis. Minimum cell distance and minimum granule distance to 
A. fumigatus were determined, with results showing that most of NK cells were in close proximity to 
the fungus as well as the granules inside the cells (Figures 67 and 68).  
 
 
Figure 67: Minimum distance between NK cells and A. fumigatus. Isolated human NK cells were 
incubated overnight with A. fumigatus GFP germling at an E:T ratio of 20:1. Minimum distance 
between NK cells and A. fumigatus was calculated using “FungusDependentGranuleRelease_tools” 
code. A total of 156 cells were analysed for this donor. This data is representative of three independent 
experiments performed with NK cells from three different donors.  
 
 
Figure 68: Minimum distance between NK cell granules containing perforin and A. fumigatus. 
Isolated human NK cells were incubated overnight with A. fumigatus GFP germling at an E:T ratio of 
20:1. Perforin was detected by intracellular staining of fixed and permeabilized NK cells. Minimum 
distance between NK cell granules containing perforin and A. fumigatus was calculated using 
“FungusDependentGranuleRelease_tools” code. A total of 82 NK cells, expressing perforin, were 
analysed for this donor. This data is representative of three independent experiments performed with 
NK cells from three different donors. 
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Quantitative analysis of Granulysin  
Granulysin is a cytolytic and proinflammatory molecule that is made in a 15-kDa form and is cleaved 
into a 9-kDa form. Granulysin is broadly cytolytic against tumor and microbes, including bacteria, fungi 
and parasites (72). Granulysin is also a chemoattractant for T lymphocytes and monocytes and 
activates the expression of a number of chemokines and cytokines, including RANTES, MIP-1α, IL-10, 
IL-1, IL-6 and IFN)-α (74). Polarization of lytic granules containing granulysin was assessed in NK cells 
co-incubated with A. fumigatus by confocal microscopy. NK cells were stained with anti-human 
granulysin antibody after cell permeabilization. Several images were captured under a confocal 
microscope for further quantitative analysis. Similarly to CD107a and perforin, the analysis of 
minimum cell distance and minimum granule distance to A. fumigatus showed the majority of NK cells 
were in close proximity to the fungus as well as the granules inside the cells (Figures 69 and 70). 
 
 
Figure 69: Minimum distance between NK cells and A. fumigatus. Isolated human NK cells were 
incubated overnight with A. fumigatus GFP germling at an E:T ratio of 20:1. Minimum distance 
between NK cells and A. fumigatus was calculated using “FungusDependentGranuleRelease_tools” 
code. A total of 560 cells were analysed for this donor. This data is representative of three independent 
experiments performed with NK cells from three different donors. 
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Figure 70: Minimum distance between NK cell granules containing granulysin and A. fumigatus. 
Isolated human NK cells were incubated overnight with A. fumigatus GFP germling at an E:T ratio of 
20:1. Granulysin was detected by intracellular staining of fixed and permeabilized NK cells. Minimum 
distance between NK cell granules containing granulysin and A. fumigatus was calculated using 
“FungusDependentGranuleRelease_tools” code. A total of 260 NK cells, expressing granulysin, were 
analysed for this donor. This data is representative of three independent experiments performed with 
NK cells from three different donors. 
 
As previously mentioned, granules mean fungi cosine is a key parameter on the analysis of NK cell 
interaction with A. fumigatus, since it allows the quantitative analysis of lytic granule polarization 
towards the fungus. Results obtained, showed that an average of 57.5% of NK cells expressing CD107a, 
65.4% of NK cells expressing perforin and 60.5% of NK cells expressing granulysin granules, had their 
granules polarized towards A. fumigatus (Figure 71). Previous studies have reported maximum 
polarization levels of 70% for the conjugates formed between NK cells and the target cells 721.221, a 
MHC I-deficient cell line that has been extensively used to study the mechanisms of NK cell activation 
(595,596). Therefore, the degree of polarization observed towards A. fumigatus is similar to the 
maximum observed for NK cells when challenged with the NK-sensitive 721.221 cell line. 
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Figure 71: Percentage of lytic granule polarization in NK cells co-incubated with A. fumigatus. 
Isolated primary human NK cells were challenged with A. fumigatus overnight at the E:T ratio of 20:1. 
After the incubation period, cells were fixed, permeabilized, stained for CD107a, perforin or granulysin 
and analysed by confocal microscopy. The graph displays the percentage of CD107a, perforin and 
granulysin polarization towards A. fumigatus. Bar graph, mean ± SD of three independent 
experiments; at least 150 cells were evaluated in each experiment.  
 
These data indicate that NK cells, besides adhering to the fungus and reorganizing F-actin, polarize the 
cytolytic granules towards A. fumigatus, a key step in NK cell mediated-cytotoxicity. However, 
polarization of the lytic granules is not equivalent to a commitment to their secretion, and several 
more events are required before the granules fuse with the plasma membrane and their content is 
released into the synaptic cleft (59). More, cytolytic granule polarization and degranulation are two 
steps in NK cell-mediated cytotoxicity that are controlled separately by signals emanating from distinct 
receptors (47).  Further assays were performed in order to assess granule release, including analysis 
of CD107a expression on NK cell surface and quantification of perforin and granzyme B secretion upon 
contact with A. fumigatus.  
 
4.3.4 NK cell interaction with A. fumigatus induces NK cell degranulation 
The final step of NK cell cytotoxic response, is the polarized secretion of the granules content by a 
process called degranulation. The wall of NK cell lytic granules contains a range of lysosomal-
membrane-associated glycoproteins including CD107a, which protect the NK cells from the granules 
contents. CD107a is upregulated on NK cell surface following the release of cytotoxic granules and has 
been extensively used as a marker of NK cell functional activity, allowing the identification of cell 
degranulation (68). CD107a expression on NK cell surface was assessed by FACS. Isolated human NK 
cells were incubated with swollen A. fumigatus and germlings at different MOIs in order to assess NK 
cell degranulation in response to the fungus. CD107a analysis showed a significant increase in the 
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percentage of cell degranulation when NK cells were incubated with swollen A. fumigatus at E:T ratios 
of 1:1 and 20:1 and with A. fumigatus germlings at E:T ratio of 20:1 (Figure 72).  
 
 
Figure 72: NK cell degranulation (CD107a) in response to A. fumigatus. Isolated human NK cells were 
incubated overnight with A. fumigatus swollen or germling at E:T ratios of 1:1, 20:1 and 100:1. CD107a 
antibody was added at the beginning of the co-incubation. After incubation time, the cells were 
collected and washed with PBS. Cells were stained with surface antibodies, followed by the staining 
with Aqua zombie dye. CD107a expression by NK cells was determined by FACS analysis. Bar graph 
shows the mean + SEM of CD107a expression. This data is representative of three independent 
experiments. Statistical analysis was performed using the Student’s unpaired t-test. *p<0.05, 
***p<0.001 
 
Further analysis was performed with NK cells from several healthy donors. NK cells were challenged 
with A. fumigatus swollen at E:T ratio 1:1 and with A. fumigatus germling at E:T ratio 20:1. Results 
showed that the incubation of NK cells with swollen A. fumigatus or germlings, results in a significant 
increase of NK cell degranulation (Figure 73). As described above, a high percentage of NK cells could 
not be analysed by FACS after co-incubated with A. fumigatus since they adhered strongly to the 
fungus, therefore perforin and granzyme B were quantified in the supernatant of co-cultures by ELISA. 
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Figure 73: NK cells respond via degranulation (CD107a) to swollen A. fumigatus and germlings. 
Isolated human NK cells were incubated overnight with A. fumigatus. Co-incubation with K562 cell line 
at E:T ratio 1:1 was used as positive control for NK cell degranulation. CD107a antibody was added at 
time 0 hours. After the incubation time, the cells were collected and washed with PBS. Cells were 
stained with surface antibodies, followed by the staining with Aqua zombie dye. CD107a expression 
by NK cells was determined by FACS analysis. A) NK cells were challenged with swollen A. fumigatus 
at E:T ratio 1:1 (n=9); B) NK cells were challenged with A. fumigatus germlings at E:T ratio 20:1 (n=10). 
Graphs show the mean ± SEM of CD107a expression. Statistical analysis was performed using the 
Student’s paired t-test. ***p<0.001 
 
4.3.5 NK cells do not release perforin or granzyme B in response to A. fumigatus 
Perforin and granzyme B levels were determined in the supernatant of co-cultures of NK cells and A. 
fumigatus by ELISA. Surprisingly, no significant increase on perforin or granzyme B levels was detected 
when NK cells were incubated with A. fumigatus (Figure 74). It has been reported that the fusion of 
granule content can be incomplete with the formation of a transient fusion pore at the plasma 
membrane accompanied by release of some but retention of most of the granule contents (66). This 
might explain the fact that despite the significant increase in CD107a expression on NK cell surface 
when challenged with A. fumigatus, no significant increase in perforin or granzyme B levels was 
detected.  
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Figure 74: Granzyme B and perforin levels in co-cultures of NK cells and A. fumigatus. Isolated human 
NK cells were incubated overnight with A. fumigatus swollen at E:T ratios of 1:1 and 20:1 and with A. 
fumigatus germling at E:T ratios of 20:1 and 100:1. Granzyme B and perforin levels were measured in 
the culture supernatant by ELISA. A) Levels of granzyme B (n=3); B) Levels of perforin (n=4). Graphs 
show the mean ± SEM of granzyme B and perforin production. Statistical analysis was performed using 
the Student’s paired t-test.  
 
4.3.6 Analysis of NK cell degranulation when PBMCs are incubated with A. fumigatus 
NK cell degranulation was also assessed when PBMCs were incubated with A. fumigatus. PBMCs were 
challenged with A. fumigatus swollen or germling at different E:T ratios followed by the analysis of 
CD107a expression on NK cell surface by FACS (Figure 75). The co-culture of PBMCs with A. fumigatus 
swollen at E:T ratio of 1:1 results in significant increase of NK cell degranulation (Figure 76).  
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Figure 75: NK cell degranulation (CD107a) in response to A. fumigatus in the presence of other 
populations of PBMCs. PBMCs were incubated overnight with A. fumigatus swollen or germling at E:T 
ratios of 1:1 and 5:1. CD107a antibody was added at the beginning of the co-incubation. After 
incubation time, the cells were collected and washed with PBS. Cells were stained with surface 
antibodies NKp80 and CD3, followed by the staining with Aqua zombie dye. CD107a expression by NK 
cells was determined by FACS analysis. Graph shows the mean ± SEM of CD107a expression. Statistical 
analysis was performed using the Student’s paired t-test. n=4 
 
 
Figure 76: NK cell degranulation (CD107a) in response to A. fumigatus in the presence of other 
populations of PBMCs. PBMCs were incubated overnight with A. fumigatus swollen at E:T ratio of 1:1. 
Co-incubation with K562 cell line at E:T ratio 1:1 was used as positive control for NK cell degranulation. 
CD107a antibody was added at time 0 hours. After incubation time, the cells were collected and 
washed with PBS. Cells were stained with surface antibodies NKp80 and CD3, followed by the staining 
with Aqua zombie dye. CD107a expression by NK cells was determined by FACS analysis gating NKp80+ 
CD3- live cell population. Graph shows the mean ± SEM of CD107a expression. Statistical analysis was 
performed using the Student’s paired t-test. n=6 *p<0.05 
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4.4 Assessment of antifungal activity of human NK cells 
The analysis of CD107a expression showed that a small percentage of NK cells respond to A. fumigatus 
via degranulation. We therefore investigated the antifungal activity of human NK cells. To evaluate 
the possible damage induced by NK cells on A. fumigatus, we performed different assays including 
XTT colorimetric assay, PLATELIATM Aspergillus galactomannan enzyme immunoassay and live imaging 
using propidium iodide (PI) dye. The analysis of fungal viability by XTT assay did not show a significant 
difference in the mitochondrial metabolism of A. fumigatus when the fungus was incubated in the 
presence of NK cells (Figure 77). Relative quantification of galactomannan in the supernatant of co-
cultures was also performed using a galactomannan enzyme immunoassay. Similarly to what was 
observed with XTT assay, the co-incubation of A. fumigatus with NK cells did not induce an inhibition 
of fungal burden, with the levels of galactomannan released into the supernatant being similar in the 
absence or presence of NK cells (Figure 78).  
 
 
Figure 77: Quantification of fungal burden by XTT assay. Aspergillus fumigatus germling were 
incubated overnight either in the absence or presence of NK cells at an E:T ratio of 20:1. Incubation 
with 1 μg/mL Amphotericin B was used as a positive control for the assay. Total fungal burden was 
determined by XTT assay. Graph shows the mean ± SEM of fungal burden. Statistical analysis was 
performed using the Student’s paired t-test. n=4 
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Figure 78: Analysis of fungal burden by galactomannan assay. Aspergillus fumigatus germling were 
incubated either in the absence or presence of NK cells at different MOIs. The culture supernatant 
was collected at different time points and glactomannan was determined using the PLATELIATM 
Aspergillus galactomannan enzyme immunoassay. A) A. fumigatus vs NK cells + A. fumigatus (MOI 1); 
B) A. fumigatus vs NK cells + A. fumigatus (MOI 0.05); C) A. fumigatus vs NK cells + A. fumigatus (MOI 
0.01). Graphs show the mean ± SEM of fungal burden. This data is representative of three independent 
experiments. Statistical analysis was performed using the Student’s unpaired t-test. 
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4.5 NK cell interaction with A. fumigatus results in fungal DNA release  
Another assay was then performed using propidium iodide in order to detect dead or dying A. 
fumigatus by live imaging. This approach was previously used by other groups to assess cell viability 
and plasma membrane damage in yeast (531–533). PI also demonstrated to be useful to stain 
extracellular DNA and it was particularly important on the identification of neutrophil extracellular 
traps (NETs) consisting of nuclear DNA decorated with fungicidal proteins (280).  
A. fumigatus germlings were incubated in absence or presence of NK cells at an MOI of 0.05. After 
overnight incubation, PI was added to each well (Dil 1:500) and live imaging was performed on 
confocal microscope. The analysis showed PI staining on A. fumigatus surface, suggesting fungal DNA 
release from the fungus (Figure 79). PI staining on A. fumigatus surface was always observed when 
the fungus were incubated with NK cells from different donors.  
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Figure 79: Representative images of fungal viability analysis by live imaging. A. fumigatus germlings 
were incubated overnight in absence or presence of isolated human NK cells at an E:T ratio of 20:1. 
After the incubation period, PI was added to all wells and fungal viability was analysed by confocal 
microscopy. A. fumigatus are indicated in green and PI staining indicated in red. A) A. fumigatus GFP; 
B) A. fumigatus GFP + NK cells, E:T ratio 20:1 (brightfield laser on); C) A. fumigatus GFP + NK cells, E:T 
ratio 20:1 (brightfield laser off). n=3 
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In order to determine if the interaction of NK cells with A. fumigatus was inducing fungal DNA release, 
as suggested by the images obtained by confocal microscopy, fungal gDNA was quantified in the 
supernatant of A. fumigatus cultures and in the supernatant of co-cultures of A. fumigatus and NK 
cells. Quantification of fungal gDNA was performed by qPCR using specific primers and an Aspergillus-
specific probe designed to bind an Aspergillus-specific region of the 28S rRNA gene (414). Results 
showed a significant increase in fungal DNA release from A. fumigatus when NK cells are present 
(Figure 80A). However, calculating the fold change between the concentrations determined in the 
supernatant of A. fumigatus cultures and in the supernatant of co-cultures of A. fumigatus and NK 
cells, the fungal gDNA release increased by less than two-fold (Figure 80B). Fungal DNA was also 
detected in the supernatant of A. fumigatus cultures, probably as a result of the presence of 
complement proteins since the human serum used in the cultures was not heat inactivated.  
 
 
 Figure 80: NK cell interaction with A. fumigatus results in fungal DNA release. A. fumigatus germlings 
were incubated overnight in absence or presence of isolated human NK cells at an E:T ratio of 20:1. 
After the incubation period, culture supernatants were collected and fungal gDNA was quantified by 
qPCR. A) fungal gDNA (copies/μL); B) fungal gDNA (fold change). Bar graphs show the mean + SEM of 
fungal gDNA. This data is representative of three independent experiments. Statistical analysis was 
performed using the Student’s unpaired t-test. ***p<0.001 
 
4.6 Effect of the presence of Aspergillus fumigatus on NK cell response to K562 cell line 
The interaction between NK cells and A. fumigatus induced a major downregulation of CD56 
expression on NK cell surface as a result of CD56 internalization. In addition, a detailed in vitro analysis 
of NK cell response to A. fumigatus, showed that primary human NK cells do not produce cytokines 
neither release perforin or granzyme B when co-cultured with the fungus. Previous studies have 
suggested that CD56 is involved in NK-target cell interactions, playing an important role in the process 
of target killing (548,549). More, a significant increase in the frequency of CD3negCD56negCD16+ NK cell 
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population was observed in HIV-1 and HCV chronic infected patients, together with an impaired 
effector function of the cells, suggesting an important role of CD56 in NK cell response (550–552). 
These observations raised a question: “Does A. fumigatus inhibit NK cell response mediated by the 
induction of CD56 internalization?”. The analysis of CD56 expression on NK cell surface, showed that 
A. fumigatus induces CD56 downregulation also in the presence of K562 cell line (Figure 81).  
 
 
Figure 81: Analysis of CD56 expression on NK cell surface when incubated with K562 cell line in the 
presence of A. fumigatus. Isolated human NK cells were incubated with K562 cell line at an E:T ratio 
of 1:1 either in absence or presence of A. fumigatus resting conidia at different MOIs. Co-incubation 
was performed overnight. CD56 expression was determined by FACS, gating live NK cells. Bar graph 
shows the mean + SEM of CD56 expression. This data is representative of three independent 
experiments. Statistical analysis was performed using the Student’s unpaired t-test. ***p<0.001 
 
In order to assess the effect of the presence of A. fumigatus and consequently of CD56 downregulation 
on NK cell response to K562 cells, isolated NK cells were challenged with K562 cell line in the absence 
and presence of A. fumigatus. IFN-γ, TNF-α, granzyme B and perforin levels were determined in the 
supernatant of co-cultures by ELISA.  
 
4.6.1 A. fumigatus impairs NK cell cytokine response to K562 cell line 
In order to determine the effect of A. fumigatus in the ability of NK cells to respond to K562 cell line 
via cytokine production, IFN-γ and TNF-α were quantified in the supernatant of co-cultures of NK cells 
and K562 cell line in the absence and presence of the fungus. Results showed a significant reduction 
on cytokine production by NK cells in response to K562 cell line induced by the presence of A. 
fumigatus (Figure 82). For all donors, the presence of A. fumigatus induced a stronger inhibition of 
IFN-γ production in comparison with the inhibition observed for TNF-α release. IFN-γ inhibition 
showed to occur in a MOI-dependent manner. Curiously, for all donors tested, the reduction of TNF- 
α release was more pronounced in the presence of A. fumigatus at MOI 0.01.  
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 Figure 82: A. fumigatus inhibits NK cell cytokine response to K562 cell line. Isolated human NK cells 
were incubated with K562 cell line at an E:T ratio of 1:1 either in absence or presence of A. fumigatus 
resting conidia at different MOIs. The co-incubation was performed overnight. After the incubation 
period, the supernatant of the co-cultures was collected and IFN-γ and TNF-α concentration was 
determined by ELISA. Bar graphs show the mean + SEM of IFN-γ and TNF-α production. This data is 
representative of three independent experiments. Statistical analysis was performed using the 
Student’s unpaired t-test. *p<0.05, **p<0.01, ***p<0.001 
 
4.6.2 Effect of the presence of A. fumigatus on granzyme B and perforin release by NK cells  
In order to determine the effect of the presence of A. fumigatus on NK cell cytotoxic response to K562 
cell line, the levels of granzyme B and perforin were assessed in the supernatant of NK cells challenged 
with K562 cell line, either in the absence or presence of the fungus. Results showed a significant 
reduction of granzyme B levels when A. fumigatus is present at an MOI of 0.01. Similar inhibition 
pattern was observed for TNF-α, with the lowest MOI inducing a higher inhibition. The analysis of 
perforin levels did not show a significant reduction induced by A. fumigatus.  
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Figure 83: The effect of A. fumigatus on granzyme B and perforin release by NK cells in response to 
K562 cell line. Isolated human NK cells were incubated with K562 cell line at an E:T ratio of 1:1 either 
in absence or presence of A. fumigatus resting conidia at different MOIs. The co-incubation was 
performed overnight. After the incubation period, the supernatant of the co-cultures was collected 
and granzyme B and perforin concentration was determined by ELISA. Bar graphs show the mean + 
SEM of granzyme B and perforin production. This data is representative of three independent 
experiments. Statistical analysis was performed using the Student’s unpaired t-test. *p<0.05 
 
The precise function of CD56 antigen in NK cells is still poorly understood but the few studies published 
on this subject suggest that CD56 might be important in NK cell response. The analysis of the effect of 
the presence of A. fumigatus in the NK cell response to K562 cell line, showed that the fungus has a 
high effect on IFN-γ-mediated response with the presence of A. fumigatus resulting in a significant 
inhibition on IFN-γ release. The inhibitory effect of A. fumigatus on IFN-γ production by NK cell, it was 
already previously reported for IL-2 pre-stimulated NK cells (372). The quantitative analysis of TNF-α 
showed an inhibitory effect of A. fumigatus in the production of this cytokine by NK cells, but not so 
pronounced compared with the effect on IFN-γ. Granzyme B was also measured in the supernatant of 
co-cultures of NK cells and K562 cell line in absence and presence of A. fumigatus and results 
surprisingly showed a significant reduction in granzyme B release when the fungus is present at lowest 
MOI. The inhibitory effect of A. fumigatus on granzyme B levels was observed at MOI 0.01 for all 
donors tested. Quantification of perforin levels did not show a significant reduction induced by the 
presence of A. fumigatus.  
Overall, my results showed that A. fumigatus has an inhibitory effect on NK cell cytokine production, 
mainly on IFN-γ. The presence of A. fumigatus also results in a reduction of granzyme B release by NK 
cells, but perforin levels are not significantly affected.  
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4.7 Discussion 
NK cells represent a population of highly specialized large granular lymphocytes capable of mediating 
cytotoxic activity and endowed with the ability to release chemokines and cytokines when activated 
by specific targets or pro-inflammatory stimuli (571). Upon activation, NK cell response can result in 
the direct elimination of the recognized target, via release of perforin, granzyme B or granulysin, as 
well as in the recruitment and activation of other immune cells via secretion of chemokines and 
cytokines (44). Besides their main role in tumour immunosurveillance and in the host defence against 
viral infections, there is increasing evidence indicating that NK cells may also play an important role in 
the early defence against fungal infections.  
The detailed analysis of NK cell interaction with A. fumigatus in vitro, showed that a high percentage 
of NK cells adhere to the fungus, accumulate F-actin at the immune synapse and polarize the cytotoxic 
granules, containing perforin and granulysin, towards A. fumigatus. The quantification of NK cell 
degranulation by FACS, showed a significant increase in the percentage of NK cells expressing CD107a 
on their surface when co-incubated with A. fumigatus in vitro. However, the measurement of perforin 
and granzyme B levels in the supernatant of the co-cultures, showed that the incubation of NK cells 
with the fungus do not induce the release of these two cytotoxic molecules. It has been reported that 
polarization of the lytic granules is not equivalent to a commitment to their secretion with several 
more events being required before the granules fuse with the plasma membrane and their content is 
released into the synaptic cleft. More, the fusion of granule content can be incomplete with the 
formation of a transient fusion pore at the plasma membrane accompanied by release of some but 
retention of most of the granule contents (66). This might explain the fact that despite the significant 
increase in CD107a expression on NK cell surface when challenged with A. fumigatus, no significant 
increase in perforin or granzyme B levels was detected. Western blot analysis was also performed in 
order to detect granulysin in NK cells and for some donors an increase in protein expression was 
observed after incubation with A. fumigatus, but the results were not conclusive since for other 
donors no significant difference was observed. On the other hand, degranulation might also result in 
the release of other molecules which are also stored in the lytic granules, such as granzyme A and 
granzyme K that were not determined in our studies. The study published by Schmidt et al. claims that 
human NK cells kill A. fumigatus hyphae with perforin acting as the mediator of the cytotoxic 
mechanism (372). In his study, the levels of perforin in co-cultures of NK cells and A. fumigatus were 
not determined. Their conclusions were based on the effect of concanamycin A, an antibiotic that 
blocks perforin-based cytotoxic activity, on anti-fungal activity of IL-2 pre-stimulated NK cells. They 
showed that the presence of concanamycin A and consequently the inhibition of the perforin pathway, 
results in a significant decrease of NK cell anti-A. fumigatus activity. However, concanamycin A is not 
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a specific inhibitor of perforin pathway and has shown to inhibit intracellular protein and vesicular 
trafficking through the specific inhibition of V-ATPases (597–599). In the same report, Schmidt et al. 
observed that isolated human perforin alone exhibits a significant killing of A. fumigatus hyphae (372). 
Overall, these observations suggest that perforin causes hyphal damage but do not demonstrated that 
perforin is released in response to A. fumigatus. My results showed that A. fumigatus does not induce 
the secretion of perforin by NK cells, but in the context of an in vivo immune response to the fungus, 
perforin might have an important role in anti-fungal activity since its production can be induced by 
the direct interaction of NK cells with other immune cells or by circulating cytokines or chemokines.  
I also performed an extensive analysis to detect cytokine production, including measurement of IFN-
γ and TNF-α in the supernatant of co-cultures, intracellular staining to detect cytokine production by 
FACS and also Luminex multiplex assay. My results showed that NK cells do not produce IFN-γ or TNF-
α in response to A. fumigatus. More, my results demonstrated that A. fumigatus inhibits NK cell IFN-
γ and TNF-α -mediated response to K562 cell line, indicating an immunosuppressive effect of the 
fungus. The inhibitory effect of A. fumigatus on IFN-γ production by NK cells, it was previously 
described for IL-2 pre-stimulated NK cells (372). The analysis of cytokine production by NK cells in 
response to A. fumigatus ΔgliGAF293, also showed a lack of cytokine release, suggesting that gliotoxin 
is not responsible for the absence of IFN-γ and TNF-α-mediated response.  
However, NK cells demonstrated to secrete MIP-1α, MIP-1β and RANTES when co-incubated with A. 
fumigatus. MIP-1α, MIP-1β and RANTES are known important chemoattractants for 
monocytes/macrophages and distinct populations of lymphocytes to the site of infection (84,85). 
Studies performed in vivo demonstrated that RANTES, MIP-1α and MIP-1β together with IFN-γ are 
also coactivators of macrophages and T cells (86). 
Several studies have revealed a hierarchy in terms of the strength of the activating stimuli for induction 
of specific responses in NK cells. The process of adhesion exhibit a low threshold for activation, 
induction of chemokines requires stronger activating stimuli, whereas degranulation and production 
of cytokines display the most stringent requirements for induction (47–49). These observations may 
explain the fact that the interaction between NK cells and A. fumigatus results in cell adherence, 
granule polarization and chemokine release but no perforin, granzyme B or cytokines are secreted.  
Analysis of NK cell antifungal activity, showed that the interaction between NK cells and A. fumigatus 
do not result in the reduction of fungal viability or inhibition of fungal metabolism. However, live 
imaging analysis using PI, suggest that NK cells might induce damage on A. fumigatus. The 
quantification of fungal DNA in the supernatant of co-cultures of A. fumigatus and NK cells was also 
performed and showed a significant increase in fungal DNA release from A. fumigatus when NK cells 
are present, but the increase was less than two-fold. The biological relevance of these observations is 
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difficult to define and more experiments would be necessary to draw any specific conclusions. It would 
be important to understand if the small increase in fungal DNA release induced by the presence of NK 
cells, results in a significant activation of other cells. Two different assays could be performed in order 
to answer this question, one would consist in the incubation of isolated neutrophils or dendritic cells 
with the supernatant collected from A. fumigatus cultures and the supernatant collected from co-
cultures of A. fumigatus and NK cells. Following the co-incubation with the two different supernatants, 
the levels of cell activation would be determined and compared between the two conditions. The 
other assay that could be performed to understand the impact of small changes of fungal DNA 
concentration on the levels of cell activation, would be the incubation of neutrophils or DC with 
different concentrations of A. fumigatus DNA, followed by the analysis of cell activation. Cell activation 
could be determined by quantification of cytokine release by ELISA or by the analysis of specific cell 
surface activation markers by FACS.  
Some studies have demonstrated that fungal DNA is released only as a consequence of fungal damage 
as a result of the host immune response or autolysis due to lack of nutrients (7,8). In addition, the 
induction of fungal DNA release might represent an important immune mechanism by which NK cells 
induce the activation of other immune cells. Several studies have demonstrated that TLR9 is activated 
by DNA rich in unmethylated CpG motifs (600–602) and the expression of this receptor on cell surface 
has been described for different immune cells such as neutrophils, alveolar macrophages, 
macrophages, monocytes and dendritic cells (603–605). More, pathogen-derived DNA has shown to 
be able to directly induce the activation of neutrophils, dendritic cells, macrophages, T cells and B cells 
(606–610). Similar observations have been reported for fungal DNA that was demonstrated to induce 
dendritic cell proinflamatory response via TLR9 activation (9–11). A study published by Ramirez-Ortiz 
et al., showed that TLR9 detects A. fumigatus DNA and that this interaction results in the activation of 
human plasmacytoid dendritic cells and mouse bone marrow-derived dendritic cells (9). These 
observations together with my results, suggest that NK cells might induce fungal DNA release from A. 
fumigatus in order to activate other immune cells at the site of infection but as referred above, more 
experiments would be necessary to confirm this hypothesis. 
In conclusion, my results showed that NK cells interact with A. fumigatus resulting in activation of the 
initial steps of NK cell response. These steps include adhesion to the target, F-actin reorganization, 
polarization of the lytic granules towards the fungus and chemokine release. However, NK cell 
interaction with A. fumigatus did not result in cytokine secretion or in a significant increase of perforin 
or granzyme B release. This can be due to the tight control and higher activation threshold required 
for induction of cytokine secretion and degranulation. The interaction between NK cell receptors and 
A. fumigatus antigens might result in low affinity interactions and consequently in low receptors 
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activation. The analysis of phenotypic changes on NK cell surface, showed that activating receptors 
such as NKG2D and NKp46 are involved in the NK cell interaction with A. fumigatus. However, this 
interaction does not seem to be strong enough to activate cytokine secretion and secretion of perforin 
or granzyme B. On the other hand, the lack of cytokine production and NK cell degranulation might 
also be due to a fungal evasion mechanism, resulting in the prevention of NK cell activation. This 
hypothesis is supported by the fact that A. fumigatus demonstrated to inhibit IFN-γ and TNF-α release 
in the NK cell response to K562 cell line, suggesting that the fungus has an inhibitory effect on cytokine 
signalling. The analysis of granzyme B and perforin levels showed that A. fumigatus has an inhibitory 
effect on granzyme B but no effect on perforin release. The observed inhibitory effect, might have 
implications in NK cell immune response in AML patients with invasive aspergillosis, since in the 
presence of A. fumigatus NK cell activity against malignant cells is impaired. 
The action of NK cells alone showed to be insufficient to contain A. fumigatus growth, however the 
most important effect of NK cells during the host defence against A. fumigatus might be indirect, since  
NK cells showed to secrete chemoattractant chemokines in response to the fungus. 
The adoptive transfer of NK cells is being thoroughly investigated as a therapeutic tool for acute 
myeloid leukaemia (611). Transplantation of alloreactive NK cells, showed to control myeloid 
leukaemia relapse and to improve engraftment without causing graft-versus-host disease (5,6). In 
addition to the potential to eradicate AML cells, it has been suggested that the adoptive transfer of 
NK cells could also be an attractive strategy in the prophylaxis or treatment of common infections in 
these patients. The characterization of NK cell response to A. fumigatus, indicates that the infusion of 
NK cells on their own would be unable to control A. fumigatus infection in AML patients. However, 
novel approaches are being developed aiming to maximize NK cell efficacy, including genetic 
manipulation of their specificity. Genetically modified NK cells showed to have enhanced reactivity 
and recognition specificity toward multiple myeloma cells (612). This, leaves open the possibility of 
genetically modified NK cells in order to improve their cytotoxicity against A. fumigatus, namely 
through the induction of expression of specific receptors.  
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5. The effects of myeloid leukaemia on NK cell response to A. fumigatus 
5.1 Introduction 
Acute myeloid leukaemia (AML) is a malignant disease characterized by uncontrolled proliferation of 
myeloid progenitor cells that accumulate in the bone marrow and interfere with normal 
haematopoiesis. The standardised therapeutic regimen for AML comprises two phases: a remission 
induction phase and a consolidation therapy phase. The induction phase consists of chemotherapy 
administration in order to achieve complete remission, followed by consolidation chemotherapy to 
prevent relapse and/or haematopoietic stem cell transplantation (HSCT) (613). During AML 
treatments, including chemotherapy and/or HSCT, patients are immunocompromised and highly 
susceptible to life-threatening infections, including invasive fungal infections (614). Invasive 
aspergillosis is a major clinical complication in myeloid leukaemia patients before treatment, during 
chemotherapy and after transplantation (1). At least 10% of AML patients develop IA during the 
chemotherapy-induced period of aplasia. The mortality rate caused by IA can reach 50% in patients 
with chemotherapy-induced neutropenia and can exceed 90% in patients receiving hematopoietic 
stem cell transplantation (HSCT) (404,405). Neutrophils, macrophages, monocytes and dendritic cells, 
cells that belong to myeloid lineage, have been shown to be the key effectors in the immune defence 
against aspergillosis (615). In AML patients, cell differentiation is interrupted in those cells committed 
to the myeloid lineage resulting in impaired effector cell function. In the absence of an efficient 
immune response mediated by myeloid cells, cells that belong to lymphoid line may have a crucial role 
in host protection.  However, several studies have revealed that NK cells from AML patients have also 
impaired cytotoxicity.  The analysis of NK cells from 32 AML patients showed that NK cells have an 
abnormal surface phenotype, with downregulation of the activating receptor NKp46 and upregulation 
of the inhibitory receptor NKG2A. More, NK cells from these patients had impaired effector function 
against autologous blasts and K562 targets, with significantly reduced CD107a degranulation, TNF-α 
and IFN-γ production (407). Another study performed with cells from AML patients showed a weak 
NK cell cytolytic activity against autologous leukemic cells and a downregulation on NKp46 and NKp30 
expression (408).  
In vitro analysis of NK cell response to A. fumigatus using NK cells derived from healthy donors, showed 
that NK cell interaction with A. fumigatus results in cell adhesion to the fungus, accumulation of F-
actin at the immune synapse and polarization of lytic granules towards A. fumigatus. In addition, NK 
cell interaction with A. fumigatus results in a significant increase in fungal DNA release, suggesting 
that NK cells might induce fungal damage. The phenotypic analysis of NK cell receptors, suggests that 
NKG2D and NKp46 receptors are involved in the interaction between NK cells and A. fumigatus. In 
order to define the effect of myeloid leukaemia on NK cell interaction with A. fumigatus, I performed 
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in vitro assays using NK cells from AML patients. I analysed the ability of NK cells to adhere to the 
fungus, to accumulate F-actin at the immune synapse, to polarize the lytic granules towards the A. 
fumigatus and the ability to induce fungal DNA release.  
 
5.2 Isolation of NK cells from acute myeloid leukaemia patients 
NK cells were isolated from leukodepletion samples from AML patients that were kindly sent by 
Professor Katy Rezvani from MD Anderson Cancer Center. Leukodepletion is defined as a blood 
processing step for reducing the leukocyte content of whole blood and is a procedure often used in 
the treatment of hematologic malignancies (517–521). Leukodepletion samples were collected in 
blood collection bags containing EDTA, shipped to our lab with dry ice and upon arrival they were 
immediately stored at -80°C. The number of NK cells obtained from AML patient samples was very low 
with a yield of around 0.5%. Following NK cell isolation, the viability and purity of the cell population 
was always verified on FACS (Figure 84). A few times, FACS analysis showed the presence of myeloid 
blasts in the cell population after isolation procedure and in those cases cells were not used for further 
analysis.  
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A) Unstained cell population 
  
 
B) Cell population stained with live/dead staining (Zombie Aqua), CD56 and CD3 antibodies  
 
 
Figure 84: Example of FACS plots showing cell viability and NK cell purity of NK cells from AML 
patients after isolation. Cells were first gated using forward and side scatter, followed by the 
identification of the live population using Aqua zombie staining. NK cell population purity was 
determined gating on CD56+, CD3- cell population.  
 
5.3 Comparative analysis of NK cell cytotoxic response to Aspergillus fumigatus in healthy donors 
and AML patients 
NK cell cytotoxic response, involves discrete regulated steps namely adhesion, immune synapse (IS) 
formation, granule polarization and exocytosis. Analysis of NK cell cytotoxic response to A. fumigatus 
using NK cells from healthy donors showed that NK cell interaction with A. fumigatus results in cell 
adhesion to the fungus, accumulation of F-actin at the immune synapse and polarization of lytic 
granules towards A. fumigatus. In order to accurately compare NK cell cytotoxic response from AML 
patients with NK cell cytotoxic response from healthy donors, and since AML samples were kept frozen 
at -80°C upon arrival, the analysis of NK cell cytotoxic response for healthy cells was also performed 
using NK cells isolated from frozen samples. 
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5.3.1 Analysis of the interaction of healthy donor-derived NK cells with A. fumigatus 
Similarly to what was observed for NK cells isolated from fresh blood, NK cells isolated from frozen 
samples also adhere to A. fumigatus, accumulate F-actin at the immune synapse and polarize lytic 
granules towards the fungus. Isolated human NK cells were incubated overnight with A. fumigatus 
germling, at an E:T ratio of 20:1, followed by the intracellular staining of CD107a.  
Quantitative analysis of granule polarization towards A. fumigatus was performed using the 
“FungusDependentGranuleRelease_tools” code. Several parameters were determined using this 
mathematical code, including minimum cell distance to A. fumigatus, minimum granule distance to A. 
fumigatus and granules mean fungi cosine. Similarly to the results obtained for NK cells from fresh 
blood, NK cells from frozen samples were in close proximity to the fungus as well as the granules inside 
the cells (Figures 85 and 86).  
 
 
Figure 85: Minimum distance between NK cells and A. fumigatus. Isolated human NK cells were 
incubated overnight with A. fumigatus GFP germling at an E:T ratio of 20:1. Minimum distance 
between NK cells and A. fumigatus was calculated using “FungusDependentGranuleRelease_tools” 
code. A total of 684 cells were analysed for this donor. This data is representative of three independent 
experiments performed with NK cells from three different donors.  
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Figure 86: Minimum distance between NK cell granules and A. fumigatus. Isolated human NK cells 
were incubated overnight with A. fumigatus GFP germling at an E:T ratio of 20:1. CD107a was detected 
by intracellular staining of fixed and permeabilized NK cells. Minimum distance between NK cell 
granules and A. fumigatus was calculated using “FungusDependentGranuleRelease_tools” code. A 
total of 378 NK cells, expressing CD107a, were analysed for this donor. This data is representative of 
three independent experiments performed with NK cells from three different donors. 
 
As previously mentioned, granules mean fungi cosine is a key parameter on the analysis of NK cell 
interaction with A. fumigatus, since it allows the quantitative analysis of lytic granule polarization 
towards the fungus. The comparative analysis of granule polarization observed for NK cells isolated 
from fresh blood and NK cells isolated from frozen samples, showed that there is no significant 
difference in the percentage of cells that had their granules polarized towards A. fumigatus (Figure 
87). An average of 57.5% of NK cells, isolated from fresh blood, and an average of 55% of NK cells, 
isolated from frozen samples, showed to have their granules polarized to A. fumigatus.  
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Figure 87: Comparison among the percentage of lytic granule polarization in NK cells isolated from 
fresh blood and from frozen samples when co-incubated with A. fumigatus. Primary human NK cells 
isolated from fresh blood or from frozen PBMCs, were challenged with A. fumigatus overnight at the 
E:T ratio of 20:1. After the incubation period, cells were fixed, stained for CD107a and analysed by 
confocal microscopy. The graph displays the percentage of CD107a polarization towards A. fumigatus 
in human NK cells isolated from fresh blood or from frozen PBMCs. Bar graph, mean ± SD of three 
independent experiments; at least 400 cells were evaluated in each experiment.  
 
5.3.2 Analysis of the interaction of AML patient-derived NK cells with A. fumigatus 
In order to determine the effect of myeloid leukaemia on NK cell interaction with A. fumigatus, NK 
cells isolated from AML patients were co-incubated with the fungus and different parameters were 
assessed. Similarly to the analysis performed with NK cells from healthy donors, the ability of NK cells 
to adhere to the fungus, to accumulate F-actin at the immune synapse, to polarize the lytic granules 
towards the A. fumigatus and the ability to induce fungal DNA release, were determined. 
 
5.3.2.1 NK cell interaction with A. fumigatus results in NK cell adhesion to the fungus 
The co-incubation of isolated human NK cells from AML patients with A. fumigatus in vitro results in 
NK cell adhesion to the fungus. The images below show the co-culture of NK cells with A. fumigatus at 
an E:T ratio of 20:1 after fixation and it is possible to visualize the NK cells attached to the hyphae 
(Figure 88A and 88B). 
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Figure 88: NK cells adhere to A. fumigatus when co-incubated with the fungus in vitro. Isolated 
human NK cells from AML patients were incubated with A. fumigatus overnight at an E:T ratio of 20:1. 
Images were captured using a confocal microscopy after sample fixation.  
 
5.3.2.2 Observation of filamentous actin (F-actin) accumulation at the immune synapse 
F-actin reorganization is one of the first steps of immune synapse formation. Accumulation of F-actin 
at the immune synapse is a prerequisite for the cytotoxic function of NK cells (51). Phalloidin is a high-
affinity F-actin probe conjugated to a fluorescent dye and is commonly used in imaging applications 
to selectively label F-actin, including to study the dynamic rearrangement of F-actin at the IS in NK 
cells (594).  
Isolated human NK cells from AML patients were incubated with A. fumigatus and accumulation of F-
actin at the immune synapse was assessed by confocal microscopy, using phalloidin staining. The 
images below show F-actin accumulation at the interface formed between NK cells and A. fumigatus 
(Figure 89). 
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Figure 89: Accumulation of filamentous actin at the immune synapse formed between NK cells and 
A. fumigatus. Isolated human NK cells from AML patients were incubated with A. fumigatus GFP 
germling at an E:T ratio of 20:1. The co-incubation was performed overnight. After the incubation 
period, cells were washed, fixed, permeabilized and incubated in blocking buffer. F-actin staining was 
performed incubating the cells with Alexa Fluor® 633 phalloidin (Dil 1:500) for 1 hour at room 
temperature. Cover slips were washed 3 times in PBS before being mounted with Vectashield 
mounting medium containing DAPI (Vectorlabs). Phalloidin staining is indicated in red, the nuclei are 
indicated in blue and A. fumigatus GFP is shown in green. All images were taken with a Zeiss LSM-510 
confocal microscope. 
 
5.3.2.3 NK cell interaction with A. fumigatus results in lytic granule polarization towards the 
fungus 
NK cell mediated-cytotoxicity is characterized by polarized delivery of the granules to the 
immunological synapse, in order to prevent damage of normal cells. A key step during this process is 
the intracellular polarization of the cytolytic granules towards the target. In order to assess the 
polarization of the lytic granules towards A. fumigatus, granule polarization was analysed by confocal 
microscopy. Isolated human NK cells were incubated overnight with A. fumigatus germling, at an E:T 
ratio of 20:1, followed by the intracellular staining of CD107a.  
Confocal microscopy analysis showed that NK cells polarize the cytotoxic granules towards A. 
fumigatus (Figure 90). 
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Figure 90: NK cell incubation with A. fumigatus induces granule polarization towards the fungus. 
Isolated human NK cells were incubated overnight with A. fumigatus GFP germling at an E:T ratio of 
20:1. After the incubation period, cells were washed, fixed, permeabilized and incubated overnight 
with anti-human CD107a antibody at 4°C. Cells were then washed in PBS, followed by the incubation 
with Alexa Fluor 555 goat anti-mouse secondary antibody and Alexa Fluor® 633 phalloidin for 1 hour 
at room temperature. Cover slips were washed 3 times in PBS before being mounted with Vectashield 
mounting medium containing DAPI (Vectorlabs). Phalloidin staining is indicated in red, the nuclei are 
indicated in blue, CD107a staining is indicated in magenta and A. fumigatus GFP is shown in green. All 
images were taken with a Zeiss LSM-510 confocal microscope. 
 
Quantitative analysis of granule polarization in NK cells in response to Aspergillus fumigatus 
Images obtained by confocal microscopy were analysed using the 
“FungusDependentGranuleRelease_tools” code. Several parameters were determined, including 
minimum cell distance to A. fumigatus, minimum granule distance to A. fumigatus and granules mean 
fungi cosine. Results showed that most of NK cells were in close proximity to the fungus as well as the 
granules inside the cells (Figures 91 and 92). 
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Figure 91: Minimum distance between NK cells and A. fumigatus. Isolated human NK cells from an 
AML patient were incubated overnight with A. fumigatus GFP germling at an E:T ratio of 20:1. 
Minimum distance between NK cells and A. fumigatus was calculated using 
“FungusDependentGranuleRelease_tools” code. A total of 576 cells were analysed for this donor. This 
data is representative of three independent experiments performed with NK cells from three different 
donors. 
 
 
Figure 92: Minimum distance between NK cell granules and A. fumigatus. Isolated human NK cells 
were incubated overnight with A. fumigatus GFP germling at an E:T ratio of 20:1. CD107a was detected 
by intracellular staining of fixed and permeabilized NK cells. Minimum distance between NK cell 
granules and A. fumigatus was calculated using “FungusDependentGranuleRelease_tools” code. A 
total of 295 NK cells, expressing CD107a, were analysed for this donor. This data is representative of 
three independent experiments performed with NK cells from three different donors. 
 
The quantitative analysis of lytic granule polarization in NK cells from AML patients, showed that an 
average of 53.6% of NK cells, expressing CD107a, have their granules polarized towards A. fumigatus. 
When compared with the percentage of polarization observed in NK cells from healthy donors, no 
significant differences were observed between the two groups (Figure 93).  
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Figure 93: Comparison among the percentage of lytic granule polarization in NK cells from healthy 
donors and from AML patients when co-incubated with A. fumigatus. Primary human NK cells 
isolated from healthy donors or from AML patients, were challenged with A. fumigatus overnight at 
the E:T ratio of 20:1. After the incubation period, cells were fixed, stained for CD107a and analysed by 
confocal microscopy. The graph displays the percentage of CD107a polarization towards A. fumigatus 
in human NK cells isolated from healthy donors and from AML patients. Bar graph, mean ± SD of three 
independent experiments; at least 400 cells were evaluated in each experiment. 
 
5.3.2.4 NK cell interaction with A. fumigatus results in fungal DNA release  
The incubation of A. fumigatus with NK cells from healthy donors, showed to induce a significant 
increase in fungal DNA release. In order to determine if NK cells from AML patients were also able to 
induce A. fumigatus DNA release, fungal gDNA was quantified in the supernatant of A. fumigatus 
cultures and in the supernatant of co-cultures of A. fumigatus and NK cells. Similarly to what was 
observed with NK cells from healthy donors, results showed a significant increase in fungal gDNA 
release from A. fumigatus when NK cells from AML patients are present (Figure 94A). However, 
calculating the fold change between the concentrations determined in the supernatant of A. 
fumigatus cultures and in the supernatant of co-cultures of A. fumigatus and NK cells, the fungal gDNA 
release increased by less than two-fold (Figure 94B). Fungal DNA was also detected in the supernatant 
of A. fumigatus cultures, probably as a result of the presence of complement proteins since the human 
serum used in the cultures was not heat inactivated. 
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Figure 94: NK cell interaction with A. fumigatus results in fungal DNA release. A. fumigatus germlings 
were incubated overnight in absence or presence of human NK cells from AML patients at an E:T ratio 
of 20:1. After the incubation period, culture supernatants were collected and fungal gDNA was 
quantified by qPCR. A) fungal gDNA (copies/μL); B) fungal gDNA (fold change). Bar graphs show the 
mean + SEM of fungal gDNA. This data is representative of three independent experiments. Statistical 
analysis was performed using the Student’s unpaired t-test. ***p<0.001 
 
5.4 Discussion 
Overall, my results indicate that NK cells maintain their ability to interact with A. fumigatus in acute 
myeloid leukaemia patients. In vitro analysis of NK cell interaction with A. fumigatus, showed that NK 
cells from AML patients, similarly to NK cells from healthy donors, are able to adhere to the fungus, 
accumulate F-actin at the immune synapse, polarize their lytic granules towards A. fumigatus and are 
able to induce fungal gDNA release. Unfortunately, due to the low number of NK cells obtained after 
cell isolation from AML samples, it was not possible to assess NK cell degranulation (CD107a 
expression) and to determine NK cell ability to produce chemokines as a result of the interaction with 
A. fumigatus. I decided to perform confocal microscopy analysis since it was the assay that could give 
the most comprehensive analysis of NK cell interaction with A. fumigatus, including cell adherence to 
the pathogen, reorganization of F-actin filaments and polarization of lytic granules towards the fungus. 
These steps are known to be crucial in NK cell-mediated cytolytic defence, as well as important 
checkpoints required for the regulation of NK cell effector function (616). The dysregulation of one of 
those mechanisms showed to result in impaired NK cell function (617,618). Results obtained by 
confocal microscopy analysis showed that NK cells from AML patients maintain the ability to activate 
these discrete steps in response to A. fumigatus. As previously referred, all these stages require low 
threshold for activation and my results suggest that NK cells from AML patients maintain the ability to 
activate them.  
Similarly to the results obtained with NK cells from healthy donors, NK cells from AML patients also 
significantly induced the release of fungal DNA from A. fumigatus, but again the increase was less than 
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two-fold. As referred above, it would be important to understand the biological relevance of this 
observation since previous reports have demonstrated that fungal DNA is be able to induce dendritic 
cell proinflamatory response (9–11). Several studies have demonstrated that DNA rich in 
unmethylated CpG motifs it is the natural ligand for TLR9 (600–602) and the expression of this receptor 
on cell surface has been described for different immune cells such as neutrophils, alveolar 
macrophages, macrophages, monocytes and dendritic cells (603–605). These observations suggest 
that the induction of fungal DNA release might represent an important immune mechanism by which 
NK cells induce the activation of other immune cells. To confirm this hypothesis, it would be necessary 
to understand if the small increase in fungal DNA release induced by the presence of NK cells, would 
result in a significant activation of other immune cells in the specific case of AML patients and make 
in parallel the respective comparison with healthy donors.  
The analysis of NK cell degranulation would be also an important feature to be assessed because 
different studies have reported that NK cells from AML patients have a decreased ability to undergo 
degranulation production (407) and even though no significant increase of perforin or granzyme B 
levels were detected in co-cultures of NK cells from healthy donors and A. fumigatus, NK cell cytotoxic 
activity may be mediated by the release of other granzymes or granulysin that were not determined 
on our studies. On the other hand, as previously suggested by Schmidt et al. (619), perforin might act 
as the mediator of the cytotoxic mechanism with the perforin levels, constitutively produced by NK 
cells in vitro, being sufficient to induce fungal damage. Chemokine levels were also not assessed but 
they are known to have a key role in the recruitment of other immune cells to the site of infection and 
it would be important to determine if NK cells from AML patients maintain the ability to recruit other 
cells upon interaction with A. fumigatus. Up to date, no studies have assessed the ability of NK cells 
from these patients to produce chemokines in response to target cells, all studies have been focused 
on NK cell ability to secrete cytokines and release lytic granule contents.  
Several studies have reported that NK cells from AML patients have an abnormal surface phenotype, 
usually characterized by the downregulation of activating receptors and upregulation of inhibitory 
receptors. These phenotypic changes in the NK cell population are highly heterogeneous, with 
different patients showing different phenotypic patterns (408,620–622). NKp30 and NKp46 present 
reduced expression levels on NK cell surface in a large proportion of AML patients (407,408). 
Interestingly, the phenotypic analysis of NK cell receptors in healthy donors, showed that NKp46 
activating receptor might be involved in the interaction between NK cells and A. fumigatus. Thereby, 
the results obtained with NK cells from AML patients suggest that NKp46 might not be the main 
activating receptor responsible for the induction of F-actin accumulation at the immune synapse and 
granule polarization during NK cell interaction with A. fumigatus. Actually, previous reports have 
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shown that NKG2D can signal on its own for granule polarization (595). However, to draw any concrete 
conclusions, it would be necessary to perform in parallel the phenotypic and functional 
characterization for each AML patient.  
In conclusion, my results showed that NK cells from AML patients maintain their ability to interact 
with A. fumigatus, adhere to the fungus, polarize the lytic granules and induce the release of fungal 
DNA. However, the action of NK cells alone showed to be insufficient to contain A. fumigatus growth 
and this was observed for NK cells from healthy donors or from AML patients.  
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6. The effect of the inhibition of sphingosine signalling on human NK cell response to cancer cells 
6.1 Introduction 
Sphingolipids are structural and functional components of biological membranes and include 
ceramide, sphingosine and sphingosine 1-phosphate (S1P). These molecules have emerged as critical 
players in a number of fundamental biological processes, such as survival, proliferation, differentiation 
and apoptosis (415,444,489). In addition, sphingolipid metabolism has been reported to play a key 
role in cancer pathogenesis, progression, angiogenesis, migration, drug resistance and cell death of 
tumour cells (489–491). Involvement of sphingolipid metabolism in cancerogenesis was demonstrated 
in solid tumours as well as in haematological malignancies. Elevated expression of SphK1 has been 
observed in acute leukemia and SphK1 was shown to mediate chemotherapy sensitivity in AML cells 
(498,499). The dynamic balance between the cellular levels of ceramide and S1P, which has been 
called the “sphingolipid rheostat”, is a mechanism of particular importance controlling the sensitivity 
of AML cells to daunorubicin (499). While ceramide and sphingosine have been established as 
antigrowth molecules triggering differentiation and apoptosis, S1P exerts an anti-apoptotic effect 
enhancing cell growth and survival (433,623). SphKs, particularly SphK1, play a central role regulating 
the equilibrium between proapoptotic ceramide and prosurvival S1P and consequently represent a 
potential new target for developing novel therapeutics for cancer (624). The inhibition of SphKs 
activity, resulting in alterations of the sphingolipid rheostat, namely ceramide increase and S1P 
decrease, represent a promising therapeutic option to block the growth of leukemic cells and redirect 
them towards apoptosis, contributing also to overcome drug resistance (Figure 95). This finding has 
stimulated the development and evaluation of numerous SphK inhibitors over the past decade (500).  
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Figure 95: Effect of sphingosine kinase inhibitors on sphingolipid rheostat: SphK1 and SphK2 catalyse 
the conversion of the proapoptotic sphingosine to the prosurvival product S1P. Accumulation of S1P 
has been linked to the development and progression of cancer. Sphingosine kinases are key enzymes 
in the sphingolipid pathway, regulating the ratio between ceramide, sphingosine and sphingosine-1-
phosphate. The use of SphK inhibitors can reverse low ceramide:S1P ratios, resulting in increase of 
ceramide levels and redirecting cancer cells towards apoptosis. 
 
Several SphK1 and SphK2 inhibitors, with different potency, selectivity and stability have been 
developed in the last decade. The classes of compounds identified include those derived from 
sphingolipids, natural products and small drug like molecules (500). Numerous SphK inhibitors, such 
as DMS, F-12509A, safingol, SKI-I and enigmol demonstrated to have anticancer activity namely by 
inducing apoptosis in tumour cells (495,496,625–627). Two specific inhibitors of the sphingolipid 
signalling pathway have aroused special interest in acute myeloid leukaemia treatment, FTY720 and 
SKI-II. FTY720, a sphingosine analogue, was demonstrated to induce toxic effects in both primary 
leukemic cells from AML patients and in AML cell lines (628). This inhibitor showed antitumorigenic 
activity against the Kasumi-1 cell line, leukemic blasts isolated from AML-M2 patients and supressed 
Kasumi-1 xenograft tumour growth in mouse models. FTY720 treatment resulted in a rapid and 
significant increase of pro-apoptotic ceramide levels, inducing cell death of the AML cells (629). 
FTY720 was also shown to induce cell death of T-cell large granular lymphocyte leukaemia cells and in 
different B-cell malignancies (630,631). The mechanism of FTY720 induced cell death is still not clear. 
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FTY720 could induce apoptosis or non-apoptotic cell death through either caspase-dependent or -
independent pathways (632,633).   
SKI-II is an inhibitor of both SphK1 and SphK2 and was discovered in 2003 (539). A recent study showed 
that SKI-II inhibits acute myelogenous leukaemia cell growth in vitro and in vivo (540). The incubation 
of AML cells with SKI-II, resulted in an increase of the ceramide:S1P ratio and in higher sensitivity of 
AML cells to daunorubicin (499). This inhibitor has also been shown to induce apoptosis of T cell large 
granular lymphocytic leukemia cells in a dose-dependent manner but not of normal peripheral blood 
mononuclear cells (634).  
Collectively, these data suggest that inhibitors of the sphingosine kinase pathway might represent a 
novel strategy in the treatment of hematologic malignancies. However, it is important to study the 
effect of these inhibitors in the other cells, since sphingolipid metabolism has been shown to be 
involved in several biological processes. Of particular interest, is to understand how SphK inhibitors 
affect NK cell function, since they have a crucial role in tumour surveillance.  
Previous reports demonstrated that S1P pathway might be important for the regulation of NK cell 
migration and sphingolipid metabolism seems to be involved in NK cell activation (487,505,506). 
Therefore, I investigated the effect of FTY720 and SKI-II, and consequently of the inhibition of 
sphingosine kinase pathway, on NK cell response to human leukemic K562 cells in vitro.  
 
FTY720 
FTY720 (Fingolimod) is a sphingosine analogue that is synthetically derived from myriocin (ISP-1), a 
metabolite isolated from fungus Isaria Sinclairii (534,535). FTY720 becomes active following 
phosphorylation by sphingosine kinases 1 and 2 to form FTY720-phosphate (536). Studies performed 
in vivo and in vitro showed that SphK1 and SphK2 phosphorylate FTY720, with SphK2 being 
quantitatively the more important enzyme in producing the active form FTY720-P (453). 
Phosphorylated FTY720 acts as an agonist for four of the five known S1P receptors, S1P1, S1P4 and 
S1P5 (EC50 values of 0.3-0.6 nM) and S1P3 (EC50 values of 3 nM) (536). FTY720-P is also a functional 
antagonist of S1P1, leading to internalization and degradation of this specific S1P receptor (472,537). 
In addition, FTY720 possess SphK1-, but not SphK2-inhibiting properties (538). 5μM was shown to 
inhibit 70% of SphK1 activity in rodent heart cytosolic fractions and in prostate cancer cells (538,635).  
FTY720 is a potent immunosuppressive drug and was approved by the U.S. Food and Drug 
Administration as a first line oral therapy for relapsing-remitting multiple sclerosis (636,637). Some 
studies performed using this drug showed that FTY720 supresses T and B cell egress from lymphoid 
organs (479), increases the radio therapeutic sensitivity of prostate cancer cells and reduces tumour 
growth and metastasis without toxic side effects (635). An in vivo study, found that NK cell trafficking 
190 
 
requires the S1P5 receptor, however FTY720 treatment did not affect the trafficking of these cells in 
mice (487). 
 
 
Figure 96: FTY720 (Fingolimod) structure 
 
SKI-II 
SKI-II [2-(p-hydroxyanilo)-4-(p-chlorophenyl)thiazole] is a potent sphingosine kinase inhibitor (539). 
Treatment of cells with this compound results in reduction of SphK1 activity and reduction of 
intracellular S1P levels (540,541). SKI-II has been reported to cause an irreversible inhibition of SphK1 
by inducing its lysosomal and/or proteasomal degradation (542). SKI-II has been extensively used to 
study the involvement of SphK1 and S1P in different cellular processes (543–545).  
In addition, there is an increasing interest in the use of this SphK inhibitor for cancer therapy 
(540,541,638). A recent study demonstrated that SKI-II induces potent apoptotic death in primary 
human AML cells and in vivo supress growth of U937 leukemic xenograft tumours in severe combined 
immunodeficient (SCID) mice. 1 and 10 μM of SKI-II showed to inhibit primary AML cell proliferation 
and 5 μM dramatically inhibits SphK1 activity in these cells (540). SKI-II has been widely cited as a 
specific SphK1 inhibitor, however it has been shown that this compound also inhibits SphK2 (546). SKI-
II does not inhibit ERK2, PI3-kinase or PKCα at concentrations up to 60 μM (539).  
 
 
Figure 97: SKI-II structure 
 
6.2 Toxicity assessment of FTY720 and SKI-II inhibitors on NK cells 
Prior to performing the functional assays using SKI-II and FTY720 inhibitors, it was necessary to assess 
the cytotoxic effect of these inhibitors on NK cells. Cytotoxicity of SKI-II and FTY720 in human primary 
NK cells, was assessed performing the trypan blue dye exclusion assay, AnnexinV/7-AAD staining assay 
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and using the Zombie Aqua dye staining. Different concentrations of these two inhibitors were 
analysed in order to choose the best concentrations to proceed with the functional assays.  
 
6.2.1 Toxicity of FTY720 on NK cells  
The trypan blue dye exclusion assay was performed to test the toxicity of two different concentrations 
of FTY720 in primary human NK cells. Isolated NK cells were incubated with 5 μM and 10 μM FTY720 
for 5 hours and cell viability was determined at 0hrs, 1h, 3hrs and 5hrs. Trypan blue dye exclusion 
assay did not show any cytotoxic effect of 5 μM or 10 μM FTY720 in NK cells (appendix 1). However, 
in order to confirm these results, a more sensitive assay was performed using the AnnexinV/7-AAD 
staining. Isolated NK cells were incubated with 2.5 μM, 5 μM and 10 μM FTY720 for 6 hours (appendix 
1). Comparing the percentage of live, apoptotic and necrotic cells in the negative control with NK cells 
incubated with 2.5 μM and 5 μM of FTY720, results showed that there is no toxic effect of this inhibitor 
on the cells at these concentrations. However, 10 μM of FTY720 was shown to be toxic to NK cells with 
a significant reduction in the percentage of live cells and an increase in the percentage of necrotic 
cells. FACS analysis performed using Zombie Aqua dye viability staining demonstrated that 5 μM 
FTY720 was not toxic for NK cells (Figure 98). FTY720 stock is in DMSO, so in order to exclude a possible 
toxicity of the vehicle, the negative controls were incubated with the vehicle at the same dilution used 
for the drug.  
Based on the results obtained with Annexin-V/7-AAD assay and also on previous studies published by 
other groups (503), 5 μM FTY720 was used for further functional studies.  
 
Figure 98: Analysis of the cytotoxicity of 5μM FTY720 on NK cells. NK cells were incubated with A) 
DMSO or B) 5 μM of FTY720 for 5h. After incubation time, cells were collected and cell viability was 
assessed using Zombie Aqua dye. Cells were analysed by FACS. These FACS plots are representative of 
three independent experiments. 
 
6.2.2 Toxicity of SKI-II on NK cells  
Trypan blue dye exclusion assay was performed to test the toxicity of two different concentrations of 
SKI-II in human primary NK cells. Isolated NK cells were incubated with 5 μM and 10 μM SKI-II for 5 
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hours and cell viability was determined at 0hrs, 1h, 3hrs and 5hrs. Trypan blue dye exclusion assay did 
not show any cytotoxic effect of 5 μM or 10 μM SKI-II in NK cells (appendix 1). However, in order to 
confirm these results, a more sensitive assay was performed using the AnnexinV/7-AAD staining. 
Isolated NK cells were incubated with 2.5 μM, 5 μM and 10 μM SKI-II for 6 hours. Comparing the 
percentage of live, apoptotic and necrotic cells in the negative control with NK cells incubated with 
2.5 μM and 5 μM of SKI-II, results showed that there was no toxic effect of this inhibitor on the cells 
at these concentrations. Two independent experiments showed that 10 μM of SKI-II was not 
significantly toxic for NK cells, however further assays with higher concentrations showed a significant 
increase in the percentage of necrotic cells for this concentration (appendix 1). Based on these results, 
5 μM SKI-II was used for further functional studies. FACS analysis performed using Zombie Aqua dye 
viability staining showed that 5 μM SKI-II was not toxic for NK cells (Figure 99). SKI-II stock is in DMSO, 
so in order to exclude a possible toxicity of the vehicle, the negative controls were incubated with the 
vehicle at the same dilution used for the drug.  
 
 
Figure 99: Analysis of the cytotoxicity of 5μM SKI-II on NK cells. NK cells were incubated with A) 
DMSO or B) 5 μM of SKI-II for 5h. After incubation time, cells were collected and cell viability was 
assessed using Zombie Aqua dye. Cells were analysed by FACS. These FACS plots are representative of 
three independent experiments. 
 
6.3 Sphingosine kinases and S1P receptors contribute to cytokine production in NK cells 
Natural killer cells play a critical role in host immunity against cancer. NK cells rapidly recognize and 
kill malignantly transformed cells without prior sensitization. NK cell response to tumour cells is 
mediated by direct cytotoxicity and by cytokine and chemokine release (639). The K562 cell line is 
often used to study specific features of NK cell activation since the co-incubation of NK cells with this 
cell line, results in both cytotoxicity response and cytokine production (640). In order to assess the 
impact of the inhibition of SphKs and S1P receptors in NK cell-response to cancer cells, induced by SKI-
II and FTY720 respectively, primary human NK cells were incubated with K562 cell line at an Effector : 
Target (E:T) ratio of 1:1.  
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I analysed the effect of these two inhibitors in the ability of NK cells to produce cytokines and also in 
the ability to release the cytotoxic granules in response to K562 cells. My results showed that SphK1, 
SphK2 and S1P receptors contribute to NK cell cytokine production in response to K562 cells. NK cell 
pre-incubation with SKI-II or FTY720, resulted in significant reduction in IFN-γ and TNF-α production 
by NK cells in response to K562 cell line (Figures 100 and 102). My results suggest that the sphingosine 
kinase pathway is required for optimal cytokine production by NK cells in response to cancer cells. 
Figure 100:  SKI-II inhibitor supresses IFN-γ and TNF-α production in primary human NK cells. Human 
NK cells were isolated from healthy donors using NK cell isolation kit (human) from Miltenyi Biotec. 
Isolated NK cells were pre-incubated with DMSO or 5 μM of SKI-II for 1 h, washed and incubated with 
K562 cells at an E:T ratio of 1:1 for 5 hours. After incubation, the cells were collected and washed with 
PBS. Cells were stained with surface antibodies CD56 and CD3 and after permeabilization were 
incubated with IFN-γ and TNF-α antibodies. Intracellular expression of A) IFN-γ and B) TNF-α by NK 
cells was determined by FACS analysis. Graphs show mean ± SEM of IFN-γ and TNF-α expression. 
Statistical analysis was performed using the Student’s paired t-test. n=8, *p<0.05, **p<0.01 
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Figure 101: Example of FACS plots showing the gating strategy to analyse intracellular expression of 
TNF-α and IFN-γ by primary human NK cells. A) NK cells non stimulated; B) NK cells incubated with 
K562 cells at an E:T ratio of 1:1; C) NK cells incubated with K562 cells at an E:T ratio of 1:1 after NK cell 
pre-incubation with 5μM SKI-II. 
195 
 
 
Figure 102: FTY720 inhibitor supresses IFN-γ and TNF-α production in primary human NK cells. 
Human NK cells were isolated from healthy donors using NK cell isolation kit (human) from Miltenyi 
Biotec. Isolated NK cells were pre-incubated with DMSO or 5 μM of FTY720 for 1 h, washed and 
incubated with K562 cells at an E:T ratio of 1:1 for 5 hours. After incubation time, the cells were 
collected and washed with PBS. Cells were stained with surface antibodies CD56 and CD3 and after 
permeabilization were incubated with IFN-γ and TNF-α antibodies. Intracellular expression of A) IFN-
γ and B) TNF-α by NK cells was determined by FACS analysis. Graphs show mean ± SEM of IFN-γ and 
TNF-α expression. Statistical analysis was performed using the Student’s paired t-test. n=9, **p<0.01 
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Figure 103: Example of FACS plots showing the gating strategy to analyse intracellular expression of 
TNF-α and IFN-γ by primary human NK cells. A) NK cells non stimulated; B) NK cells incubated with 
K562 cells at an E:T ratio of 1:1; C) NK cells incubated with K562 cells at an E:T ratio of 1:1 after NK cell 
pre-incubation with 5μM FTY720. 
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6.4 Sphingosine kinase signalling pathway does not mediate NK cell degranulation in response to 
K562 cells  
In addition to cytokine production, upon activation NK cells initiate a very important mechanism of 
cytotoxicity characterized by the release of cytotoxic granules containing perforin, granzymes and 
granulysin. The wall of these granules contains a range of lysosomal-membrane-associated 
glycoproteins including CD107a, which protect the NK cells from the granules contents. CD107a has 
been extensively used as a marker of NK cell functional activity, allowing the identification of cell 
degranulation (68). In order to determine if SphKs and S1P receptors are involved in the NK cell 
degranulation process, primary human NK cells were incubated with K562 cells at an E:T ratio of 1:1 
for 5 hours after 1 hour pre-incubation with DMSO, 5 μM FTY720 or 5 μM SKI-II. NK cell degranulation 
was assessed measuring CD107a expression on NK cell surface by FACS. My results showed that the 
inhibition of SphKs or the blocking of S1P receptors did not reduce the percentage of NK cell 
degranulation in response to K562 cells (Figures 104 and 105). These data suggest that sphingosine 
kinase pathway was not involved in NK cell degranulation.  
 
 
Figure 104: SKI-II do not inhibit NK cell degranulation. Human NK cells were isolated from healthy 
donors using NK cell isolation kit (human) from Miltenyi Biotec. Isolated NK cells were pre-incubated 
with DMSO or 5 μM of SKI-II for 1 h, washed and incubated with K562 cells at an E:T ratio of 1:1 for 5 
hours. CD107a antibody was added at the beginning of the co-incubation. After incubation time, the 
cells were collected and washed with PBS. Cells were stained with surface antibodies CD56 and CD3 
and CD107a expression by NK cells was determined by FACS analysis. Graph shows mean ± SEM of 
CD107a expression. Statistical analysis was performed using the Student’s paired t-test. n=5 
198 
 
 
Figure 105: FTY720 do not inhibit NK cell degranulation. Human NK cells were isolated from healthy 
donors using NK cell isolation kit (human) from Miltenyi Biotec. Isolated NK cells were pre-incubated 
with DMSO or 5 μM of FTY720 for 1 h, washed and incubated with K562 cells at an E:T ratio of 1:1 for 
5 hours. CD107a antibody was added at the beginning of the co-incubation. After incubation time, the 
cells were collected and washed with PBS. Cells were stained with surface antibodies CD56 and CD3 
and CD107a expression by NK cells was determined by FACS analysis. Graph shows mean ± SEM of 
CD107a expression. Statistical analysis was performed using the Student’s paired t-test. n=5 
 
6.5 FTY720 inhibits NK cell-mediated cytotoxicity against K562 cells 
To assess the impact of the two inhibitors, FTY720 and SKI-II, in the functional efficacy of NK cells, the 
NK cell-mediated cytotoxicity against K562 cell line was analysed. NK cells were incubated with K562 
cell line and K562 cell death was determined by FACS, using the Zombie Aqua dye staining.  
The inhibition of S1P receptors on NK cells, using FTY720, resulted in a significant reduction on the 
percentage of K562 dead cells. However, the inhibition of SphKs, using SKI-II, did not reduce the 
percentage of K562 cells killed by NK cells (Figure 106).  
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Figure 106: FTY720 inhibits NK cell-mediated cytotoxicity against K562 cells. Human NK cells were 
isolated from healthy donors using NK cell isolation kit (human) from Miltenyi Biotec. Isolated NK cells 
were pre-incubated with DMSO, 5 μM SKI-II or 5 μM FTY720 for 1 h, washed and incubated with K562 
cells at an E:T ratio of 1:1 for 5 hours. After incubation time, the cells were collected and washed with 
PBS. Cells were stained with surface antibodies CD56 and CD3 in order to gate NK cell population, and 
with Zombie Aqua dye to discriminate dead cells. Analysis of K562 cell death was performed by FACS. 
Graph shows mean ± SEM of K562 cell death. Statistical analysis was performed using the Student’s 
paired t-test. n=4, *p<0.05 
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Figure 107: Example of FACS plots showing results from one experiment assessing the effect of 
FTY720 and SKI-II on NK cell ability to kill K562 cells. A) NK cells incubated with K562 cells at an E:T 
ratio of 1:1 after NK cell pre-incubation with DMSO; B) NK cells incubated with K562 cells at an E:T 
ratio of 1:1 after NK cell pre-incubation with 5μM FTY720; C) NK cells incubated with K562 cells at an 
E:T ratio of 1:1 after NK cell pre-incubation with 5μM SKI-II.  
 
6.6 K562 cells induce SphK1 gene expression in NK cells  
The results obtained using FTY720 and SKI-II inhibitors, indicate that sphingosine kinase signalling 
pathway is required for cytokine production in NK cell response to K562 cell line. To date, two 
functional SphK isoenzymes, SphK1 and SphK2, have been characterized in mammalian cells (446,447). 
SphK1 is the best characterized sphingosine kinase and it is known to be involved in IL-18-induced IFN-
γ production in primary human NK cells (505). To evaluate the involvement of the sphingosine kinase 
pathway during NK cell activation, I investigated the SphK1 gene expression profile in NK cell response 
to K562 cells. NK cells were incubated with K562 cells at an E:T ratio of 1:1 for 1h, 2hrs, 4hrs and 6hrs. 
After various incubation times, cells were collected and sorted in order to isolate live NK cells. SphK1, 
IFN-γ and TNF-α mRNA expression was determined in the collected live NK cell population. As 
expected, the incubation with K562 cells, rapidly induced IFN-γ and TNF-α mRNA expression in NK 
cells. Quantification of mRNA expression after 1h co-incubation, showed an increase of ten-fold and 
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thirty two-fold in IFN-γ and TNF-α mRNA expression levels, respectively. For the following time points 
it was observed a gradual reduction in cytokine mRNA expression levels. After 6 hours co-incubation, 
the expression of IFN-γ and TNF-α was still significantly higher comparing with non-stimulated NK cells. 
Quantification of SphK1 mRNA levels, showed a significant increase in SphK1 mRNA expression in NK 
cells incubated with K562 cells. It was observed a gradual increase in SphK1 mRNA expression levels 
with increasing incubation time. Co-incubation of NK cells with the K562 cell line resulted in a 
significant increase of SphK1 expression in NK cells, with data showing a two-fold increase after 1 hour, 
four-fold increase after 2 hours, twelve-fold increase after 4 hours and twenty six-fold increase after 
6 hours.  
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Figure 108: TNF-α, IFN-γ and SphK1 expression in NK cells after stimulation with K562 cells. NK cells 
were incubated with K562 at an E:T ratio of 1:1 for 1h, 2hrs, 4hrs and 6 hrs. After incubation time cells 
were collected and sorted in order to collect the NK cell live population. Total RNA was extracted and 
analysed for A) TNF-α, B) IFN-γ and C) SphK1 mRNA levels by RT-PCR. mRNA levels are expressed as 
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absolute copies normalised for β-actin. TNF-α and IFN-γ mRNA expression rapidly increased when NK 
cells were incubated with K562 cells. SphK1 expression in NK cells was significantly up-regulated after 
1h incubation with K562 and continues increasing with longer co-incubation times. Bar graphs 
represent mean + SEM from 4 technical replicates. This data is representative of three independent 
experiments. Statistical analysis was performed using the Student’s unpaired t-test. *p< 0.05, 
**p<0.01, ***p<0.001 
 
 
Sample 
Copies of IFN-γ mRNA 
/ 105 β-actin  
(Mean ± SEM) 
Copies of TNF-α mRNA 
/ 105 β-actin  
(Mean ± SEM) 
Copies of SphK1 mRNA 
/ 105 β-actin  
(Mean ± SEM) 
 
NK cells (NS) 
 
 
15790 ± 5840  
 
1605 ± 143.8 
 
992.2 ± 46.96 
 
NK cells + K562 cells (1h) 
 
 
175100 ± 12830 
 
52650 ± 3107 
 
1841 ± 72.99 
 
NK cells + K562 cells (2h) 
 
 
146300 ± 7679 
 
44020 ± 4465 
 
3831 ± 698.4 
 
NK cells + K562 cells (4h) 
 
 
115900 ± 15350 
 
22670 ± 5201 
 
12130 ± 873.2 
 
NK cells + K562 cells (6h) 
 
 
33780 ± 4387 
 
6172 ± 1155 
 
26590 ± 2119 
Table 8: Table represents the mean ± SEM for TNF-α, IFN-γ and SphK1 mRNA expression in NK cells 
after stimulation with K562 cells. NK cells were incubated with K562 at an E:T ratio of 1:1 for 1h, 2hrs, 
4hrs and 6 hrs. After incubation time cells were collected and sorted in order to collect the NK cell live 
population. Total RNA was extracted and analysed for TNF-α, IFN-γ and SphK1 mRNA levels by RT-PCR. 
mRNA levels are expressed as absolute copies normalised for β-actin. Values represent mean + SEM 
from 4 technical replicates. This data is representative of three independent experiments. 
 
Analysis of SphK1 mRNA showed an upregulation on SphK1 gene expression during NK cell response 
to K562 cell line, suggesting that SphK1 enzyme is involved in NK cell response.  
 
6.7 K562 cells induce SphK1 protein expression in NK cells 
Gene expression analysis suggested that SphK1 might be involved in NK cell response. In order to 
evaluate if the upregulation observed in SphK1 mRNA expression resulted in an increase at protein 
levels, SphK1 protein expression in NK cells was assessed by confocal microscopy after 2hrs, 4hrs and 
6hrs of stimulation with K562 cell line. A specific SphK1 antibody was used in order to detect this 
kinase by confocal microscopy and images were analysed using Image J. The analysis performed using 
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Image J allowed calculation of the following quantitative parameters: area, mean, minimum, 
maximum and median intensity (Figure 109). The results are expressed in mean intensity*total area. 
This specific approach was used since the analysis by confocal microscopy allowed the assessment of 
SphK1 protein expression specifically in NK cells without the need of sorting the cells to separate the 
two cell populations (Figure 110) and using this technique the number of cells required was much 
lower. This approach was previously used by Lin et al. to determine SphK1 protein expression in 
amoeboid microglial cells, a nascent monocyte-derived brain macrophage, when activated with 
lipopolysaccharide (LPS) (641).  
The analysis of SphK1 protein expression in several NK cells at different time points, showed an 
increase in SphK1 protein expression in NK cells when incubated with K562 cells after 4hrs, but without 
reaching statistical significance (Figure 111). Despite not reaching statistically significance, these 
results reinforce the hypothesis that SphK1 enzyme is involved in NK cell response to K562 cell line. 
Further analysis by Western blot is required to confirm this increase in SphK1 protein levels. 
 
 
 
 
Figure 109: Example of data analysis using Image J software. The above examples show the detailed 
analysis of SphK1 expression in two confocal images. A) NK cells non stimulated; B) NK cell incubated 
with K562 cells for 4 hours. 3D images of NK cells from 9 fields of view were obtained by confocal 
microscopy. SphK1 staining is indicated in green and the nuclei are indicated in blue. To accurately 
reflect the quantity of SphK1 expressed in each NK cell analysed, the same threshold was used for all 
NK cells from the same donor. Quantitative analysis was performed using Image J and quantitative 
parameters, such as area, mean, minimum, maximum and median intensity were calculated.  
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Figure 110: Image obtained by confocal microscopy showing two NK cells and one K562 cell. NK cells 
are easily distinguished from K562 cells on confocal microscopy images since they are of different 
sizes. This fact allows the analysis of SphK1 protein expression in NK cell population without the need 
of sorting. SphK1 staining is indicated in green and the nuclei are indicated in blue. 
 
 
Figure 111: SphK1 protein expression in NK cells incubated with K562 cell line. NK cells were 
incubated with K562 at an E:T ratio of 1:1 for 2hrs, 4hrs and 6 hrs. After incubation time, cells were 
collected, washed and permeabilized. Cells were span onto a microscope slide and stained with SphK1 
antibody. SphK1 protein expression was assessed by confocal microscopy and quantified using Image 
J. Results are expressed in mean intensity*total area. Data was calculated from 6 fields of view taken 
randomly and box plot whiskers represent minimum and maximum value. This data is representative 
of two independent experiments. 
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6.8 Activating receptors involved in K562 cell line recognition by NK cells 
NK cells express a wide repertoire of activating receptors involved in NK cell interaction with target 
cells. The recognition of K562 cells by NK cells results in NK cell activation since the K562 cell line does 
not express MHC class I molecules resulting in the absence of inhibitory signals. NK cell interaction 
with K562 cells is mediated by several activating receptors, resulting in NK cell activation and target 
killing. Activating receptors such as CD16, NKG2D, NKp46 and NKp30 have been identified to be 
involved in the NK cell cytotoxic response to the K562 cell line (566,642). I also observed that NKG2D, 
NKp30 and CD16 are implicated in NK cell interaction with K562 cells. FACS analysis showed that the 
incubation of NK cells with K562 cell line results in significant reduction in expression of NKG2D, NKp30 
and CD16 activating receptors on the NK cell surface (Figure 112). 
 
 
Figure 112: NKG2D, NKp30 and CD16 receptors are involved in K562 cell line recognition by NK cells. 
Primary human NK cells were incubated with K562 cells overnight at an E:T ratio of 1:1. The expression 
of A) NKG2D, B) NKp30 and C) CD16 receptors in NK cells was determined by FACS analysis. The 
incubation of NK cells with K562 cell line results in significant reduction in expression of NKG2D, NKp30 
and CD16 activating receptors on NK cell surface. Bar graphs represent mean + SEM from 2 technical 
replicates. These data are representative of three independent experiments. Statistical analysis was 
performed using the Student’s unpaired t-test. ***p<0.001 
 
6.9 Activation of specific receptors on NK cells to dissect sphingosine kinase pathway  
In order to determine the contribution of sphingosine kinase pathway in signalling pathways initiated 
by specific activating receptors in NK cells, I performed an antibody-dependent cytotoxicity assay. This 
assay was previously described by Bryceson et al. and consists in the activation of NK cells using 
purified antibodies that engage to specific receptors on NK cell surface to induce cytokine production 
and cytotoxicity (119). In the study published by Bryceson et al., it was demonstrated that most NK 
cell receptors are unable to function independently and require the engagement of synergistic 
receptors in order to achieve NK cell activation. CD16 receptor was the only activating receptor able 
to independently induce NK cell activation (119). Using the same approach I used purified antibodies 
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to specifically activate CD16, NKp30 and NKG2D receptors. To induce NK cell activation via CD16 
receptor, NK cells were incubated in CD16-coated plates; to induce NK cell activation via NKG2D 
receptor, NK cells were incubated in NKG2D/2B4-coated plates; and to induce NK cell activation via 
NKp30 receptor, NK cells were incubated in NKp30/2B4-coated plates. 2B4 purified antibody was used 
to activate the 2B4 receptor since NKG2D and NKp30 activation do not induce NK cell activation 
without a co-receptor (119). After incubation, IFN-γ and TNF-α production was measured by FACS.  
SKI-II is known to inhibit specifically SphKs, without interfering with other kinases function at 
concentrations up to 60 μM (539). FTY720 inhibits the function of S1P1, S1P3, S1P4 and S1P5 receptors 
and may also inhibit SphK1 function in NK cells at a concentration of 5μM. To determine the 
contribution of the sphingosine kinase pathway in the signalling initiated by specific activating 
receptors in NK cells, I decided to use SKI-II inhibitor since its inhibition is more specific, allowing more 
accurate conclusions.  
CD16 induced a strong cytokine response in NK cells that was significantly inhibited when NK cells 
were pre-incubated with SKI-II, suggesting that the activation of NK cell cytokine response via CD16 
receptor requires the activity of sphingosine kinases (Figure 113). The purified antibodies for NKp30, 
together with 2B4, induced a significant but not strong cytokine response in NK cells. The pre-
incubation with SKI-II did not result in inhibition of IFN-γ or TNF-α production (Figure 114).  NKG2D 
together with 2B4 purified antibodies did not induce significant cytokine production in NK cells (Figure 
115).  
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Figure 113: IFN-γ and TNF-α expression in NK cells activated with CD16 antibody in presence or 
absence of SKI-II. Primary human NK cells were pre-incubated with DMSO or 5 μM SKI-II for 1 h, 
washed and incubated for 5hrs in wells coated with CD16 antibody. After incubation, the cells were 
collected and washed with PBS. Cells were stained with surface antibodies CD56 and CD3 and after 
permeabilization were incubated with IFN-γ and TNF-α antibodies. Intracellular expression of IFN-γ 
and TNF-α was determined by FACS analysis. Bar graphs represent mean + SEM from 2 technical 
replicates. This data is representative of three independent experiments. Statistical analysis was 
performed using the Student’s unpaired t-test. **p<0.05 
 
 
Figure 114: IFN-γ and TNF-α expression in NK cells activated with NKp30 and 2B4 antibodies in 
presence or absence of SKI-II. Primary human NK cells were pre-incubated with DMSO or 5 μM SKI-II 
for 1 h, washed and incubated for 5hrs in wells coated with NKp30 and 2B4 antibodies. After 
incubation time, the cells were collected and washed with PBS. Cells were stained with surface 
antibodies CD56 and CD3 and after permeabilization were incubated with IFN-γ and TNF-α antibodies. 
Intracellular expression of IFN-γ and TNF-α was determined by FACS analysis. Graphs show the mean 
± SEM of IFN-γ and TNF-α production. Statistical analysis was performed using the Student’s paired t-
test. n=3 
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Figure 115: IFN-γ and TNF-α expression in NK cells activated with NKG2D and 2B4 antibodies in 
presence or absence of SKI-II. Primary human NK cells were pre-incubated with DMSO or 5 μM SKI-II 
for 1 h, washed and incubated for 5hrs in wells coated with NKG2D and 2B4 antibodies. After 
incubation time, the cells were collected and washed with PBS. Cells were stained with surface 
antibodies CD56 and CD3 and after permeabilization were incubated with IFN-γ and TNF-α antibodies. 
Intracellular expression of IFN-γ and TNF-α was determined by FACS analysis. Graphs show the mean 
± SEM of IFN-γ and TNF-α production. Statistical analysis was performed using the Student’s paired t-
test. n=3 
 
6.10 Discussion 
The sphingolipid metabolic pathway has been reported to play a key role in cancer pathogenesis, 
progression, angiogenesis, migration and drug resistance of tumour cells (489–491). SphK1 and SphK2 
play a key role in regulating sphingolipid metabolism, making these enzymes potential targets for 
cancer therapy. During the last decade, several studies have focused on the development and 
evaluation of numerous SphKs inhibitors and some of them have already been demonstrated to 
possess anticancer activity (495,496,625–627). Two specific inhibitors of the sphingolipid signalling 
pathway, have aroused special interest in acute myeloid leukaemia treatment, FTY720 and SKI-II. 
These two inhibitors were demonstrated to induce apoptosis in AML cells and showed to supress 
xenograft tumour growth in mouse models (540,629). Despite the promising therapeutic potential of 
these inhibitors, their impact on NK cell responses to cancer cells have not been explored. SphK 
signalling pathways have been shown to be involved in several biological processes including cell 
proliferation, survival, apoptosis as well as regulation of inflammatory responses and cytokine 
production (436,444,643,644). Previous reports demonstrated that S1P pathway might be important 
for the regulation of NK cell migration and sphingolipid metabolism seems to be involved in NK cell 
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activation (487,505,506). I investigated the effect of FTY720 and SKI-II, and consequently of the 
inhibition of sphingosine kinase pathway, on NK cell response to human leukemic K562 cells in vitro.  
Analysis of in vitro cytotoxicity of FTY720 and SKI-II in NK cells, showed that both compounds have 
similar cellular toxicity. Incubation of NK cells with 5 μM FTY720 and SKI-II did not result in reduction 
of cell viability, while 10 μM induced an increase in the percentage of necrotic cells. Notably, the in 
vivo studies showing the inhibition of AML cell growth in xenograft model, used very different 
concentrations of FTY720 and SKI-II. Chen et al, demonstrated that the injection of 5mg/Kg of FTY720 
reduced the AML cell growth in a xenograft model by 60% (629). The same extent of reduction was 
observed by other group injecting 50mg/Kg of SKI-II (540). These results suggest that FTY720 is a more 
potent compound but also more toxic in vivo.   
NK cell-mediated effector functions include target cell killing through directed release of lytic granules 
and immunoregulation via secretion of cytokines, such as IFN-γ and TNF-α. To characterize the impact 
of the inhibition of sphingosine kinase signalling, induced by FTY720 and SKI-II, in NK cell function, I 
assessed the effect of the presence of these inhibitors in NK cell degranulation, cytokine production 
and killing efficiency.  
The incubation of NK cells with FTY720 and SKI-II, at a non-cytotoxic concentration, results in impaired 
cytokine production by NK cells in response to K562 cell line. FTY720 had a stronger inhibitory effect 
in NK cell cytokine production, inducing a higher reduction in the percentage of cells expressing IFN-γ 
and TNF-α. These results are in agreement with the more potent effect of this compound also 
observed in vivo.  
I also assessed the effect of SKI-II and FTY720 on NK cell response via release of cytotoxic granules. My 
results show that these inhibitors do not significantly reduce NK cell degranulation in response to a 
cancer cell line.  
It is not surprising that FTY720 and SKI-II showed to impair cytokine production and do not interfere 
with cytotoxic response since several studies have suggested that cytokine production and release of 
cytotoxic granules in NK cells are mediated by different intracellular pathways (557,645,646). 
Moreover, it was reported that cytokines and lytic granules are trafficked and secreted via different 
pathways (99).  
NK cells are the first line of defence against tumours and one of the key functions of these cells is their 
ability to kill the targets. The analysis of the efficiency of NK cells to kill the targets is fundamental to 
determine the importance of a specific pathway on their function, therefore the impact of both 
inhibitors on NK cell-mediated cytotoxicity against K562 cells was also analysed. The pre-incubation 
of NK cells with FTY720 resulted in a significant inhibition of NK cell-mediated killing, but no effect was 
observed for SKI-II. Despite no inhibitory effect of FTY720 on NK cell degranulation, the main process 
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responsible for NK cell-mediated target killing, this compound significantly reduced cytokine 
production by NK cells. Previous reports have demonstrated that IFN-γ plays an important role 
mediating cell death. This cytokine showed to synergistically enhance NK cell cytotoxicity against THP-
1 and Kasumi-1 cells, demonstrated to sensitize prostate cancer cells to Fas-mediated death and 
induced cell death of H6 hepatoma and L929 fibrosarcoma cell lines (647–649). NK cell-mediated K562 
cell killing was not affected by NK cell treatment with SKI-II, possibly because the reduction in cytokine 
production is not so accentuated, comparing with the inhibition observed for FTY720. The reduction 
in cytokine production with SKI-II, might not be strong enough to result in the reduction of NK cell 
efficiency to kill target cells. 
In summary, these data demonstrates that the sphingosine kinase inhibitors impair the NK cell 
cytokine response. However, only FTY720 was found to impair NK cell-mediated target cell killing. My 
results indicate that the use of SKI-II inhibitor in acute myeloid leukaemia treatment would be a better 
option regarding NK cell function. In addition, these results suggest that sphingosine kinase signalling 
pathway contributes to NK cell proinflammatory cytokine production in response to K562 cell line.  
In order to confirm the involvement of SphK1 in NK cell response to K562 cells, SphK1 gene and protein 
expression was evaluated. SphK1 gene expression showed to be gradually upregulated in NK cells 
when co-incubated with K562 cell line. This gradual increase, suggests that SphK1 might be involved 
in the late stages of cytokine production such as protein production and/or release. The analysis of 
protein levels by immunofluorescence is not conclusive but suggests that there is an increase in SphK1 
protein expression. Futher analysis by Western blot is required to draw a concrete conclusion. Two 
studies performed in microglia and amoeboid microglial cells showed an increase in SphK1 gene and 
protein expression upon treatment with LPS and demonstrated that suppression of SphK1 reduced 
TNF-α production (641,643).  
Overall, the results obtained suggest that SphK1 might be involved in NK cell cytokine production in 
response to cancer cells. 
The analysis of the contribution of sphingosine kinase pathway, following NK cell activation via specific 
activating receptors, showed that the cytokine response initiated by activation of the CD16 receptor 
is significantly reduced when SphK1 and SphK2 are inhibited by SKI-II, suggesting that this signalling 
pathway is involved in NK cell activation via this receptor. CD16 is an important NK cell activating 
receptor that mediates antibody-dependent cellular cytotoxicity by binding to the Fc portion of IgG 
but have also shown to mediate cytotoxicity independent of antibody ligation (181). Upon interaction 
with specific ligands, CD16 receptor initiates an intracellular signalling pathway binding to ITAM-
containing adaptor proteins, such as FcεRIγ and CD3ζ, followed by the recruitment and activation of 
the tyrosine kinase Syk (650). Following Syk activation, downstream pathways are initiated via 
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activation of PI3K, PLC-γ, p38 MAPK and ERK1/2 and the elevation of intracellular Ca2+ levels is induced 
(115,119,651–653). Actually, previous studies have demonstrated an important role of sphingolipid 
pathway triggering Ca2+ release from internal stores (426,427) and have shown that SphKs interact 
with PI3K, PLC-γ, p38 MAPK and ERK1/2 in different cells (449,654–656). Overall, this observations 
together with my results suggest that SphKs might have an important role in CD16-mediated NK cell 
activation. 
Although the obtained data do not define the molecular basis for the SphKs pathway in NK cell 
responses, the results indicate that SphKs are likely to be involved in cytokine production pathway in 
NK cells. In addition, the functional assay using purified CD16 antibody to activate NK cell cytokine 
expression, constitutes a robust assay for future investigations of the role of this pathway in NK cell 
response. 
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7. Conclusions and Future work 
7.1 Conclusions 
The phenotypic analysis of NK cells in response to A. fumigatus, showed that the interaction between 
NK cells and the fungus in vitro, results in a major downregulation of CD56 expression on NK cell 
surface as a consequence of the internalization of this glycoprotein. The induction of CD56 
downregulation, showed to be dependent on the direct contact between the cells and the fungus and 
on the pathogen viability, and occurs also in the presence of other populations of PBMCs. It was also 
observed that A. fumigatus induces CD56 downregulation on NK cells co-cultured with K562 cell line, 
together with a significant inhibition in IFN-γ production. The inhibitory effect of A. fumigatus on IFN-
γ production by NK cells, has been previously reported for IL-2 pre-stimulated NK cells (372). 
Interestingly, a study focused on the process of NK cell differentiation, demonstrated that acquisition 
of CD56 and IFN-γ expression occurs at the same time in the process of developmental progression in 
vitro (657). More, the CD56brightCD16- NK cell subset is characterized by the great ability to produce 
IFN-γ and TNF-α that during the NK cell maturation process is lost, together with the reduction of CD56 
expression in the CD56dimCD16bright subset (31,33). The function of CD56 glycoprotein in NK cells is 
unclear but some studies have suggested that it is involved in both homophilic and heterophilic 
adhesion and might play an important role in the process of target cell killing (548,549). In addition, 
CD56neg NK cell population, highly frequent in HIV-1 and HCV patients, is characterized by impaired 
capacity to kill target cells and to produce IFN-γ but maintaining the ability to produce chemokines 
(550–552). Studies performed in a neutropenic mouse model showed that NK cells are the major 
source of IFN-γ in the lungs during aspergillosis (368) but curiously mouse NK cells do not express CD56 
glycoprotein (658). Overall, my results together with the impaired NK cell function observed in the 
CD56neg NK cell population in HIV-1 and HCV patients, suggest that the induction of CD56 
internalization might represent a novel mechanism of immune evasion for A. fumigatus, with the 
fungus inhibiting NK cell effector function.  
The co-incubation of NK cells with A. fumigatus also results in the downregulation of important 
activating receptors, such as NKG2D and NKp46 suggesting that these receptors are involved in the 
process of interaction between NK cells and the fungus. The only activating receptor able to 
independently induce NK cell activation without requiring the engagement of synergistic receptors is 
CD16 receptor (119)  and my results demonstrated that this receptor is not involved in the recognition 
of A. fumigatus by NK cells.  
The detailed analysis of NK cell interaction with A. fumigatus in vitro, showed that NK cells adhere to 
the fungus, accumulate F-actin at the immune synapse and polarize the lytic granules, containing 
perforin and granulysin, towards A. fumigatus. The quantification of CD107a expression on the NK cell 
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surface, showed that a significant percentage of NK cells degranulate in response to A. fumigatus. 
However, no significant increase in perforin or granzyme B levels was observed in the supernatant of 
NK cells and A. fumigatus co-cultures. It has been reported that polarization of the lytic granules is not 
equivalent to a commitment to their secretion, with several more events being required before the 
granules fuse with the plasma membrane and their content is released into the synaptic cleft. More, 
the fusion of granule content can be incomplete with the formation of a transient fusion pore at the 
plasma membrane accompanied by release of some but retention of most of the granule contents 
(66). This might explain the fact that despite the significant increase in CD107a expression on the NK 
cell surface when challenged with A. fumigatus, no significant increase in perforin or granzyme B levels 
was detected. On the other hand, degranulation might also result in the release of other cytotoxic 
molecules that were not determined during my studies. 
Incubation of NK cells with A. fumigatus in vitro, induces the secretion of important chemokines, 
including MIP-1α, MIP-1β and RANTES that have been shown to play an important role as 
chemoattractants and coactivators for monocytes/macrophages and lymphocytes (84–86). These 
results suggest that NK cells might have an important role in the recruitment of other immune cells to 
the site of infection once they recognize the fungus in the host. Interestingly, the CD56neg NK cell 
population observed in HIV and HCV patients maintain the ability to produce chemokines in response 
to the targets (659). Analysis of cytokine production by NK cells in response to A. fumigatus, showed 
that NK cells do not produce IFN-γ or TNF-α in response to the fungus in vitro.  
Regardless of the possible inhibitory effect of A. fumigatus, several studies have revealed a hierarchy 
in terms of the strength of the activating stimuli for induction of specific responses in NK cells. The 
process of adhesion exhibits a low threshold for activation, induction of chemokines requires stronger 
activating stimuli, whereas degranulation and production of cytokines displays the most stringent 
requirements for induction (47–49). These observations may also be the explanation for the fact that 
the interaction between NK cells and A. fumigatus results in cell adherence, granule polarization and 
chemokine release but no perforin, granzyme B or cytokines secretion. The interaction between NK 
cell receptors and A. fumigatus antigens might result in low affinity interactions and consequently in 
low receptor activation. The analysis of phenotypic changes on NK cell surface, showed that activating 
receptors such as NKG2D and NKp46 are involved in the NK cell interaction with A. fumigatus. 
However, this interaction does not seem to be strong enough to activate cytokine secretion and 
secretion of perforin or granzyme B. 
Analysis of NK cell antifungal activity, showed that the interaction between NK cells and A. fumigatus 
do not result in the reduction of fungal viability or inhibition of fungal metabolism. However, live 
imaging analysis using PI, suggests that NK cells might induce damage on A. fumigatus. More, the 
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quantification of fungal DNA in the supernatant of co-cultures of A. fumigatus and NK cells showed a 
significant increase in fungal DNA release from A. fumigatus when NK cells are present, but the 
increase was less than two-fold. It would be important to understand if the small increase in fungal 
DNA release induced by the presence of NK cells, results in a significant activation of other cells 
because the induction of fungal DNA release might represent an important immune mechanism by 
which NK cells induce the activation of other immune cells including neutrophils, dendritic cells, 
macrophages, T cells and B cells. CpG-rich DNA motifs have been described as the natural ligands for 
TLR9 receptor (600–602) and this interaction has been demonstrated to induce the activation of 
neutrophils, dendritic cells, macrophages, T cells and B cells (606–610). Studies performed with fungal 
DNA have shown that deoxynucleic acids from A. fumigatus, C. albicans and C. neoformans directly 
activate dendritic cells (9–11). Fungal DNA release might result from the action of perforin or from the 
action of other molecules that are constitutively released from NK cells when in the presence of IL-2. 
In conclusion, the action of NK cells alone was demonstrated to be insufficient to contain A. fumigatus 
growth, however NK cells may contribute to the immune response against this fungus through the 
recruitment of other immune cells to the site of infection and through the induction of immune cell 
activation mediated by fungal DNA.   
The functional characterization of NK cell response in AML patients, has demonstrated that NK cells 
from these patients have an impaired effector function against autologous blasts and K562 targets, 
with significantly reduced CD107a degranulation, TNF-α and IFN-γ production (407). The functional 
analysis of NK cells from AML patients, showed that NK cells maintain their ability to interact with A. 
fumigatus, adhere to the fungus and polarize their lytic granules. This may be due to the fact that all 
these mechanisms have a low threshold for activation and NK cells in AML patients might retain the 
ability to initiate the early steps of NK cell activation. It was also observed that NK cells from AML 
patients maintain the ability to induce fungal DNA release. However, this mechanism that might 
contribute to A. fumigatus elimination in healthy donors through the activation of important myeloid 
cells that are able to recognize fungal DNA, might not be as relevant in AML patients since myeloid 
cells are dysfunctional and unable to initiate an effective immune response against pathogens. 
Complementary experiments would be necessary to confirm this hypothesis.   
The adoptive transfer of NK cells is being thoroughly investigated as a therapeutic tool for acute 
myeloid leukaemia (611). Transplantation of alloreactive NK cells has been shown to control myeloid 
leukaemia relapse and to improve engraftment without causing graft-versus-host disease (5,6). In 
addition to the potential to eradicate AML cells, it has been suggested that the adoptive transfer of 
NK cells could also be an attractive strategy in the prophylaxis or treatment of common infections in 
these patients. The characterization of the NK cell response to A. fumigatus, indicates that the infusion 
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of NK cells on their own would be unable to control A. fumigatus infection in AML patients. However, 
novel approaches are being developed aiming to maximize NK cell efficacy, including genetic 
manipulation of their specificity (612). This, leaves open the possibility of the use of genetically 
modified NK cells in order to improve their cytotoxicity against A. fumigatus, namely through the 
induction of expression of specific receptors. Nevertheless, the efficacy of NK cell immunotherapy 
would also be dependent on the possible inhibitory effect of A. fumigatus on NK cells.  
Another therapeutic approach of special interest in acute myeloid leukaemia treatment, is the use of 
SphKs inhibitors in order to suppress the sphingolipid metabolic pathway, that has been reported to 
play an important role in cancer pathogenesis, progression, angiogenesis, migration and drug 
resistance of tumour cells (489–491). I characterized the impact of the inhibition of sphingosine kinase 
signalling, induced by FTY720 and SKI-II, in NK cell function, and I assessed the effect of the presence 
of these inhibitors in NK cell degranulation, cytokine production and killing efficiency. Both inhibitors 
were shown to impair the NK cell cytokine-mediated response but showed no effect on NK cell 
degranulation in response to K562 cell line. FTY720 had a stronger inhibitory effect on NK cell cytokine 
production, inducing a higher reduction in the percentage of cells expressing IFN-γ and TNF-α. These 
results are in agreement with the more potent effect of this compound also observed in vivo. The 
impact of both inhibitors on NK cell-mediated cytotoxicity against K562 cells was also analysed and 
showed that the pre-incubation of NK cells with FTY720, results in a significant inhibition of NK cell-
mediated killing, but no effect was observed for SKI-II. Overall, my results suggest that the use of SKI-
II inhibitor, as a combined therapy, in AML treatment would be a better option regarding NK cell 
function. In addition, my observations suggest that sphingosine kinase signalling pathway is involved 
in NK cell cytokine response. Supporting this idea, the analysis of SphK1 gene expression showed that 
the expression of the SphK1 gene is gradually upregulated in NK cells when co-incubated with the 
K562 cell line. This gradual increase, suggests that SphK1 might be involved in the late stages of 
cytokine production such as protein production and/or release. Similar observations were reported in 
microglia and amoeboid microglial cells, with LPS inducing SphK1 gene and protein expression and 
suppression of SphK1 resulting in significant reduction of TNF-α production (641,643). The specific 
activation of NK cell cytokine production via CD16 receptor, also showed to be inhibited by SKI-II, 
suggesting that sphingosine kinase signalling pathway is involved in NK cell activation via this receptor.  
In conclusion, the action of NK cells alone has been shown to be insufficient to contain A. fumigatus 
growth but a possible role of NK cells in the immune defence against A. fumigatus cannot be entirely 
excluded since they demonstrated to release important chemokines involved in cell recruitment and 
cell activation. 
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The role of NK cells in A. fumigatus infection might be indirect, through the recruitment of immune 
cells to the site of infection, the induction of immune cell activation mediated by fungal DNA, the 
elimination of infected cells or/and through the release of cytotoxic molecules upon activation by 
circulating cytokines or chemokines.  
 
7.2 Future work 
Research over the last years has provided strong evidence that pathogens have evolved several 
strategies to evade the host immune system. These strategies not only aim to avoid pathogen killing 
but are also important to promote pathogenesis. The mechanisms of immune evasion are subtle and 
highly diverse and have been described for all major parasite groups, such as fungi, viruses and 
bacteria (564,660–664). My results, together with previous observations published by other groups, 
suggest that the induction of CD56 internalization might represent a novel mechanism of immune 
evasion for A. fumigatus, with the fungus being able to inhibit NK cell effector function. In order to 
confirm this hypothesis, it would be important to block specifically CD56 glycoprotein on the NK cell 
surface, using a blocking antibody, followed by functional analysis of NK cells, including cytokine 
production and degranulation. This analysis could be performed by FACS, ELISA or Luminex multiplex 
assay and would allow to determine if CD56 blocking results in impaired NK cell effector function. 
However, if NK cell inhibition is dependent on CD56 internalization, this approach would not be able 
to address that question. Another assay that could help to understand the role of CD56 in the 
interaction between NK cells and A. fumigatus, would be the in vitro co-culture of mouse NK cells with 
the fungus, followed by the measurement of cytokine production and degranulation. Mouse NK cells 
do not express CD56 on their surface but express NKG2D and NKp46 activating receptors (658), that 
have been shown to be involved on the NK cell interaction with A. fumigatus.  
In order to characterize, even in more detail, the phenotypic changes induced by A. fumigatus on NK 
cell surface, other activating receptors could be analysed such as NKp44, 2B4 and NKG2C.  
The analysis of NK cell degranulation showed that despite the significant increase in CD107a 
expression on NK cells surface when challenged with A. fumigatus, no perforin or granzyme B were 
secreted by NK cells. It would be important to determine if NK cell degranulation results in the release 
of other cytotoxic molecules that are also stored in the lytic granules, such as granulysin, granzyme A 
and granzyme K.  
NK cells from AML patients demonstrated to maintain the ability to interact with A. fumigatus, adhere 
to the fungus and polarize the lytic granules. Unfortunately, due to the low number of NK cells 
obtained after cell isolation from AML samples, it was not possible to determine NK cell ability to 
produce chemokines as a result of the interaction with A. fumigatus. It would be important to 
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determine if NK cells from AML patients produce chemokines when challenged with A. fumigatus, in 
order to assess their ability to recruit other immune cells to the site of infection.  
The incubation of NK cells from healthy donors and AML patients with A. fumigatus showed to induce 
a significant increase in fungal DNA release from the fungus. However, calculating the fold change 
between the concentrations determined in the supernatant of A. fumigatus cultures and in the 
supernatant of co-cultures of A. fumigatus and NK cells, the fungal gDNA release increased by less 
than two-fold. In order to determine the biological relevance of these observations two assays could 
be performed. One would consist in the incubation of isolated neutrophils or dendritic cells with the 
supernatant collected from A. fumigatus cultures and the supernatant collected from co-cultures of 
A. fumigatus and NK cells, followed by the comparative analysis of cell activation between the two 
conditions. The other assay that could be performed to understand the impact of small changes of 
fungal DNA concentration on the levels of cell activation, would be the incubation of neutrophils or 
DC with different concentrations of A. fumigatus DNA, followed by the analysis of cell activation. Cell 
activation could be determined by quantification of cytokine release by ELISA or by the analysis of 
specific cell surface activation markers by FACS. 
The incubation of NK cells with FTY720 and SKI-II results in impaired cytokine production by NK cells 
in response to K562 cell line. This inhibitory effect was also observed when NK cells are activated via 
CD16 activating receptor, with SKI-II significantly inhibiting NK cell cytokine response. My observations 
suggest that sphingosine kinases are involved in the cytokine production pathway in NK cells. The 
antibody-dependent cellular cytotoxicity assay (ADCC) using CD16 antibody to specifically activate the 
CD16 activating receptor, it seems to be a good approach to dissect sphingosine kinase signalling 
pathway in NK cells, since cytokine production was strongly induced via this receptor and significantly 
reduced when SphKs were inhibited with SKI-II. Proteins such as PI3K, PLC-γ and ERK1/2 are known to 
mediate SphK1-dependent response in other cells (464,654,655). A detailed westernblot analysis, 
using specific antibodies and protein inhibitors, would allow to dissect the sphingosine kinase 
signalling pathway in NK cell cytokine response, when cells are activated via CD16 receptor. Such 
experiments were not performed and should be the subject of future work. 
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9. Appendices 
 
9.1 Supplementary figures 
 
 
Figure 116: Cytotoxicity of different concentrations of FTY720 on NK cells. NK cells were incubated 
with DMSO, 5 μM or 10 μM of FTY720. Cell viability was assessed at different time points by trypan 
blue dye exclusion. Data are mean ± SEM of two technical replicates. This data is representative of 
two independent experiments. 
 
 
 
Figure 117: Cytotoxicity of different concentrations of FTY720 on NK cells. NK cells were incubated 
with DMSO, 2.5 μM, 5 μM or 10 μM of FTY720 for 6h. After incubation time, cells were collected and 
cell viability was assessed using Annexin V/7-AAD staining kit. Cells were analysed by FACS. Bar graph 
shows mean + SEM. This data is representative of three independent experiments. Statistical analysis 
was performed using the Student unpaired T-test. *p<0.05, **p<0.01, ***p<0.001 
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Figure 118: Cytotoxicity of different concentrations of SKI-II on NK cells. NK cells were incubated with 
DMSO, 5 μM or 10 μM of SKI-II. Cell viability was assessed at different time points by trypan blue dye 
exclusion. Graph shows mean ± SEM of two technical replicates. This data is representative of two 
independent experiments. 
 
 
Figure 119: Cytotoxicity of different concentrations of SKI-II on NK cells. NK cells were incubated with 
DMSO, 2.5 μM, 5 μM, 10 μM or 20 μM of SKI-II for 6h. After incubation time, cells were collected and 
cell viability was assessed using Annexin V/7-AAD staining kit. Cells were analysed by FACS. Bar graph 
shows mean + SEM. This data is representative of two independent experiments. Statistical analysis 
was performed using the Student unpaired T-test. *p<0.05 
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Figure 120: Blast analysis comparing CD56 protein sequence with all known proteins expressed by 
Aspergillus fumigatus. SH3 domain protein was found to have significant homology.  
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Figure 121: Alignment for human CD56 and A. fumigatus SH3 domain protein. Analysis was 
performed using EMBOSS Needle tool.  
